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ABSTRACT 
 
Transforming growth factor-β1 (TGF-β1) is implicated in inflammation and airway wall 
remodeling in inflammatory airway disease. Oxidative stress has also been implicated in the 
pathogenesis of inflammatory lung disorders. Reactive oxygen species (ROS), such as 
hydrogen peroxide (H2O2), in the airway may activate intracellular signalling cascades and 
transcription factors to exaggerate lung inflammation. The balance between nuclear histone 
acetylation/deacetylation has also been shown to be altered by oxidative stress and may 
further upregulate lung inflammation.  
The aim of this thesis was to determine whether ROS, alone or in combination with 
interleukin (IL)-1, can modulate TGF-1 expression in lung epithelial cells and whether the 
effect was regulated by histone methylation. 
Stimulation of human airway epithelial cells (A549) with H2O2 or H2O2 plus IL-1 
enhanced TGF-1 mRNA and total protein expression. IL-1 and H2O2 together showed a 
greater than additive effect on TGF-1 mRNA transcription, but not on the total protein level. 
The NF-B-IKK2 inhibitor AS602868 suppressed IL-1- and H2O2 plus IL-1-induced TGF-
1 mRNA expression. NF-B p65 protein was also shown to be upregulated by IL-1β plus 
H2O2 stimulation. Chromatin immunoprecipitation (ChIP) experiments demonstrated that p65 
was recruited to the B3 binding site on the native TGF-β1 promoter area. The upregulation 
of TGF-1 mRNA by IL- plus H2O2 could be suppressed by fluticasone propionate (FP) 
although to the same extent as seen with IL-1-stimulated TGF-1 mRNA expression. This 
suggests that H2O2 induced a relative steroid insensitivity. 
Both Suv39H1 protein level and mRNA expression were downregulated by IL-1β and 
H2O2 stimulation. Knockdown of Suv39H1 with siRNA transfection induced a trend towards 
increased TGF-ß1 mRNA expression upon stimulation with IL-1β and H2O2. Suv39H1 was 
shown to be recruited to glucocorticoid receptor by co-immunoprecipitation. The anti-
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inflammatory effect of FP was impaired under Suv39H1 knockdown which indicate that 
Suv39H1 may act as a corepressor of GR function. 
DNA methylation is also involved in epigenetic regulation of gene expression. IL-1β and 
H2O2 stimulation rapidly upregulated CpG methylation at specific sites in the TGF-1 
promoter as demonstrated by direct sequencing after bisulphite treatment and by methylation 
dependent immunoprecipitation study (MeDIP).  Methylation at the ATG start start induced 
by IL-1 was reversed over time indicating an active demethylation. 
These results indicate that H2O2, acting via the NF-B pathway, increases TGF-ß1 
mRNA production and that this is regulated by FP possibly through an effect on the histone 
methyltransferase, Suv39H1. DNA methylation is also involved in the regulation of IL-1β 
plus H2O2 induced TGF-β1 mRNA expression. 
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CHAPTER ONE 
GENERAL INTRODUCTION
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BACKGROUND TO THE PROJECT 
1.1 Chronic inflammatory airway disease 
Many airway diseases are characterized by chronic inflammation resulted from multiple 
insults. Among them, asthma and chronic obstructive pulmonary disease (COPD) are two of 
the world's most prevalent diseases (O'Byrne and Postma, 1999). Both asthma and COPD are 
identified by the presence of characteristic symptoms and functional abnormalities with 
airway obstruction being the main feature. The inflammatory process in COPD is very 
different from that in asthma with different inflammatory cells, mediators, inflammatory 
effects and response to therapy (Barnes, 2000b). 
In COPD, the airway obstruction is believed to result from a chronic inflammatory 
process mainly occurring in the small airway which leads to airway scarring and narrowing 
(Barnes, 2003). Reduced lung recoil, which relates to the emphysematous destruction of the 
lung parenchyma, is also due to the presence of chronic inflammatory which further 
compromises pulmonary function (Ogawa et al., 2004). In acute asthma, mucus plugging in 
the small airways and acute airway inflammation results from the exaggerated lower airway 
response to an environmental exposure leading to airway obstruction (Wark and Gibson, 
2006). However, in chronic asthma, persistent airway obstruction results from airway 
remodelling with airway thickening due to basement membrane thickening, increased 
vascularity, mucous gland hypertrophy and smooth muscle hyperplasia (Vignola et al., 2003). 
In most asthmatics, the occurrence of airway inflammation is in response to allergenic 
stimulation which is characterized by an eosinophilic inflammation with the predominant 
involvement of mast cells and CD4+ T-lymphocytes (Fabbri et al., 2003). By contrast, 
inflammation in COPD is a response to noxious stimuli, such as cigarette smoke, and is 
characterized by a neutrophilic inflammation mediated by macrophages and CD8+ T-
lymphocytes (Barnes, 2000a). 
At sites of lung inflammation and injury, numerous resident and recruited cell types, 
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including activated macrophages, eosinophils, platelets, epithelial cells, and fibroblasts, 
release TGF-β1 (Chung, 2001) which in turn regulates many pathological changes in 
pulmonary disorders. 
 
 
1.2 TGF-1 and its role in inflammatory airway disease 
The TGF- superfamily consists of a diverse range of proteins that regulate many 
different physiological processes including embryonic development, homeostasis, wound 
healing chemotaxis and cell cycle control. There are three TGF- isoforms in humans - TGF-
1, TGF-2 and TGF-3 - the amino acid sequences of which are 70–80% homologous but 
encoded by distinct genes located on chromosomes 19q13.1-q13.3, 1q41 and 14q24, 
respectively (Prime et al., 2004). TGF-1 is expressed in epithelial, hematopoietic and 
connective tissue cells; TGF-2 in epithelial and neuronal cells and TGF-3 primarily in 
mesenchymal cells (Massague, 1998). TGF- isoforms are synthesized as latent precursors 
complexed with latent TGF- binding proteins (LTBP-1, -3, and -4).  
TGF- is synthesized as a pre-pro-protein (pre-pro-TGF-) (Fig. 1.1). After proteolytic 
processing in rough endoplasmic reticulum, two TGF- monomers are dimerized via a 
disulphide bond to form pro-TGF-. After cleavage by furin convertase, the mature protein 
forms non-convalent bonds with the latency associated peptide (LAP) to form the small 
latency complex (SLC). The large latent TGF- complex (LLC) is subsequently formed by 
covalent attachment of SLC with the large latent binding protein (LTBP). TGF- is activated 
by extracellular proteolytic cleavage of its carboxyl-terminal pro-region to which LTBP is 
bound thereby removing LTBP (Annes et al., 2003). 
TGF- itself cannot bind to its receptors in the latent form and must be liberated from 
the constraints of LAP and LTBP. In vitro, the activation can be achieved by using low PH 
(Jullien et al., 1989), heat, some proteases (Annes et al., 2003) or exposure to reactive oxygen 
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species (Barcellos-Hoff and Dix, 1996). In vivo, the mechanism is less clear, but possibly 
includes proteolytic activation by transglutaminase (Nunes et al., 1995), conformational 
change of LAP through physical interaction with thrombospondin (Crawford et al., 1998) or 
by mechanical traction via αvβ6 integrins (Munger et al., 1999). 
The TGF-β1 promoter contains both binding sites for the redox-sensitive transcription 
factors activator protein (AP)-1 and nuclear factor kappaB (NF-B), which are both involved 
in the transcriptional regulation of TGF-β1. TGF-β1 itself can induce c-Jun and c-Fos which 
bind to their respective binding sites to further stimulate TGF-β1 production in a feedforward 
manner (Kim et al., 1990; Kim et al., 1989). Interestingly, c-Jun-NH2-terminal kinase 1 and 2 
(JNK1 and JNK2), the kinases that activate AP-1 activity, can both inhibit TGF-β1 expression 
in fibroblasts (Ventura et al., 2004) which suggests that AP-1 may play a dual role in the 
regulation of TGF-β1. NF-B is also involved in interleukin (IL)-1-induced transcriptional 
regulation of TGF-β1 in airway epithelial cells (Lee et al., 2006). Post-transcriptional or post-
translational regulation has also been reported for TGF-1 and this often results in 
discrepancies between changes in mRNA and protein levels (Allison et al., 1998; Kim et al., 
1992). 
 TGF- β1 is the isoform commonly implicated in inflammation and is upregulated in 
response to lung injury. Elevated expression of TGF-1 occurs in a number of pulmonary 
disease such as COPD (de Boer et al., 1998; Takizawa et al., 2001), asthma (Redington et al., 
1997a; Vignola et al., 1997) as well as pulmonary fibrosis (Khalil et al., 1996). A significant 
increase in TGF-β1 expression in the mucosa and submucosal cells in asthmatic and chronic 
bronchitis patients was found by immunohistochemistry and in situ hybridization of TGF-β1 
mRNA, (Vignola et al., 1997). The numbers of TGF-β1+ve cells were also associated with 
basement membrane thickness and fibroblast numbers. In COPD patients, it was also shown 
that the expression of TGF-β1 mRNA and protein in the airway epithelium also correlate with 
the presence of intraepithelial macrophages (de Boer et al., 1998). These findings suggest that 
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TGF-β1 is actively involved in chronic inflammatory lung disease. 
 
 
Figure 1.1 Schematic model of TGF-β regulation of synthesis and secretion. TGF-β is 
synthesized as a pre-pro-TGF-β form. After proteolytic processing in the rough endoplasmic 
reticulum, two TGF-β monomers are dimerized by the formation of disulphide bonds to 
produce pro-TGF-β. After cleaved by furin convertase, the latency associated peptide (LAP) 
and mature protein are bound together by non-convalent bonds to form the small latency 
complex (SLC). The large latency complex (LLC) is formed by covalent attachment of the 
SLC with the large latent binding protein (LTBP). Through the interaction with extracellular 
matrix, LLC is cleaved by proteolytic reaction allowing the release of mature TGF-.  
Important molecules involved in this process including elastase, bone morphogenetic protein-
1 (BMP1) and matrix metalloproteinase 2 (MMP2). TGF-β can bind to the TGFBR2 and 
ALK5 receptors to induce intracellular signalling.  
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1.3 The role of IL-1β and NF-B in inflammatory lung disease 
During inflammation, both resident and recruited cells can release a plethora of 
inflammatory mediators that result in clinical symptoms. IL-1 is one of the key cytokines 
involved in driving the inflammatory response in many chronic inflammatory diseases 
(Dinarello, 2009). Importantly, IL-1β levels are elevated in induced sputum from stable 
COPD patients (Keatings et al., 1996) and also observed from alveolar macrophages from 
cigarette smokers and COPD patients (Lim et al., 2000). The effects of IL-1 are mediated by 
the type I IL-1 receptor (IL-1RI) (Sims et al., 1988). Upon binding to IL-1RI, IL-1 stimulates 
the production of a series of proinflammatory proteins including enzymes, adhesion 
molecules, chemokines and acute-phase proteins (Dunne and O'Neill, 2003). 
Currently, there are 11 members of the IL-1 family (IL-1F) of ligands (Dinarello, 2009). 
IL-1β (IL-1F2) has been well studied in vivo, in disease, and in animal models and acts as an 
agonist; while IL-1Ra (IL-1F3) plays a role as a receptor antagonist for IL-1RI, which 
inhibits both effect of IL-1 and IL-1β. Both IL-1 and IL-1β bind to IL-1RI, which is 
recognized as a part as an interleukin-1 receptor/toll-like receptor superfamily and is involved 
in host defense and inflammation (O'Neill and Greene, 1998). There are major four protein 
kinase cascades which can be activated by IL-1 namely NF-B, p38 mitogen activated 
protein kinase (MAPK), extracellular regulated kinase (ERK)1 and ERK2, and JNK 
pathways (Dunne and O'Neill, 2003).  
The activation of NF-B by IL1RI is initiated by forming a complex containing myeloid 
differentiation primary response gene (MyD)88, IL-1R-associated kinase (IRAK)1 and 
IRAK-2 (Cao et al., 1996a; Wesche et al., 1997) (Fig 1.2). IRAK-1 recruits TNF receptor-
associated factor (TRAF)-6 (Cao et al., 1996b) which further attracts TGF-β-activated kinase 
(TAK1)-binding protein (TAB-2) and forms a complex which is able to activate TAK-1 
(Takaesu et al., 2000). Activation of TAK-1 triggers activation of the inhibitor of IB (IKK) 
complex and the NFB pathway. The IKK complex is composed of IKK, IKKβ and a 
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scaffold protein IKK (or NF-B essential modulator, NEMO). In most cell types, NF-B 
dimmers are retained in the cytoplasm by IBs, which are specific inhibitors that bind to the 
Rel-homology domain (RHD) and interfere with NF-B’s nuclear localization sequence 
(NLS) function. IKK and IKKβ can phosphorylate IB on two serines, Ser32 and Ser36 
(Brown et al., 1995; DiDonato et al., 1996; Traenckner et al., 1995), leading to ubiquitination 
of IB and its subsequent proteasomal degradation.  The released NF-B dimer (mostly the 
p50-p65 dimer) translocates to the nucleus, binds to specific DNA binding sites in responsive 
genes and activates gene expression (Ghosh and Karin, 2002).  IKK complexes can also 
phosphorylated and regulate NF-B1 (p105/p50) and NF-B2 (p100/p52) precursor 
processing (Salmeron et al., 2001; Senftleben et al., 2001). 
NF-B is ubiquitously expressed and is activated by numerous extracellular stimuli, 
including cytokines such as TNF- and IL-1β. NF-B activation is seen in many lung 
diseases including Adult respiratory distress syndrome (ARDS), systemic inflammatory 
response syndrome, asthma, COPD and occupational and environmental lung disease 
(Christman et al., 2000). Further studies also support that concept that epithelial-specific NF-
B is important in the control of lung inflammation and injury. Thus, it is evident that IL-1β 
and the subsequent synchronized activation of the NF-B pathway is important in lung 
inflammation. 
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Figure 1.2 Activation of NF-B pathway by interleukin (IL)-1β. Binding of IL-1β to 
the type I IL-1 receptor (IL-1RI) triggers a phosphorylation cascade involving MyD88, IRAK 
family members, TRAF6 and the IKK complex. Activation of IKK and IKKβ 
phosphorylates IB leading to release and nuclear translocation of the p50/p65 complex. In 
the nucleus, p65 binds to DNA binding sites in the promoters of responsive genes resulting in 
coordinated expression of multiple genes.  
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1.4  Oxidative Stress 
Oxidative stress refers to a state characterized by either an excess production of reactive 
oxygen species (ROS) and/or a reduction in antioxidant defences responsible for the 
metabolism and elimination of ROS (Franco et al., 2008). Biological systems are exposed to 
various oxidant stresses whether generated exogenously e.g. environmental insults as air 
pollutants or cigarette smoke, or endogenously by metabolic reactions within mitochondria 
(Rahman and Adcock, 2006). Biologically important reactive oxygen species (ROS) include 
the superoxide anion radical (O2-), hydrogen peroxide (H2O2), the hydroxyl radical (OH-) and 
hypohalous acids such as HOCl (Chow et al., 2003). ROS causes oxidation of proteins, DNA 
and lipids, which may further cause direct cellular injury or induce a variety of cellular 
responses through the generation of secondary metabolic reactive species (Fig 1.3).  
Glutathione (GSH) metabolism is involved in the balance between pro-oxidant and 
antioxidant molecules; acts as defence against constant oxidative challenge and helps to 
maintain the cellular redox status (Forman and Dickinson, 2003). Recently, the role of two 
major redox forms, reduced GSH and glutathione disulphide (GSSG) has been clarified 
(Rahman, 2005a). The ratio of cytoplasmic GSH/GSSG has been implicated in a range of 
cellular processes, such as cellular signalling and gene expression, and can be used as an 
indicator of the cellular redox state (Ghezzi, 2005). Glutathione peroxidase reduces H2O2 to 
H2O by oxidising glutathione (Fig 1.4). The other enzyme, glutathione reductase, catalyzes 
the oxidized form of GSSG to GSH, to recycle the GSH and help to maintain the cellular 
redox status. 
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Figure 1.3 Mechanisms of reactive oxygen species (ROS)-mediated lung 
inflammation.  The cascade of proinflammatory chemokine and cytokine release activated in 
lung inflammation along with increased metabolic rate may upregulate oxidative stress and 
generate distinct types of ROS including free oxygen radicals, H2O2 etc. ROS may damage 
cell membranes resulting in increased lipid peroxidation and its products including reactive 
aldehydes and acrolein which may further activate lipid oxidation.  This results in a 
feedforward cycle leading to more lipid peroxidation products, increased DNA damage and 
enhanced protein modification. These lipid peroxidation products are also able to increase the 
expression of redox sensitive transcription factors and activate MAP kinase pathways. These 
changes trigger a vicious cycle, and further exaggerate lung inflammation. 
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Figure 1.4 The Glutathione Oxidation Reduction (Redox) Cycle. Both nicotinamide 
adenine dinucleotide phosphate (NADPH) and glutathione reductase is important for 
maintenance of GSH in active form. 
 
 
1.5 Role of oxidative stress in inflammatory airway disease 
The common source of ROS in the lung is from macrophages and neutrophils and 
numbers of these cells are elevated in the lung by cigarette smoke (Rahman and MacNee, 
1996). Activated macrophages may release mediators which further attract neutrophils and 
other inflammatory cells and generate more ROS in the airways. ROS are highly reactive and, 
when generated close to cell membranes, can induce lipid peroxidation (Uchida et al., 1999). 
These lipid peroxidation products, including malondialdehyde, 4-hydroxy-2-nonenal, acrolein 
and F2-isoprostanes, may abrogate cell membrane function; inactivate membrane-bound 
receptors and enzymes and further increase tissue permeability (Rahman, 2005b). 
 ROS can also lead to the activation of intracellular signalling cascades including 
members of the MAPK family such as the JNK and p38 MAPK kinases and the 
phosphatidylinositol 3-kinase (PI3K)/Akt pathway leading to increased gene transcription 
(Adler et al., 1999). ROS are able to activate the redox-sensitive transcription factors such as 
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NF-B (Adcock et al., 1994; Janssen-Heininger et al., 2000) and AP-1 (Xanthoudakis and 
Curran, 1996), which may be responsible, at least in part, for the amplified inflammatory 
response in chronic airway disease (Barnes and Karin, 1997; Hart et al., 1998). 
 The mechanisms that lead to activation of NF-B by oxidative stress may be cell 
specific. Several mechanisms are proposed for H2O2-induced NF-B activation. H2O2 may 
enhance the activity of IKKs through phosphorylation of Ser180 in IKK1 or of Ser 181 in 
IKK2 in HeLa cells (Jaspers et al., 2001; Kamata, 2002). Oxidative stress may also cause 
ubiquitination and phosphorylation of the IB complex and thereby cause subsequent IB 
degradation (Ginn-Pease, 1996). Additionally, proteosome enzymatic activity may also be 
affected by oxidative stress leading to activation of NF-B (Okada et al., 1999). A recent 
study also indicates that H2O2 may synergise with IL-1β in a process which involves IL-
R1/Nox2 action which activates TRAF6 and leads to IKK and NF-B activation (Li et al., 
2006c) (Fig 1.5). These findings indicate that in some cells oxidative stress induces the 
activation and translocation of NF-B to the nucleus and facilitates the binding of NF-B to 
DNA. 
Recent evidence has indicated that oxidative stress is also involved in gene transcription 
through effects on chromatin modifications and in particular on the relative activities of 
histone acetylation/deacetylation (Ito et al., 2004; Moodie et al., 2004; Tomita et al., 2003). 
This results in enhanced transcription of specific inflammatory genes. Oxidative stress 
reduces histone deacetylase 2 (HDAC2) protein expression probably through proteasomal 
targeting (Kramer et al., 2003) and results in elevated proinflammatory gene expression and 
reduced glucocorticoid action (Barnes et al., 2005). The role of other histone modifications, 
such as histone methylation, is not clear in this condition. 
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Fig 1.5 Synchronized involvement of H2O2 and IL-1β in NF-B activation.  Upon 
binding of IL-1β to the type I IL-1R (IL-1RI), it triggers a MyD88-dependent endocytosis of 
IL-1RI, and endosomal ROS formation, which further triggers TRAF6 action leading to 
activation of the NF-B pathway. This event is regulated through Nox2-dependent H2O2 
production.  
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1.6  Effect of corticosteroids on regulation of lung inflammation 
Corticosteroids are the most effective anti-inflammatory treatment for asthma and many 
other inflammatory airway diseases (Barnes and Adcock, 2003). Corticosteroids exert their 
effects by binding to a glucocorticoid receptor (GR) that is localized to the cytoplasm of 
target cells (Ito et al., 2006a). A single gene encodes human GR, but several variants e.g. 
GRα, GR, GR-A and GR-B etc, generated by alternative transcript splicing and/or 
alternative translation initiation have been recognized and implicated in modulating the 
function of the major isoform GR (Rhen and Cidlowski, 2005). GR may be modified by 
phosphorylation and other modifications which thereby alter the functional response to 
corticosteroids (Barnes, 2006). After corticosteroids have bound to GR, the activated GR-
corticosteroid complex is transported to the nucleus and binds to glucocorticoid response 
elements (GREs) within the promoter region of responsive genes leading to increased anti-
inflammatory gene transcription. This DNA-binding process has been postulated to not only 
induce an anti-inflammatory effect via transactivation but may also mediate some of the side 
effects of corticosteroids when activated GR binds to negative GREs or to GREs that cross 
the ATG start site (cis-repression effect) (Fig 1.6). 
Corticosteroids also suppress inflammatory gene expression through trans-repression 
effects on pro-inflammatory transcription factors such as NF-B and AP-1 (Barnes and Karin, 
1997). Recent studies have also indicated the GR may elicit its anti-inflammatory effects 
through changes in histone acetylation. Activated GRs may bind to NF-B which is 
associated with transcriptional co-activator proteins such as cAMP response element binding 
protein (CREB) binding protein (CBP) or other coactivators to inhibit their histone 
acetyltransferase (HAT) activity (Ito et al., 2000).  Alternatively, GR may recruit repressor 
proteins such as histone deacetylase (HDAC)2 to the activated NF-B transcriptional 
complex, resulting in deacetylation of histones and thereby repressing inflammatory genes 
(Ito et al., 2000). 
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Oxidative stress due to cigarette smoking is known to affect the response to 
glucocorticoids especially in COPD and some asthmatic patients (Chalmers et al., 2002; 
Culpitt et al., 1999; Culpitt et al., 2003). ROS may affect glucocorticoid receptor activation 
either directly or indirectly.  In primary human fibroblasts exposure to H2O2 can attenuate GR 
nuclear transport in response to dexamethasone in a time- and concentration-dependent 
manner (Okamoto et al., 1999). In addition, oxidative stress may also reduce the expression 
and activity of HDAC2 which may account for the reduced expression and activity observed 
in BAL macrophages from COPD patients.  This effect occurs without significantly 
modulating HAT activity (Ito, 2004; Ito et al., 2005). The mechanism by which oxidative 
stress reduces HDAC2 activity may involve increased tyrosine nitration of HDAC2, which is 
detected in healthy smokers and COPD patients, and is inversely correlated with HDAC2 
activity (Ito, 2004). 
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Fig 1.6 Corticosteroid actions on gene expression.  Corticosteroids enter the cell and 
bind to and activate cytoplasmic glucocorticoid receptors (GR) which translocate into the 
nucleus. GR homodimers may (i) bind to glucocorticoid response elements (GREs) in the 
promoter region and induce upregulation of anti-inflammatory genes; or (ii) bind to negative 
GREs and suppress gene expression. GR may also associate with coactivator molecules, such 
as cAMP-response element binding protein binding protein (CBP), p300/CBP-associated 
factor (pCAF) or steroid receptor coactivator (SRC)-2, which have histone acetyltransferase 
(HAT) activity. Activated GR can inhibit HAT activity and recruit histone deacetylase 
(HDAC)2 which reverses histone acetylation, leading to suppression of inflammatory genes.
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1.7  Chromatin template and histone code 
Chromatin is the physiological template of the genetic information that exists in almost 
all eukaryotic cells. It may present as a decondensed polymer (euchromatin) in interphase or 
in a highly compacted state (heterochromatin) that localizes to pericentric regions (Lachner 
and Jenuwein, 2002). Chromatin is made up of nucleosomes (Kornberg, 1974), which are 
structures consisting of 147 base pairs of DNA wrapped around an octamer of two molecules 
each of the core histone proteins (histones 2A, 2B, 3 and 4) (Luger et al., 1997). Strings of 
nucleosomes line up to generate an 11nm fibre which is further compacted into a 30nm fibre 
whose structure is stabilised, at least partially, through the incorporation of the linker 
molecule, histone H1 (Cheung et al., 2000; Jenuwein and Allis, 2001; Kouzarides, 2007; Li et 
al., 2007).  
Core histones are small, highly basic proteins whose amino-terminal tails extend through 
and beyond the DNA coil. These tails are subject to a variety of post-translational 
modifications including acetylation, phosphorylation, methylation, ubiquitation, ADP-
ribosylation, sumoylation, deimination and proline isomerisation (Kouzarides, 2007). The 
term “histone code” has been used to describe the role of these modifications in controlling 
gene expression through changes in chromatin structure (Jenuwein and Allis, 2001).  
The function of histone of modifications may be divided into two parts.  Firstly, global 
changes in histone methylation for example have been linked to the establishment of global 
chromatin environments, such as the formation of heterochromatin, where DNA is accessible 
to transcription, and to that of euchromatin, where DNA is inaccessible for transcription.  
Secondly, histone modifications are associated with the orchestration of DNA-based 
biological tasks (Kouzarides, 2007).  
Chromatin structure plays an important regulatory role and multiple signalling pathways 
converge on histones (Cheung et al., 2000). Covalent modifications of histone tails directed 
by DNA sequence-directed transcription factors allows the sequential recruitment of 
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transcriptional co-activator proteins, chromatin remodelling engines, basal transcription 
factors and RNA polymerase II and the initiation of gene expression.  This, therefore, not 
only provides a mechanism to enable histone proteins to translate the information encoded by 
the underlying DNA sequence but also importantly extends the amount of information that 
regulates the genome to beyond that present in the genetic code itself (Jenuwein and Allis, 
2001). 
It was initially proposed that post-translational modifications on histone tails altered the 
charge on the histone tail thereby modulating the electrostatic interaction between the 
negatively charged DNA and the positively charged histones and thus opening up the 
chromatin structure (Collingwood et al., 1999; Wolffe et al., 2000).  It is becoming clearer, 
however, that these post-translational marks also act as recruitment signals (e.g. bromo- and 
chromo-domains) for other transcriptional co-activators or remodelling enzymes that enable 
co-ordinated transcription to occur (Li et al., 2007). 
 This mechanism may also underlie, in part, the recent studies that indicate the existence 
of crosstalk between the various histone modifications. In addition to the synergistic effect of 
enzyme activity by second chromatin modification (Clements et al., 2003), other possible 
mechanisms include the disruption of protein binding by adjacent modifications (Fischle et 
al., 2005) and that the catalytic activity of the enzyme is compromised by modifications of its 
substrate recognition site (Nelson et al., 2006).  
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Figure 1.7 Schematic of the structure of histones in nucleosomes.  The core proteins of 
nucleosomes are designated H2A (histone 2A), H2B (histone 2B), H3 (histone 3) and H4 
(histone 4). Each histone is present in two copies, so that 147bp of DNA (black) wrap itself 
almost twice around an octamer of histones — the core nucleosome. 
 
 
1.8  Histone acetylation and inflammatory gene expression 
Transcriptional co-activators such as CBP, steroid receptor coactivators (SRC)-1 and 
p300/CBP associated factor (PCAF) have intrinsic histone acetyltransferase (HAT) activity 
and increased inflammatory/immune gene transcription is associated with an increase in 
histone acetylation at transcriptional start sites (Adcock et al., 2006; Wang et al., 2009) 
Changes in the acetylation status of specific lysine (K) residues in the N-terminal tails of 
histones 3 and 4 form a molecular tag for the recruitment of ATP-dependent chromatin 
remodelling enzymes such as Brg1 (Bilodeau et al., 2006) which allows local chromatin 
unwinding and the recruitment of other transcription factors, the basal transcriptional 
complex and RNA polymerase II (Adcock et al., 2006).  This general molecular mechanism 
is common to all genes, including those involved in differentiation, proliferation, DNA repair 
and activation of cells (Adcock et al., 2006).  
In general, acetylation of histones H3 and H4 along with histone H3 K4 methylation, 
results the formation of tags that allow subsequent recruitment of other transcriptional 
complexes, loosening of the local nucleosomal structure and gene transcription to occur 
(Wang et al., 2008).  These changes occur predominantly at the transcriptional start site 
(Wang et al., 2009): are closely associated with transcription factor DNA binding and gene 
expression (Heintzman et al., 2009) and appear invariant across many cell types in contrast to 
the greater variability seen in histone modifications in enhancer regions (Heintzman et al., 
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2009).  Less frequently transcribed genes have repressive marks, remain more tightly 
packaged and therefore less accessible to the transcriptional mechanisms of the cell (Lee et 
al., 2009; Wang et al., 2008).   
In contrast to the activation effect of acetylation, the removal of the acetyl group from 
the nucleosome, often in conjunction with a change in DNA methylation status, is associated 
with gene repression (Adcock et al., 2006). HDACs interact with corepressor molecules, 
which aid HDACs in gene repression and may provide specificity by selecting which genes 
are regulated by individual HDACs.  The balance between HAT and HDAC activity is a key 
component of gene expression including inflammatory gene expression. Evidence for a key 
role of HDACs in inflammatory gene expression is provided by the fact that HDAC inhibitors 
such as trichostatin A (TSA) enhance NF-B-driven inflammatory gene transcription in vitro 
in different cell types with many distinct stimuli (Adcock et al., 2006).  The development of 
selective HAT inhibitors such as anacardic acid provides further evidence for a key role of 
HAT activity in inflammatory gene expression in primary human cells within the airways 
(Wort et al., 2009). 
Changes in histone acetylation are involved in the induction of numerous pro-
inflammatory genes in human lung epithelial and smooth muscle cells (Adcock et al., 2006).  
In human airway smooth muscle (HASM) cells TNF-stimulated eotaxin release is 
associated with NF-B binding and histone H4 acetylation of the eotaxin gene promoter 
region (Nie et al., 2005).  In contrast IFN is able to markedly inhibit TNF-induced 
expression of the NF-B-sensitive genes IL-6, IL-8, and eotaxin (Keslacy et al., 2007).  IFN 
decreased TNF-induced p65-associated HAT activity and increased total nuclear HDAC 
activity.  Importantly, the HDAC inhibitor TSA prevented the inhibitory effect of IFN on 
TNF-induced gene expression.   
Allergic diseases are characterised by a TH2 dominant immune response and evidence 
suggests that HDACs maintain pre-established TH1-like and TH2-like immunity in human T-
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cells (Ruey-Chyi et al., 2008).  Phytohemagglutinin (PHA) activation selectively stimulates 
antigen-driven CD45RO(+) memory T cells, eliciting recall cytokine responses (Ruey-Chyi et 
al., 2008).  The HDAC inhibitor TSA provoked total cell hyperacetylation and led to 
increased TH2-associated IL-13 and IL-5 cytokine expression and reduced TH1-associated 
IFN and IP10-associated recall responses.  In addition, IL-2 and IL-10 production was also 
reduced.  TSA treatment shifted the TH1:TH2  ratio 3-8-fold, skewing the recall responses 
more towards a TH2 -like phenotype, independent of the stimulus used and highlighting the 
role of HDACs in the development and maintenance of TH1:TH2  immunity (Ruey-Chyi et al., 
2008).  Using overexpression and CAT-reporter genes, Lavender and colleagues (Jee et al., 
2005) have shown that GR reduced GATA-3-mediated IL-5 and -13 promoter activity in 
human CD4+ T-cells. The authors postulated that local recruitment of GR may alter the 
ability of GATA-3 either to bind to its target site, to cause transcriptional up-regulation, or to 
maintain an environment that is permissive for transcription. Overall, inflammatory stimuli 
including environmental agents, viral infection, and allergen exposure can lead to enhanced 
inflammatory gene expression and TH2 skewing as a result of changes in histone acetylation 
status.  Enhanced histone acetylation being associated with inflammation and reduced 
acetylation with decreased inflammation.  
This simple model is more complex as it is now clear using ChIP-seq (chromatin 
immunoprecipitation linked to high throughput sequencing) that HDACs are also associated 
with actively transcribed genes (Wang et al., 2009).  The relative level of HATs and HDACs 
at specific promoters allows active gene expression or can pause the gene for transcription. 
 
 
1.9 HDAC and HAT expression in chronic lung disease 
Altered HDAC/HAT activities have been reported in chronic lung diseases (Adcock et 
al., 2006).  Nuclear HDAC activity was reduced in PBMCs from patients with steroid 
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unresponsive asthma compared with steroid responsive asthmatic patients and, importantly, 
the reduced HDAC activity correlated directly with steroid insensitivity.  In addition, 
Hayglass and colleagues have recently reported that reduced HDAC/HAT activity correlated 
with increasing bronchial hyperresponsiveness in asthmatic children (Ruey-Chyi et al., 2009).  
However, reduced HDAC2 expression has not been seen in all steroid responsive asthmatic 
patients perhaps reflecting the heterogeneity of severe asthma phenotype (Celine et al., 2006).  
HDAC2 expression and activity is also decreased in asthmatics, smokers, smoking asthmatics 
(Adcock et al., 2006), patients with COPD (Adcock et al., 2006; Barnes et al., 2005; Ito et al., 
2006b) and in cystic fibrosis (Bartling and Drumm, 2009), all of which are known to be 
insensitive to the anti-inflammatory effects of glucocorticoids (Adcock et al., 2006).  In 
addition, there is a negative correlation between the repressive effect of dexamethasone on 
cytokine production and total HDAC activity in alveolar macrophages from smokers and 
non-smokers (Adcock et al., 2006).  Overexpression of HDAC2, but not HDAC1, in primary 
macrophages from COPD patients restored dexamethasone efficacy towards suppressing 
LPS-induced GM-CSF release to levels seen in cells from healthy control subjects (Ito et al., 
2006b).   
 
 
1.10 Histone lysine (K) methylation and the histone methyltransferase (HMT) Suv39H1 
Lysine methyltransferases have more site specificity when compared to histone 
acetyltransferases. Three methylation sites on histones are implicated in activation of 
transcription: H3K4, H3K36 and H3K79; while another three lysine methylation sites are 
connected to transcriptional repression, which includes H3K9, H3K27 and H4K20. 
Histone H3 K9 can be mono-, di- or tri- methylated (Shilatifard, 2006). Different 
HMTases have recently been found responsible for each modification state. G9a is thought to 
be responsible for all mono and di methylation of H3 K9 in silent regions of heterochromatin 
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(Tachibana et al., 2002). In contrast, Suv39H1 is thought to be responsible for the tri 
methylation of H3K9 found in pericentric heterochromatin (Nakayama et al., 2001). 
Repression of gene expression by H3K9 methylation involves the recruitment of methylating 
enzymes and heterochromatin protein 1 (HP1) to the promoter of repressed genes. But 
recently, H3K9 trimethylation and HP1 recruitment have been found to be enriched in the 
coding region of active genes (Vakoc et al., 2005). This indicates that H3K9 methylation may 
have a different function on gene expression when enriched in a gene promoter area or coding 
region. 
Suv39H1, the K9 selective histone methylase in eukaryotic cells and the methyl-lysine 
binding protein HP1 may interact to repress transcription at heterochromatic sites (Rea et al., 
2000). Lysine 9 of histone H3 is methylated by Suv39H1, creating a binding site for the 
chromo domain of HP1 (Bannister et al., 2001; Lachner et al., 2001). The HMT activity of 
Suv39H1 resides in the SET domain. Suv39H1 and HP1 are both involved in the repressive 
functions of the retinoblastoma (Rb) protein (Nielsen et al., 2001). For example, Suv39H1 
cooperates with Rb to repress the cyclin E promoter (Nielsen et al., 2001). Thus, the 
Suv39H1-HP1 complex is not only involved in heterochromatic silencing but also has a role 
in repression of euchromatic genes by Rb and perhaps other repressor proteins (Martin and 
Zhang, 2005).  
It was thought originally that histone methylation marks were permanent, until the discovery 
of the first histone demethylase lysine specific demethylase 1 (LSD1) (Shi et al., 2004). 
LSD1 acts to demethylate H3K4 and repress transcription. Interestingly, when LSD1 is 
associated with the androgen receptor, it is also able to demethylate H3K9 and activate 
transcription (Metzger et al., 2005). Currently, there are two known types of demethylase 
domain with specific catalytic reactions: the LSD1 domain and the JMJC domain (Shi and 
Whetstine, 2007). H3K9 can also be demethylated by other enzymes such as JMJD2C (Cloos 
et al., 2006) and JMJD2D (Shin and Janknecht, 2007). The interplay between HMTs and 
44 
 
demethylases probably plays a role in fine tuning the histone methylation (Shi and Whetstine, 
2007). 
 
 
Figure 1.8 Schematic diagram of histone modification maps on Histone 3.  Different 
histone modifications can be detected on histone tails. Different histone demethylases and 
methyltransferases that target the lysine (K) 9 site only are shown.  
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1.11 DNA methylation 
 Epigenetic marks confer stability of gene expression during mammalian development. 
Major epigenetic regulatory mechanisms include DNA methylation, covalent post-
translational modifications of histone proteins and RNA-mediated gene silencing (Vaissiere et 
al., 2008). Cytosine (C) methylation is the only covalent DNA modification described in 
mammals (Weber et al., 2007). This occurs at cytosine residues clustered in sequences 
containing a high degree of CG dinucleotide motifs known as CpG Islands. According to 
commonly used criteria, a CpG Island is minimally defined as a minimum observed-expected 
CpG ratio of 0.65 and with a GC content greater than 55% over a distance of 500 base pair 
(bp) (Takai and Jones, 2002). 
 The chief enzyme responsible for propagating DNA methylation patterns in adult 
vertebrate cells is DNA methyltransferase 1 (DNMT1) (Yen et al., 1992) which is considered 
to responsible for the maintenance of DNA methylation. There are two other DNA 
methyltransferases, Dnmt3a and 3b which are primarily responsible for de novo DNA 
methylation (Okano et al., 1999) but in mouse embryonic stem cells Dnmt3a and Dnmt3b are 
also involved in maintenance methylation (Chen et al., 2003). Disruption of the genes Dnmt1, 
Dnmt3a, Dnmt3b results in embryonic lethality and is associated with global 
hypomethylation (Li et al., 1992). These enzymes, DNMT1, Dnmt3a, Dnmt3b, catalyze the 
transfer of the methyl donor group from S-adenosylmethionine (SAM) to the 5-carbon (C5) 
position of cytosine bases in CpG dinucleotides. Other Dnmts exist including Dnmt2, which 
have little or no DNA methylation activity in vitro; and Dnmt3L, which has similarities with 
Dnmt3 proteins, but lacks some catalytic motifs and is not expected to have DNA 
methylation activity (Goll and Bestor, 2005). 
 In mammals, methylation is restricted to CpG dinucleotides which are commonly seen 
in CpG islands and are highly represented in promoter areas (Weber et al., 2007). CpG sites 
in CpG island promoter regions are usually protected from DNA methylation, whereas CpG 
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sites in gene-coding or non-coding regions are usually methylated (Clark et al., 2006). 
Cytosine methylation can interfere with transcription factor binding, yet repression seems to 
occur largely indirectly via recruitment of methyl-CpG binding domain (MBD) proteins that 
induce chromatin changes (Klose and Bird, 2006). Approximately 70% of human genes are 
linked to promoter CpG islands, whereas the remaining promoters tend to be depleted in 
CpGs (Saxonov et al., 2006). DNA methylation does not alter the function of the gene 
product but provides information as to where and when the gene should be expressed (Clark 
et al., 2006). 
 DNA methylation patterns in human cancer cells are usually distorted. Cancer cells may 
exhibit hypermethylation within the promoter regions of many CpG island-associated tumour 
suppressor genes such as Rb1 (Sakai et al., 1991), glutathione S-transferase (GSTP1) (Lin 
and Nelson, 2003) and E-cadherin (CDH1) (Yoshiura et al., 1995). These aberrant DNA 
methylation marks, together with histone methylation marks, may act together with other  
regulatory mechanisms such as miRNA to regulate gene expression (McCabe et al., 2009). 
 
Figure 1.9 Schematic diagram of CpG island distribution on the TGF-β1 promoter.  
CpG islands are defined according to the criteria: minimum observed-expected CpG ratio of 
0.65 and GC content greater than 55% over a distance of 500 base pair and are marked as a 
blue coloured region. Individual CpG sites are marked as red line below the X axis. 
Translation start site is marked as ATG. The NF-B binding site of interest (B3) is shown 
located in a CpG rich site. 
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1.12 Oxidative stress and DNA methylation 
 Generation of hydroxyl radicals can cause a wide range of DNA lesions including base 
modifications, deletions, strand breakage, chromosomal rearrangements, and further interfere 
with the ability of DNA to function as a substrate for the DNMTs and results in global 
hypomethylation (Wachsman, 1997). Additionally, the presence of 8-hydroxydeoxyguanine 
(8-OH-dG) in CpG dinucleotide sequences has been shown to inhibit methylation of adjacent 
cytosine residues (Turk et al., 1995) and further interfere with the ability of restriction 
nucleases to cleave DNA (Turk and Weitzman, 1995). Furthermore, O6-methylguanine can 
inhibit binding of DNA methyltransferases (Hepburn et al., 1991); spontaneously mispair 
with thymine (Xiao and Samson, 1993) and thereby lead to DNA hypomethylation by means 
of inhibiting methylation of adjacent cytosine molecules. 
Incorporation of 8-OH-dG and 5-hydroxymethylcytosine into the MBP recognition 
sequence results in inhibition of MBP binding affinity and subsequent changes in gene 
expression (Valinluck et al., 2004). Additionally, repressed expression of key antioxidant 
enzymes may be affected by promoter hypermethylation-induced gene silencing. Decreased 
expression of MnSOD was detected in pancreatic carcinoma which was underlined by DNA 
hypermethylation-induced silencing (Hurt et al., 2007). GSTP1 gene expression was shown 
to be inactivated via promoter hypermethylation in hepatocellular carcinoma (Zhong et al., 
2002) and prostate cancers (Millar et al., 1999). 
 These changes further indicate the ROS-induced oxidative stress is involved in the 
epigenetic regulation of genes expression and further in controlling of DNA methylation 
(Franco et al., 2008). 
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1.13 The interplay between DNA methylation and histone methylation 
DNA methylation, histone deacetylation and H3K9 methylation are all associated with a 
repressed chromatin state. But the precise sequence of events is still unclear.  
In mammals, DNA methyltransferases interact with Suv39h H3K9 methyltransferases 
and loss of H3K9 methylation in Suv39h-knockout embryonic stem cells decreases Dnmt3b-
dependent CpG methylation at major centromeric satellites (Lehnertz et al., 2003). 
Additionally, H3K9 methylation and silencing of the p16ink4a tumour suppressor gene can 
occur before CpG methylation (Bachman et al., 2003). These observations point out that 
DNA methylation may be a secondary event in gene silencing process. Furthermore, DNA 
methylation might exert a positive feedback on lysine methylation. Methyl-CpG-binding 
domain proteins, such as MeCP2 and MBD1, might favour H3K9 methylation in the vicinity 
of the methylated genes that they regulate (Fuks et al., 2003b; Sarraf and Stancheva, 2004). 
Some H3K9 HMTs, such as SETDB1 have built-in methyl-CpG binding domains suggesting 
that these histone modifying enzymes might be directly recruited to sites of CpG methylation 
(Li et al., 2006a). 
All these observations suggest one possibility that, H3K9 methylation by an H3K9 
enzyme might create a foundation for an adaptor, HP1, which would recruit DNA 
methyltransferases, to catalyze CpG methylation in the region of the methylated lysine. The 
methyl-CpG binding domain would then bind to the methylated DNA, and further attract 
HDAC complexes, in addition to H3K9 methyltransferase which is required to prepare H3K9 
for methylation (Fuks, 2005) (Fig 1.10). 
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Figure 1.10 Diagram depicting the self-inducing epigenetic cycle.   DNA 
methyltransferase (DNMT) may be attracted to the adaptor molecule (HP1) and add a methyl 
group to DNA where chromatin is already methylated at lysine 9 of histone H3 (H3K9). 
Methyl-CpG binding domain (MBD) proteins can bind to DNA due to the generation of 
methylated DNA by DNMT. Histone deacetylase (HDAC) can be attracted to the complex in 
addition to H3K9 methyltransferases, and induce H3K9 deacethylation. Histone methylation 
then occurs which may allow further recruitment of the HP1 adaptor protein. This self-
reinforcing cycle helps to keep genes in a repressed chromatin state. 
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1.14 Hypothesis and aims of the thesis 
We hypothesise that oxidative stress, in combination with a pro-inflammatory stimulus, may 
upregulate TGF-β1 in the airways through the NF-B pathway. This enhanced expression of 
TGF-1 is regulated, at least in part, by the action of H2O2 on the expression and activity of 
the histone methyltransferase, Suv39H1; and the DNA methyltransferase, DNMT1.  
Furthermore, the enhanced expression of TGF-β1 induced by combined oxidative stress and 
inflammatory stimulation results in a relatively refractory response to glucocorticoid 
suppression.  
 
 
The specific aims were: 
1. to determine the effect of H2O2 alone, and in combination with IL-1, on TGF-1 
production by airway epithelial cells,  
2. to examine the role of redox sensitive transcription factors such as NF-B and AP-1 
on TGF-1 expression,  
3. to elucidate the degree of TGF-1 mRNA suppression by fluticasone propionate (FP) 
under conditions of oxidative stress,  
4. to examine the effect of H2O2 on recruitment of NF-B p65, Suv39H1 and DNMT1 to 
the native TGF-β1 promoter area,  
5. to evaluate the role of Suv39H1 in FP action, and 
6. to determine the effect of H2O2 and IL-1 on TGF-1 promoter DNA methylation 
status. 
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CHAPTER TWO 
MATERIALS AND METHODS 
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2.1 Cell culture 
2.1.1 A549 cells 
The human alveolar type II-like epithelial cell line A549 were grown in complete medium 
(DMEM; supplemented with 10% FCS, and 2mM L-glutamine) (Gibco, Paisley, UK). Cells 
were grown as monolayers in tissue culture flasks at 37°C, 5% CO2 until 70-75% confluent, 
and then serum starved for 24hrs before treatment to enable the cells to synchronise cell cycle 
(K-Y Lee et al., JI 2006).   
 
2.1.2 BEAS-2B cells 
BEAS-2B cells were derived from cells isolated from normal human bronchial epithelium 
obtained by autopsy of non-cancerous individuals and subsequently infected with an 
adenovirus 12-SV40 virus hybrid and cloned. They retain the ability to undergo squamous 
cell differentiation in response to serum. BEAS-2B cells were grown in keratinocyte 
conditioned medium (Gibco, Paisley, UK) together with supplements (Ito K et al., BBRC 
2004). Cells were grown as monolayer in tissue culture flasks at 37°C, 5% CO2 until 70-75% 
confluent, and then serum starved for 24hrs in medium without EGF and bovine pituitary 
extracts before treatment. Both A549 and BEAS-2B cells were purchased from the European 
Collection of Cell Cultures (ECACC) through Sigma-Aldrich (Poole, Dorset, UK). 
 
2.2  Dichlorofluorescein Assay  
Cells were split and counted by trypan blue exclusion. Viable cells (104/well) were plated into 
96-well collagen-coated plates 1 day before the experiment. On the day of the experiments, 
after removing the medium, the cells in the plates were washed with KRH buffer (118mM 
NaCl, 4.8mM KCl, 1.2mM MgSO4, 2.5mM CaCl2, 10nM HEPES, PH 7.4), and then 
incubated with 100 μM DCFH-DA (2’,7’-dichlorofluorescin diacetate) in serum-free medium 
(DMEM; supplemented with 10% FCS, and 2mM L-glutamine)(Gibco, Paisley, UK)) in 5% 
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CO2/95% air at 37°C for 30 min. After DCFH-DA was removed, the cells were washed and 
incubated with KRH buffer and stimulants for variable times as described. Cell fluorescence 
from each well was measured using a Fluorescence plate reader (Synergy HT, Biotek, 
Winooski, VT, USA) and recorded. The excitation filter was set at 485nm and the emission 
filter was set at 530nm.  
Unless otherwise stated all other chemicals and solutions used were purchased from Sigma-
Aldrich. 
 
2.3 Detection of alveolar epithelial cell apoptosis/late necrosis, and cell proliferation 
2.3.1 Flow cytometry 
Cells were collected by trypsin, and neutralized with complete medium (10% FCS, 2% L-
glutamine), washed twice with cold PBS and resuspended in 1X Binding Buffer (1 part of 
10X Binding buffer (0.1 M Hepes/NaOH (pH 7.4), 1.4 M NaCl, 25 mM CaCl2) diluted with 9 
parts of distilled water) at a concentration of 1 x 106 cells/ml. 100µl of the solution (1 x 105 
cells) was then transferred to a 5 ml culture tube and 5µl of Annexin V-FITC (BD 
Pharmingen, San Diego, CA) and 5µl propidium iodide (PI, BD Pharmingen, San Diego, CA) 
added. The cells were vortexed gently and incubated for 15 min at RT (25°C) in the dark. 
400µl of 1X Binding Buffer were added to each tube before analysis by flow cytometry 
within 1 hr. Annexin-V positive cells were considered to be apoptotic if they were PI stain 
negative (normal permeability), or as either late apoptotic or necrotic if they were PI stain 
positive (increased permeability) (Geiser et al., 2004) (Fig 2.1). 
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Figure 2.1 Analysis of cells labelled with annexin-V antibody and/or propidium 
iodide (PI) by Flow cytometry. (A) Cells were checked with forward scatter detector (FSC) 
and side scatter detector (SSC) and analyzed by density graph to check cell size and 
granularity. Fragmented cells were excluded from the study. (B) The amplitude of the 
detector was adjusted to separate cells positive for PI stain (FL2-H reading > 15) from those 
negative for PI according to the FL2 detector reading. (C) Distribution of cells over FL2 
readings are analyzed by histogram. The results are shown as M1 (positive for PI) to all cells 
ratio. (D) After optimization for FL1 and FL2 detector setting, four quadrant density graph 
views were used to separate cells that were PI/Annexin V positive (right upper quadrant); 
Annexin-V positive, PI negative (right lower quadrant) and PI positive, annexin-V negative 
(left upper quadrant). Distribution of cells is shown in right table. 
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2.3.2 MTT assay 
After cell stimulation, the supernatant was removed and A549 cells were incubated with 1 
mg/ml methylthiazolyldiphenyl-tetrazolium bromide (MTT) solution at 37°C for 20-30 min. 
MTT solution was then removed and DMSO was added to dissolve the resulting formazan 
product and absorbance was measured at 550 nm. 
 
2.4  cDNA preparation and real-time PCR 
Total RNA was isolated from cultured cells using RNeasy Mini Kit by Qiagen (Crawley, East 
Sussex, UK). The concentration and purity of RNA was evaluated by spectrophotometry at 
260 and 280 nm. The extracted RNA was reverse transcribed in RT reaction mixture (AMV-
RT, Promega, Southampton, UK) with 1xRT buffer, dNTP mix, random hexamer primers and 
ribonuclease inhibitor (all Promega). Single stranded cDNA was synthesized by 1h 
incubation at 42°C and the reaction terminated by incubation at 90°C for 4min. 
QPCR was performed in a Rotor-Gene 3000TM Four-Channel Multiplexing System (Corbett 
Research, Cambridge, UK) using a QuantiTect SYBR Green PCR Kit (Qiagen) to quantify 
TGF-1 and GAPDH or GNB2L1 control mRNAs. Cycle parameters were 95°C for 15 min 
to activate HotStarTaq DNA® Polymerase, followed by annealing and extension for 40 cycles 
at 94°C for 15s, 60°C for 25s and 72°C for 25s. DNA was quantified by the standard curve 
method of relative quantification according to instructions provided by Corbett Research. The 
amount of TGF-1 mRNA was normalized to GAPDH or GNB2L1 and all RT-QPCR data is 
presented as a ratio to control samples. 
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Table 2.1.  PCR primers for real-time RT-PCR 
TGF-β1 forward 5’-CCC AGC ATC TGC AAA GCT C-3’ 
TGF-β1 reverse 5’-GTC AAT GTA CAG CTG CCG CA-3’ 
Suv39H1 forward 5’-AAG ATC CGC GAA CAG GAA TA-3’ 
Suv39H1 Reverse 5’-GGA ACT GCT TGA GGA TAC GC-3’ 
GAPDH forward 5’-TTC CAG GAG CGA GAT CCC T-3’ 
GAPDH reverse 5’-CAC CCA TGA CGA ACA TGG G-3’ 
GNB2L1 forward 5’-CTCCGCCTCTCGAGATAAGACC-3’ 
GNB2L1 reverse 5’-GCAAACTGGCCATCTGAGGA-3’ 
G9a forward 5’-GAC CCT GAC GAA AGG GGA C-3’ 
G9a Reverse 5’-AGA CTT GCT GRC GGA GTC CA-3’ 
Suv39H2 forward 5’-TCT TCC CCG AAT AGC ATT GT-3’ 
Suv39H2 Reverse 5’-TCT GAC CCT CTT TTT GGC TG-3’ 
DNMT1 forward 5’-GTC TGA AAG AGC CAA ATC GG-3’ 
DNMT1 reverse 5’-AGC GGT CTA GCA ACT CGT TC-3’ 
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B                                      C 
 
D 
 
 
Figure 2.2 Specificity and Sensitive Quantification results by reverse transcription-
quantitative PCR (RT-QPCR). (A) Raw channel graphs for RT-QPCR demonstrate serial 
dilution of unknown concentration DNA (1x, 0.1x, 0.01x, 0.001x) results. (B) Standard curve 
of the RT-QPCR result. (C) Melting curve analysis of the amplified products shows good 
specificity of the final amplified products by RT-QPCR. (D) Normalized fluorescence results 
for serial dilution of DNA of unknown concentration after normalization. The threshold cycle 
is marked by a red line.  
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2.5 Western blotting 
2.5.1 Preparation of protein samples 
Proteins were extracted from A549 cells using two different protocols: whole cell 
protein extraction, or nuclear/cytoplasmic protein extraction depending on the application 
used.  
For whole-cell extraction, 2x106 cells from a 6cm petri dish were washed twice with ice-cold 
phosphate buffered saline (PBS), and scraped with cell lifter. After centrifugation at 500xg 
for 3 mins, PBS was aspirated and the cell pellet lysed by repeated pipetting with 100µl ice-
cold radioimmunoprecipitation (RIPA) buffer [containing PBS, pH 7.4, 1% (v/v) Nonidet P-
40, 0.5% (w/v) sodium deoxycholate, 0.1% (v/v) SDS, and complete protease inhibitors 
cocktail (Roche Applied Science, Lewes, East Sussex, UK)] on ice for 30mins. After 
vigorous vortexing for 10secs, lysates were collected and cell debris was removed by 
centrifugation for 10 min at 12,000 rpm at 4°C. The supernatants were transferred to a fresh 
tube and stored at -80°C until use. The efficiency of cell lysis was verified by light 
microscopy. 
For nuclear/cytoplasmic protein extraction, subcellular fractionation was performed by 
using a Nuclear Extract Kit (Active Motif, Carlsbad, CA, USA), which provides cytoplasmic 
and nuclear subcellular fractionation of proteins. All procedures were performed following 
the Manufacturer’s recommended procedures. Briefly, 2x106 cells from a 6cm petri dish were 
rinsed twice with ice-cold PBS and collected by scrapping with 1ml ice-cold PBS containing 
phosphatase inhibitors. Cells were pelleted by centrifugation at 1,500 rpm for 5min and 
resuspended in 500µl Hypotonic Buffer, and then incubated for 15min on ice. After adding 
25µl detergent and vortexing for 10secs, the suspension was centrifuged at 14,000 x g for 
30secs, and the supernatant (cytoplasmic fraction) collected. The remaining nuclear pellets 
were resuspended in 50µl Complete Lysis Buffer (containing 1mM DTT, Lysis buffer AM1, 
and protease inhibitors cocktail), vortexed and incubated for 30mins at 4°C on a rocking 
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platform. After a further vortex, the suspension was centrifuged at 14,000 x g for 10min and 
the supernatant (nuclear fraction) was collected, and stored at -80°C for subsequent analysis. 
 
2.5.2  Bradford protein assay 
Protein concentrations were determined using Bradford’s reagent (BioRad Laboratories, 
Hemel Hempstead, Hertfordshire, UK) before downstream application. A set of standard 
samples of known concentrations (0, 1, 2, 4, 6, 8, 10µg/µl) was made up by dilution of a 
stock 10µg/10µl BSA solution.  This was used to construct a standard curve. The volume of 
the unknown protein samples were adjusted to ensure the measured concentration were 
within the range of the standard curve. 
To quantify the concentration of the unknown protein, 1µl of unknown of protein 
samples and serial diluted standard concentrations including a blank diluent was mixed with 
200µl diluted Bradford reagent (1:4 ratio with distilled water) and then added to each well of 
a 96-well plate. All samples were tested in duplicate and each sample was measured within 5 
mins on a plate reader with absorbance at 600nm. A standard curve of absorbance against 
concentration was plotted, and used to establish the concentration of the unknown samples. 
 
2.5.3  Polyacrylamide gel electrophoresis (PAGE) 
To separate proteins of different molecular weight, pre-cast Nupage® 10%, or 4-16% Bis-
Tris Gels (Invitrogen Ltd, Paisley, UK) combined with Nupage® MES or Nupage® MOPS 
SDS running buffer were used. These gels give an optimal separation/resolution range of 6-
200 kDa. Gels were rinsed with deionised water and assembled into the gel tank. Both inner 
and outer chambers were filled with 1x MES SDS running buffer[50mM MES, 50mM Tris 
base, 0.1% SDS, 1mM EDTA, pH 7.3] or MOPS Running Buffer [50mM MOPS, 50mM Tris 
base, 0.1% SDS, 1mM EDTA, pH 7.7]. Protein samples for electrophoresis were mixed with 
1/4 volumes of 4x Nupage LDS sample buffer [106mM Tris HCl, 141mM Tris base, 2% 
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LDS, 10% Glycerol, 0.51mM EDTA, 0.22mM SERVA® Blue G250, 0.175mM Phenol Red, 
pH 8.5], and 1/10 volume of 0.5M DTT as reducing agent was added and heated at 70°C for 
10mins to denature the proteins. Samples were vortexed and centrifuged before loaded onto 
the gels. Electrophoresis was performed at 200 V for 50mins. 
 
2.5.4  Western transfer of protein to nitrocellulose membranes 
After electrophoresis was complete, the gel was taken out from the tank, and removed from 
the gel cassette. The gel was kept wet at all times and trimmed with a clean scalpel to the 
appropriate size. A piece of Nitrocellulose-ECL membrane (GE Healthcare, Little Chalfont, 
UK) was cut to the dimensions of the gel and equilibrated in 1x Nupage® Transfer Buffer 
[25mM Bicine, 25mM Bis-Tris (free base), 1mM EDTA, pH 7.2] before the transfer process. 
The transfer blot module was assembled as follows: cathode core, blotting pad, filter paper, 
gel, transfer membrane, filter paper, blotting pad, with the gel on the cathode side and the 
membrane on the anode side. All procedures were performed in the transfer tank filled with 
transfer buffer, and roller was used to ensure the removal of any air bubbles. The tank was 
filled with chilled 1 x Nupage® Transfer Buffer. The transfer was performed at 30 V for 1 hr. 
 
2.5.5  Immunodetection of specific proteins 
After the transfer process, the transfer module was disassembled and the membrane was 
removed and equilibrated in TBS-Tween 20 washing buffer (Tris-HCl pH 7.0, 0.5% Tween 
20) briefly. Membranes were blocked in 5% nonfat milk TBS-Tween 20 for 1hr at room 
temperature with shaking. The blocking solution was removed and the membrane incubated 
with 10ml of diluted primary antibody in blocking solution overnight at 4°C with shaking. 
Antibodies used for Western blotting and their individual dilution ratios are shown in Table 
2.2. After the incubation, membranes were rinsed and washed three times for 10mins each 
with TBS-Tween 20 washing buffer. After washing, membranes were incubated with 
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horseradish peroxidase (HRP)-conjugated secondary antibodies (raised against the host of the 
primary antibody) which were diluted in blocking solution for 1hr at room temperature with 
shaking. Membranes were washed three times with TBS-Tween 20 each time for 10mins and 
then rinsed twice with TBS. Finally, antigen-antibody interactions were detected using a 
chemiluminescence detection kit (ECL; Amersham Biosciences, Little Chalfont, UK), and the 
image was exposed with film with different exposure time based on signal density. The 
results were analyzed with image analysis software (UVP, Cambridge, UK) and were shown 
as integrated optical density (IOD). 
 
2.5.6  Protein loading control 
After detection with the relevant primary antibody, the blots were re-probed with an anti-β-
actin antibody for cytoplasmic and whole cell lysates and with an anti-lamin A/C antibody for 
nuclear extracts to control for protein loading. If the protein size overlapped with a previously 
detected signal, membrane stripping was performed. Briefly, the membrane was washed 
twice for 10mins in TBS-Tween 20 with shaking, placed in 20ml Western blot stripping 
buffer (Perbio Science Ltd, Tattenhall, Cheshire, UK) and incubated for 10mins at room 
temperature. Finally, the membranes were washed as before and re-probed for the appropriate 
protein control. 
  
Table 2.2  Antibodies used for Western blotting 
Primary antibody 
(dilution) 
Company 
(catalogue number) 
Secondary antibody 
(dilution) 
Molecular weight 
(kDa) 
TGF-β1 
 
Santa Cruz 
(sc-146) 
Goat anti-rabbit 
(1:2000) 
12.5 
(dimer at 25) 
p65 (1:700) Santa Cruz Goat anti-mouse 65 
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(sc-8008) (1:2000) 
Suv39H1 (1:500) 
Millipore 
(05-615) 
Goat anti-mouse 
(1:2000) 
50 
GR (1:700) 
Santa Cruz 
(sc-8992) H-300 
Goat anti-rabbit 
(1:2000) 
94 
GR (1:700) 
Santa Cruz 
(sc-1003) E-20 
Goat anti-rabbit 
(1:2000) 
94 
Dimethyl-Histone 
H3K9 (1:2000) 
Millipore 
(07-441) 
Goat anti-rabbit 
(1:2000) 
17 
Trimethyl-histone 
H3K9 (1:2000) 
Millipore 
(07-442) 
Goat anti-rabbit 
(1:2000) 
17 
Lamin A/C (1:700) 
Santa Cruz 
(sc-7292) 
Goat anti-mouse 
(1:2000) 
64 
β-actin 
(1:10000) 
Santa Cruz 
(sc-47778 HRP) 
 43 
DNMT1 
(1:500) 
Santa Cruz 
(SC-20701) 
Goat anti-mouse 
(1:2000) 
170-195 
 
2.6  TGF-β1 ELISA 
The concentrations of TGF-1 in supernatants were measured using human TGF-β1 DuoSet 
ELISA (enzyme-linked immunosorbent assay) Development kits (R&D Systems Europe, 
Abingdon, UK). 96-well microplates were pre-coated with Capture Antibody (mouse anti-
TGF-β1) by incubating 100µl per well of the diluted Capture Antibody (20µg/mL in PBS) 
overnight at room temperature followed by blocking with 200μl of Block Buffer (5% Tween 
20 in PBS) for 1h at room temperature. For the assay of total TGF-β1, the supernatants 
prepared from cultured cells were first activated by incubating with 1N HCl for 10mins at 
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room temperature and neutralized (pH7.2-7.6) by 1.2N NaOH/0.5M N-2-
hydroxyethylpiperazine-N’-ethane sulfonic acid. Activated samples were then transferred to 
the Capture antibody-precoated plates and incubated for 2hr at room temperature. After 
thorough washing, Detection Antibody (biotinylated chicken anti-human TGF-β1, 300ng/ml) 
was added to the test wells. After further 2hr incubation at room temperature, free antibodies 
were removed by washing, and plates incubated with streptavdin-HRP for 20mins at room 
temperature. After washing, HRP Substrate Solution was added, incubated at room 
temperature for 20mins before the reaction was stopped with 2N H2SO4 and the color 
intensity measured with a microtitre plate reader (Synergy HT) set to 450nm corrected at 
540nm. Concentrations were calculated by using a four parameter logistic (4-PL) curve-fit, 
created by 2-fold serial dilutions of Standard (2000pg/ml of recombinant human TGF-β1). 
Samples and standards were run in duplicate and averages were used for calculation. Active 
TGF-β1 in the supernatant was also determined using the same procedure without the 
activation step with acidification. 
 
2.7  Suv39H1 siRNA Transfection 
A549 cells were trypsinized and counted one day before transfection. The cells were diluted 
in complete medium (DMEM; supplemented with 10% FCS, and 2mM L-G), plated out at a 
density of 2.5x105 cells/ml in 6 well plate and incubated at 37°C, 5% CO2. Small interfering 
RNA (siRNA) constructs were obtained as the siGENOME SMARTpool Suv39H1 SiRNA 
duplexes (M-009604-01, Dharmacon, Lafayette, CO, USA ). The Suv39H1 siRNA was 
diluted with siRNA buffer (Dharmacon) and stored at -20 C. On the day experiment, siRNA 
was diluted with Opti-MEM medium (Invitrogen) with generous vortexing and then mixed 
with INTERFERin Kit (Polyplus transfection, Illkirch, France) with vigorous shaking before 
incubation for 10mins at room temperature according to the Manufacturer's instructions. 
During this time, each well in a 6 well plate was washed with PBS, and then changed to fresh 
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complete medium. The siRNA complex with Opti-MEM medium was mixed with complete 
medium to the final concentration 25nM added to the cells which were subsequently 
incubated at 37°C, 5% CO2 for 24hrs and then in serum free media for another 24hrs before 
treatment.  
 
2.8  Co-Immunoprecipitations 
Whole cell lysates were prepared by incubation with immunoprecipitation (IP) buffer (50mM 
Tris-HCl, pH 8.0; 150mM NaCl; 0.5% NP-40; 0.5% deoxycholate; complete protease 
inhibitor cocktail [Roche Applied Science]) on ice for 15min before centrifugation for 10mins 
at 4°C. Nuclear extraction was performed with the Nuclear Extract Kit (Active Motif). The 
measurement of protein concentrations was performed as previously described. 500g of 
whole cell lysates or 500g of nuclear extracts were immunoprecipitated with 5μg of primary 
antibodies (Table 2) for 4hrs (for GR-IP) or overnight at 4°C (all other IPs) followed by a 
further incubation with 15ul of 50% protein A/G-Sepharose beads for 2hrs at 4°C on a 
rotator. The beads were then collected by brief centrifugation at 6000 rpm and washed four 
times with IP buffer. After a final wash, the buffer was aspirated completely and the beads 
resuspended in Laemmli buffer prior to being boiled at 100°C for 5mins. The 
immunoprecipitated proteins were fractionated by 10% or 16% SDS-PAGE) and detected by 
Western blotting as previously described with antibodies specific for the proteins under 
investigation.  
 
Table 2.3  Antibodies used in co-immunoprecipitation 
Primary antibody 
(dilution) 
Company 
(catalogue 
number) 
Secondary antibody 
(dilution) 
Molecular weight 
(kDa) 
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p65 (1:700) 
Santa Cruz 
(sc-8008) 
Goat anti-mouse (1:2000) 65 
Suv39H1 (1:500) 
Santa Cruz 
(SC-23961) 
Goat anti-mouse 
(1:2000) 
45 
GR (1:700) 
Santa Cruz 
(sc-8992) H-300 
Goat anti-rabbit 
 
94 
DNMT1 
Santa Cruz 
(SC-20701) 
Goat anti-mouse 
(1:2000) 
170-195 
 
2.9  In-vitro NF-B/TGF-1 Promoter binding assay 
In-vitro NF-B/TGF-1 Promoter Binding Assays were an ELISA based assay based on the 
same principle in TransAM Kit. This assay measures the binding affinity of NF-B proteins 
to specific sequences in the TGF-β1 promoter (Fig. 2.3). DNA oligonucleotides containing a 
putative NF-B or AP-1 site in the TGF-β1 promoter and mutated oligonucleotides were 
prepared by mixing equal amounts of 100μM sense and anti-sense oligonucleotides in 
annealing buffer (10mM Tris-HCl pH7.5, 50mM NaCl, 0.1% Tween 20, 2.7mM KCl) in a 
preheated block (95°C) before leaving at room temperature for 60min. Streptavidin coated 
microplates (Thermo Labsystems, Helsinki, Finland) were immobilized with 0.25μM 
biotinated DNA oligonucleotides containing a TGF-1 promoter NF-B binding site in 
annealing buffer (10mM Tris-HCl pH7.5, 50mM NaCl, 1mM EDTA) overnight at 4°C. The 
binding reaction was performed by incubating nuclear extracts (20μg/20μl) from A549 cells 
with 30μl of binding buffer (4mM HEPES pH7.5, 120mM KCl, 8% glycerol, 1% BSA, 2mM 
DTT, 10µg/ml Herring sperm DNA) for 1h at room temperature in each well of the DNA 
oligonucleotide-immobilized microtitre plate. In competitive binding experiments, non-
biotinated wild-type (0.2 or 2μM) or mutated oligonucleotides (2μM) were added to the 30μl 
binding buffer. After washing with washing buffer [10mM PB (Phosphate Buffer; 1.16g 
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Na2HPO4, 0.2g KCl, 0.2g KH2PO4/L) pH7.5, 50mM NaCl, 0.1% Tween 20, 2.7mM KCl], 
DNA oligonucleotide-bound protein was detected with anti-p65 (1:1000, Active Motif and an 
HRP conjugated goat anti-rabbit secondary antibody (1:500, Dako, Cambridge, UK) diluted 
in buffer (10mM PB, pH7.5, 50mM NaCl, 0.1% Tween 20). The colorimetric reaction was 
performed with 100µl of substrate reagent (R&D Systems Europe), stopped with 50µl stop 
solution (2N H2SO4) and was measured at 450 nm with a reference wavelength of 550nm. 
The oligonucleotides employed in these studies are listed in Table 2.4. 
 
 
Table 2.4  TGF-β1 promoter oligonucleotides used in in vitro NF-κB/TGF-β1 
Promoter Binding Assays 
Name Oligonucleotide sequence 
NF-B site 
B1      Sense 
        Antisense 
5’-agg ctg ggt TGG AAA CTC Tgg gac aga a-3’ 
5’-ttc tgt ccc aga gtt tcc aac cca gcc t-3’ 
B2      Sense 
        Antisense 
5’-agg agt ctg GTC CCC ACC Cat ccc tcc t-3’ 
5’-agg agg gat ggg tgg gga cca gac tcc t-3’ 
wB3     Sense 
        Antisense 
5’-ggg ggc agg GGG GAC GCC Ccg tcc ggg g-3’ 
5’-ccc cgg acg ggg cgt ccc ccc tgc ccc c-3’ 
mB3     Sense 
        Antisense 
5’-ggg ggc agg GGG GAG CCC Ccg tcc ggg g 
5’-ccc cgg acg ggg gct ccc ccc tgc ccc c-3’ 
 
2.10  Production of Suv39H1 plasmid, and Suv39H1 overexpression 
Full length Suv39H1 cDNA was cloned from a human cDNA library (Origene, 
Rockville, MD, USA) with specific Suv39H1 primers which include CACC for forward 
primers with a stop codon for reverse primers to produce blunt-end PCR products using an 
Invitrogen Platinum Pfx DNA polymerase system (Invitrogen). 100ng full length Suv39H1 
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cDNA which was to be inserted into the overexpression vector (pcDNA 3.1/V5-His-TOPO 
vector)) was mixed with Pfx Amplification buffer (1X), dNTP mixture (0.3mM), MgSO4 
(1mM), Primer mix (0.3μM each) and 1.5 units Platinum Pfx DNA polymerase® (all 
Invitrogen). Autoclaved nuclease-free water was added to the mixture to a final volume of 
50μl. The cycling conditions for the PCR reaction were: 94°C for 5mins, 94°C for 15secs and 
55°C for 30secs with a final extension step of 68°C for 2mins. The cycling was repeated for 
40 cycles and included a final step of 72°C for 10mins. The final product was analyzed by 
1% agarose gel electrophoresis to check if there are nonspecific products. The pcDNA 3.1 
Directional TOPO expression kit (Invitrogen) was used to make the Suv39H1 overexpression 
plasmid exactly according to the Manufacturer’s instructions. Briefly, 5ng fresh PCR product 
from the previous PCR reaction was mixed with salt solution, TOPOR (pcDNA 3.1 vector), 
and sterile water was added to a final volume of 6μl. The reaction was mixed gently and 
incubated for 5mins at room temperature. 2μl of the TOPOR Cloning reaction was added to a 
vial of Chemically Competent E. coli (One Shot® Top10 Chemically Competent cells) and 
mixed gently before incubating on ice for 30mins. Cells were then heat shocked for 30secs at 
42°C in a pre-warmed water bath without shaking and tubes immediately transferred to ice. 
250μl of SOB (Super optimal broth) or SOC (Super optimal broth with catabolite repression; 
2% Tryptone, 0.5% Yeast Extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM 
MgSO4, 20 mM glucose) medium kept at room temperature was added and the tube shaken 
horizontally (200rpm) at 37°C for 1hr. Transformed cells were spread (50-200μl) onto pre-
warmed selective LB plates containing ampicillin and incubated overnight at 37°C. The next 
morning 5 colonies were picked from each plate for further analysis. 
Plasmid mini-preps were isolated from colonies using a plasmid purification kit 
(Qiagen). The presence of the correct product in the correct orientation was confirmed using 
restriction enzymes and subsequent sequence analysis by Cogenics (Takeley, Essex, UK). 
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Table 2.5  Primers for cloning Suv39H1 cDNA 
Suv39H1 forward  5’-CACCATGGCGGAAAATTTAAAAGGC-3’ 
Suv39H1 reverse 5’-TCTAAGGGCTAGAAGAGGTATTTGC-3’ 
 
 
 
 
 
 
 
 
Figure 2.3 Structure of Suv39H1-pcDNA 3.1 overexpression plasmid. Schematic 
diagram of Suv39H1-pcDNA 3.1 overexpression plasmid. pCMV: CMV promoter; SV40: 
SV40 origin of replication; Neomycin: Neomycin resistance gene; Ampicillin: Ampicillin 
resistance gene. 
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Figure 2.4 Validation of successfully transfected vector. Colonies of transformed E. 
coli (BL21 Star (DE3) One Shot Competent) grown successfully on Ampicillin-containing 
LB plates were picked and cultured overnight in S.O.C medium containing 50μg/ml 
ampiciilin. Plasmid DNA was isolated, and analyzed by restriction digest (EcoR V: two 
cutting sites; Xho I: one cutting site) to confirm the presence and correct orientation of the 
insert. The digested DNA was run on a 1% agarose DNA gel and stained with ethidium 
bromide. Samples A, B, C, D, E & F were transformed successfully, with two fragments after 
cutting by EcoR V, and one fragment only by Xho I. Samples G & H were not transformed 
successfully, with one fragment after cutting by both EcoR V and Xho I. 
 
2.11  Transfection of Suv39H1 plasmid 
Transfection was performed using the Roche FuGene 6® system (Roche Applied Science). 
Briefly, A549 cells were incubated in a 6-well plate and growing up to 50-60% confluence. 
Fugene 6 reagents (6l) were pipetted into 100μl serum-free media and the mixture vortexed 
for 1sec before incubation for 5mins in room temperature. Suv39H1 overexpression plasmid 
(2g) was added and the mixture vortexed for 1sec before incubation at room temperature for 
a minimum of 15mins. The transfection reagent/DNA complex was finally added to each well 
of the 6-well plate and complete fresh medium added to give a total 2 ml in each well. The 
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cells were incubated with plasmid for 24hrs before stimulation. 
 
2.12  Chromatin immunoprecipitation 
A549 cells from 2 wells of 6-well plate (2x106 cells) were collected for each experiment. 
After stimulation, protein-DNA complexes were cross-linked by formaldehyde (1% final 
concentration) for 10mins at 37°C before the reaction was stopped by the addition of glycine 
(0.125M final concentration). Cells were washed twice with ice-cold PBS and scrapped with 
ice-cold PBS containing complete protease inhibitors cocktail (Roche Applied Science). Cells 
were pelleted by centrifugation at 4000 rpm for 5min and resuspended in 200μl SDS lysis 
buffer (50mM Tris, pH 8.1, 1% SDS, 5mM EDTA, complete protease inhibitor mixture) and 
subjected to sonication on ice with 5 cycles of 10secs pulses. This sonication is optimal for 
shearing DNA to 150-1000 bp pieces (500 bp on average, Fig. 2.4). Sonicated samples were 
centrifuged at 13,000 rpm for 10mins 8°C to spin down cell debris. The soluble chromatin 
solution (200μl) was further diluted with ChIP dilution buffer (0.01%SDS, 1.1% Triton X-
100, 1.2mM EDTA, 16.7mM Tris-HCl, pH8.1, 167mM NaCl, complete protease inhibitor) to 
a final volume of 2ml. 20μl (1%) of the ChIP dilution solution was kept as input control. The 
remained diluted solution was pre-cleared by incubating with 80μl salmon sperm 
DNA/protein A agarose-50% slurry (Millipore, Billerica, MA, USA) for 30min at 4°C on a 
rotator. 
After brief centrifugation, the supernatant was separated into two microcentrifuge tubes 
(900μl each). Each sample was immunoprecipitated by incubation with 1μg antibodies 
specific for protein of interest (see Table 5) overnight at 4°C with rotation and followed by 
1hr incubation with 60μl salmon sperm DNA/protein A agarose-50% slurry at 4°C on a 
rotator. Protein-bound immunoprecipitated DNA was sequentially washed once with 1ml low 
salt immune complex wash buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-
HCl, pH8.1, 150mM NaCl), 1ml high salt immune complex wash buffer (0.1% SDS, 1% 
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Triton X-100, 2mM EDTA, 20mM Tris-HCl, pH8.1, 500mM NaCl), 1ml LiCl immune 
complex wash buffer [0.25M LiCl, 1% IGEPAL-CA630, 1% deoxycholic acid (sodium salt), 
1mM EDTA, 10mM Tris-HCl, pH8.1] and twice with 1ml TE buffer (10 mM Tris, 1 mM 
EDTA, pH 8.0). The immune complexes were then eluted by adding 250μl fresh elution 
buffer (1% SDS, 0.1 M NaHCO3) twice followed by incubation for 4hrs at 65°C in 200mM 
NaCl to reverse cross-links between proteins and DNA. The solution was subsequently 
incubated with 70μg/ml proteinase K (Sigma-Aldrich) for 1h at 45°C to digest proteins. DNA 
was finally extracted with an equal amount (500μl) of phenol/chloroform/isoamyl alcohol 
(25:24:1; Invitrogen), precipitated with 1ml ethanol/0.3M CH3COONa/20μg glycogen and 
resuspended in 100μl nuclease free water. QPCR was performed with 3μl of DNA sample and 
the primer sets listed in Table 6 for quantification. Data were normalized to input control 
samples. A no antibody control was also used to show the specificity of the IP antibodies 
used; QPCR with primer sets amplifying DNA sequences away from the transcription factor 
binding sites under study in the TGF-β1 gene was also used to demonstrate the specificity of 
DNA enrichment. 
 
Table 2.6  Antibodies used in ChIP assay experiments 
Antibody Host 
Company 
(catalogue number) 
p65 (C-20) Rabbit Santa Cruz (sc-372) 
Suv39H1 Mouse Millipore (05-615) 
DNMT1 Mouse Santa Cruz (SC-20701) 
RNA PolII Mouse Abcam (ab5408) 
GR (H300) Rabbit Santa Cruz (sc-8992) 
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Table 2.7  Sequences for all primers used in QPCR for ChIP analysis 
 
 
 
Figure 2.5 Gel analyses for optimization of sonication setting.  A549 cells were fixed 
for 10mins with 1% formaldehyde (final concentration) and chromatin sheared with 4, 8, 12, 
or 16 pulses at 40% power for 10sec in 200μl SDS lysis buffer. The chromatin samples were 
subjected to cross-link reversal, treated with proteinase K followed by phenol/chloroform 
extraction and finally precipitated with alcohol. Air-dried DNA was dissolved in 50μl 
nuclease free water and two aliquots (5μl, 10μl) separated by 1% agarose gel electrophoresis. 
DNA sonicated for 8 pulses were suitable to be used in ChIP assays showing a chromatin 
smear between 200-1500bp.  
Name Sequence Product size 
κB Site 
B1   Forward 
      Reverse 
5’-GCT GCT GTG TGG GGA TAG AT-3’ 
5’-GGC CCA GTC TTT TCC TCT CT-3’ 
95 
B2   Forward 
      Reverse 
5’-AAC CCA GAG AGG AAA AGA CT-
3’ 
5’-TGC AGG AAA GGA GAG AGA G-3’ 
116 
B3   Forward 
      Reverse 
5’-GCC ATC TCC CTC CCA CCT-3’ 
5’-CCT CGG CGA CTC CTT CCT-3’ 
153 
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A 
 
B                              C 
 
 
Figure 2.6  Specificity and Sensitivity quantification by QPCR in Chromatin 
immunoprecipitation experiments. (A) Raw channel data for QPCR demonstrates serial 
dilution of unknown concentration DNA (1x, 0.1x, 0.01x, 0.001x) results. The CT values for 
both input control (blue curve) and IP DNA (green curve) were in the range between 1x and 
0.001x the unknown concentration sample. (B) Standard curve of the QPCR result. (C) 
Melting curve analysis of the amplified products shows a single peak demonstrating good 
specificity of the final product. 
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2.13  GR-IP and NF-B-IP histone methyl transferase (HMT) activity assay 
HMT activity assay was modified from a previous report (Li et al., 2002). GR was 
immunoprecipitated from 500μg of nuclear extracts by incubating in 200μl of 
immunoprecipitation buffer (IP buffer; 25mM Tris [pH 8.0], 150mM NaCl, 1mM DTT, 0.1% 
NP-40, and 1mM PMSF) with a specific anti-GR antibody (5g, H-300, Santa Cruz 
Biotechnology, Santa Cruz, CA). After 1hr incubation in a cold room with rotation, 15μl of 
50% protein A/G-Sepharose beads was added to each tube and further incubated for 2hrs. The 
beads were then collected by brief centrifugation and washed five times with IP buffer and 
once with HMT buffer (50mM Tris pH 8.0, 1mM PMSF, and 0.5mM DTT). The HMT assay 
was performed by incubating the washed beads with 2.5μg of calf thymus core histones 
(Roche Molecular Biochemicals) as substrate along with S-(5’-Adenosyl)-L-methionine 
chloride (SAM, 100μM) as a methyl donor in 25μl of the HMT buffer at 30°C for 1hr. 
Histones were fractionated by 16% SDS-PAGE). H3K9-directed HMT activity was detected 
by Western blotting analysis with an antibody against trimethyl-H3K9 (Upstate 
Biotechnology, Buckingham, U.K.). 
 
2.14  GR and NF-B activation assay 
This procedure essentially followed that of the active motif TransAM® Kit protocol. Briefly, 
10μg nuclear extracts were collected using the Nuclear Extraction Kit from Active Motif 
(Active Moltif) as previously described for the assay. NF-B activation was measured with 
TransAm NF-B family kit (Active Motif) according to the manufacturer’s instructions. 30μl 
complete binding buffer (2µM DTT, 10ng/µl Salmon sperm DNA in binding buffer AM3 was 
added to each well of 96 well plate. 10μg nuclear extracts dissolved in 20μl complete lysis 
buffer (1mM DTT, 0.2µl protease inhibitor cocktail, in lysis Buffer AM1) into each well. 
Blank wells containing complete lysis buffer or binding buffer only were included. Samples 
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were incubated at room temperature for 1hr with mild agitation. 200μl wash buffer was used 
for washing wells before adding 50μl diluted NF-B p65 antibody to each well being used, 
including the blank wells. The plate was then incubated for 1hr at room temperature. After 
washing, 50μl diluted HRP-conjugated antibody was added to each well and incubated at 
room temperature for 1hr. At the end of this time, each well wash washed 4 times before 50μl 
Developing solution was added with minimal exposure of the plate to light. Stop solution (2N 
H2SO4) was added after 10mins as the blue colour developed and chemiluminescence was 
read using a plate reader. 
 
2.15  Bisulphite sequencing 
Genomic DNA was extracted using phenol/chloroform as described above (Section 
2.12). DNA concentration was determined using a nanodrop machine (Invitrogen). Bisulphite 
conversion was performed exactly as described in the MethylSEQr bisulfite conversion kit 
(Applied biosystem, Foster City, CA, USA). 250ng of genomic DNA (gDNA) was combined 
with 5µl methylSEQr® Denaturation Buffer to a final volume of 50µl and mixed thoroughly 
before incubation at 37°C for 15mins. 100µl methylSEQr® Conversion Reagent was mixed 
with the denatured gDNA and incubated in the dark at 50°C for 16hrs.  The mixture was then 
diluted with 250µl deionized water and purified on a purification column. 350µl 0.1M 
sodium hydroxide was added to column to start the conversion reaction and the converted 
DNA washed off with TE buffer. 
The converted DNA was then processed by PCR using specific primers spanning the 
gene promoter region of interest. The primers used for PCR amplification and sequencing are 
listed in the Table within Fig 2.7. 0.4ug DNA was mixed with PCR master mix [consisting of: 
Green GoTag® Flexi Buffer, 2mM MgCl2, 0.2mM each dNTP, 0.2μM for both sense and 
antisense primer, 1.25unit GoTaq® Hot Start Polymerase](All Promega).  After an initial 
2mins denaturing step at 94.5°C, 40 cycles of PCR were performed (94°C for 30secs, 72°C 
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for 1min). After product size confirmation using gel electrophoresis, samples were purified 
with a Qiagen PCR purification kit and sent for sequencing by Cogenics (Takeley, Essex, 
UK). 
 
 
 
Figure 2.7 Schematic diagram of the steps involved in the bisulphite conversion and 
PCR amplification reaction. Genomic DNA was denatured to obtain single stranded DNA. 
The DNA then underwent the bisulphite conversion reaction. In this method unmethylated C 
residues are transformed to a T residue and methylated C residues remain as C residues. 
Specific DNA regions were amplified using sequence-specific primers. After PCR 
amplification, the methylation status of the CpG sites can be determined by direct 
sequencing, or by cloning and sequencing. 
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2.16  Methylation dependent immunoprecipitation (MeDIP) assay 
The assay was modified from a previous report (Zhang et al., 2006). A549 cells (2 x 106) 
from 2 wells of 6-well plate were used in each experiment. DNA sonication conditions were 
the same as used in the ChIP protocol above (section 2.x) i.e. 8x 10secs at 40% amplitude. 
Genomic DNA was extracted using phenol/chloroform and after air drying was dissolved in 
100ul of DEPC water. 10µl gDNA was stored as input control. The remaining 90µl was 
incubated with 110µl FB buffer [consisting 10mM Tris-HCl, PH 7.5, 50mM NaCl, 1mM 
EDTA) with 1.8µg 5meC-specific antibody (Calbiochem, , Nottingham, UK) overnight at 
4°C on a rotator. Antibody-DNA complexes were isolated by addition of 35µl protein A/G 
beads (Santa Cruz Biotechnology) for 6hrs at 4°C. Beads were washed five times in 100µl 
FB buffer and DNA eluted by vortexing in 100µl TE buffer containing 1.5%, 0.5% and 0.1% 
SDS sequentially. Elutes were pooled and DNA purified by phenol/chloroform extraction. 
The amount of methylated DNA in each sample was analyzed by QPCR with specific primers 
and compared with input control DNA for each sample. 
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Figure 2.8 Schematic diagram of the steps involved in the Methylation dependent 
immunoprecipitation (MeDIP) assay.  Cells were lysed in SDS lysis buffer and genomic 
DNA (gDNA) fragmented by sonication. 1/20 of sonicated gDNA was used as input control. 
All remaining sonicated DNA was immunoprecipitated with 5meC antibody overnight and 
purified by phenol/chloroform extraction. Methylated DNA was quantified by QPCR with 
primers specific for regions of interest in selected promoters as a ratio to input control. 
 
2.17  Statistics 
Data points are values in the text and figure legends represent the mean S.E.M of at least 
3 independent determinations taken from different cell preparations. Groups of data were 
compared using the Mann-Whitney test. Statistical significance was set at P<0.05. 
  
Q
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CHAPTER THREE 
THE EFFECT OF OXIDATIVE TRESS ON TGF-β1 TRANSCRIPTION 
IN A549 CELLS 
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3.1 Rationale 
Chronic inflamed tissues are characterized by a complex milieu of pro-inflammatory 
cytokines (e.g. IL-1β and TNF), and ROS (e.g. H2O2) (Enesa et al., 2008). In smokers 
(Nowak et al., 1996), asthmatic patients (Antczak et al., 1997), and COPD patients (Nowak et 
al., 1998) also tend to have higher levels of exhaled H2O2 than non-smokers, and levels are 
even higher during exacerbations of COPD (Dekhuijzen et al., 1996). Other markers of 
oxidative stress including lipid peroxidation products and changes in redox capacity are also 
abnormal in the lungs and biopsies of COPD patients and subjects with severe asthma 
(Rahman review).  Oxidative stress, like H2O2, may activate intracellular cascades through 
redox sensitive transcription factors such as NF-B and AP-1 (Gloire et al., 2006) to 
exaggerate lung inflammation in the airways. Oxidative stress has been implicated in the 
pathogenesis of inflammatory lung disorders (Rahman and Adcock, 2006). IL-1 is a 
proinflammatory cytokine which is secreted from monocytes/macrophages, neutrophils, and 
airway epithelial cells (Chung, 2001). Increased IL-1β is reported in induced sputum from 
stable COPD patients (Keatings et al., 1996) and greater IL-1 release is observed from 
alveolar macrophages from cigarette smokers and COPD patients (Lim et al., 2000). Upon 
binding to IL-1 receptors on the cell surface, IL-1β stimulates the expression of a large 
number of proinflammatory proteins, including enzymes, adhesion molecules, chemokines, 
and acute phase proteins (Dunne and O'Neill, 2003). Transcription factor NF-B is one of the 
key signalling molecules activated by IL-1β, and leads to increased transcription of target 
genes (Barnes and Karin, 1997). 
Elevated expression of TGF-β1 occurs in a number of pulmonary diseases such as 
COPD (de Boer et al., 1998), asthma (Minshall et al., 1997; Redington et al., 1997b), as well 
as pulmonary fibrosis (Khalil et al., 1996). Analysis of the 5’ end of the human TGF-β1 gene 
revealed that the promoter region is very G+C rich, containing binding sites for AP-1 (Kim et 
al., 1990; Kim et al., 1989), and NF-B. Increased recruitment of NF-B p65 to the TGF-1 
81 
 
promoter is found following IL-1β stimulation of A549 cells (Lee et al., 2006). However, 
information concerning the transcriptional regulation of TGF-β1 under conditions of 
oxidative stress remains unclear. 
Since TGF-β1 is upregulated in some chronic inflammatory lung disease, it is interesting 
to investigate whether oxidative stress, together with IL-1β, are involved in this 
transcriptional regulation, and whether the redox-sensitive transcription factor NF-B is 
involved in IL-1β and H2O2 induced TGF-β1 transcription. 
 
3.1.1 Hypothesis and aims of this Chapter 
We hypothesise that oxidative stress, in combination with IL-1β, may upregulate TGF-
β1 in the airways. And the upregulated TGF-β1 can be suppressed by glucorticoid. 
The specific aims were: 
1. To determine the effect of H2O2, and in combination with IL-1β, on TGF-β1 
production by A549 cells, and BEAS-2B cells. 
2. To evaluate the role of redox sensitive transcription factors, such as NF-κB, on TGF-
β1 expression. 
3. To examine the effect of FP treatment on H2O2 stimulation alone, and in combination 
with IL-1β induced upregulation of TGF-β1 production. 
 
3.2 Experiment Protocols 
3.2.1  Cell Survival and Apoptosis study under oxidative stress 
85-95% confluent A549 cells were cultured in serum-free DMEM medium supplemented 
with L-glutamine for 48hrs before stimulation. Cells were stimulated with IL-1β (10ng/ml), 
H2O2 (40, 200, 400 and 2000μM) and fluticasone propionate (10-8 and 10-10M) for 6h. Cells 
were collected following treatment with trypsin and neutralized with complete medium (10% 
FCS, 2% L-glutamine). Cells were subsequently washed twice with cold PBS and then 
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resuspend in 1X Binding Buffer at a concentration of 1 x 106 cells/ml. 100µl of the solution 
(1 x 105 cells) were transferred to a 5ml culture tube. 5µl of Annexin V-FITC and 5µl PI were 
added to the solution. The cells were vortexed gently and incubated for 15mins at RT (25°C) 
in the dark. 400µl of 1X Binding Buffer were added to each tube before analysis by flow 
cytometry within 1h. Annexin-V positive cells were considered to be apoptotic if they stained 
negative for PI (normal permeability) or as either late apoptotic or necrotic if they stained 
positive for PI (increased permeability) (Geiser et al., 2004). 
 
3.2.2 Measurement of intracellular oxidative stress by Dichlorofluorescein Assay 
A549 cells were split and counted by trypan blue exclusion. Viable cells (104/well) were 
plated into 96-well collagen-coated plates 1 day before the experiments. On the day of the 
experiments, after removing the medium, the cells were washed with KRH buffer (118mM 
NaCl, 4.8mM KCl, 1.2mM MgSO4, 2.5mM CaCl2, 10nM HEPES, PH 7.4), and then 
incubated with 100μM DCFH-DA (2’,7’-dichlorofluorescin diacetate) in loading medium in 
5% CO2/95% air at 37°C for 30mins. After DCFH-DA was removed, the cells were washed 
and incubated with KRH buffer and IL-1β (10ng/ml), with or without H2O2 (200µM), or left 
untreated for various times. The cell fluorescence from each well was measured by 
Fluorescence plate reader (Synergy HT) and recorded. The excitation filter was set at 485nm 
and the emission filter was set at 530nm.  
 
3.2.3 TGF-1 release from stimulated cells 
85-95% confluent A549 cells were cultured in serum-free DMEM medium supplemented 
with L-glutamine for 36hrs before stimulation. Cells were stimulated with IL-1β (10ng/ml), 
with or without H2O2 200μM, or left untreated for variable times (0, 8, 16 and 24hrs). Total 
TGF-β1in the supernatant was determined by ELISA. 
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3.2.4  Effect of AS602868, SP600125 and actinomycin D on active TGF-1 release 
A549 cells were pre-treated with AS602868 (10μM, an IKKb inhibitor), SP600125 (10μM, a 
JNK inhibitor) or Actinomycin D (ACD, 10μg/ml, an inhibitor of transcription) for 1hr before 
incubation with medium alone or IL-1β, with or without H2O2, for 6hrs. Supernatants were 
collected and assayed for TGF-β1 by RT-QPCR. 
 
3.2.5 TGF-1 mRNA expression 
Cells were incubated with medium or IL-1β (0.01, 0.1, 1, 5 and 10ng/ml), with or without 
H2O2 (40, 100, 200, 1000 and 2000μM), for 4, 8, 16 and 24hrs. RNA was isolated and levels 
of TGF-β1 mRNA were quantified by RT-QPCR as a ratio of control housekeeping mRNA 
(-actin or GNB2L1). 
 
3.2.6 TGF-1 protein production  
Cells were incubated with medium or IL-1β (10ng/ml), with or without H2O2 (200μM), for 8 
or 24hrs. Protein extracts were obtained and TGF-1 detected by Western blotting. 
 
3.2.7 Effect of oxidative stress on BEAS-2B cells 
90% confluent BEAS-2B cells were serum-starved for 24hrs before stimulating with IL-1β 
(10ng/ml), with or without H2O2 (200µM), or left untreated and samples collected after 6hrs. 
Total RNA was isolated and levels of TGF-β1 mRNA were quantified by RT-QPCR with 
primers specific for TGF-β1. Relative TGF-β1 mRNA expression levels were normalized to 
GNB2L1 mRNA expression. 
  
3.2.8 NF-B DNA binding activity  
Cells were left untreated or were stimulatedwith IL-1β (10ng/ml), with or without H2O2 
(200μM), for 1hr.  Nuclear protein was extracted and NF-B DNA binding activity was 
84 
 
determined by TransAm NF-B p65 assay kit (Active motif, Belgium). 
 
3.2.9 NF-B p65 occupancy at the native TGF-1 promoter 
A549 cells were untreated, or stimulated with IL-1β (10ng/ml), with or without H2O2 
(200μM), for variable times (0, 30, 60 and 120mins). NF-B p65 recruitment to the TGF-β1 
promoter was determined by ChIP assay with a specific p65 antibody. Enrichment of DNA 
was quantified by QPCR with primer pairs amplifying DNA sequences around the putative 
B sites. 
 
3.2.10 In vitro p65 TGF-1 promoter binding affinity 
A549 cells were treated with IL-1β (10ng/ml), with or without H2O2 (200µM), or left 
untreated for 1h. NF-B p65 binding affinity to specific TGF-β1 sites was determined by an 
in vitro p65 DNA binding assay with a specific antibody against p65. Competitive 
experiments for the B-3 site were carried out by incubating samples with wild-type and 
mutant competitor DNA oligonucleotides (wB3 and mB3). 
 
3.2.11 Effect of Fluticasone propionate (FP) on oxidative stress induced TGF-1 up-
regulation 
A549 cells were serum-starved for 48hrs and then pre-treated with variable concentrations of 
FP (10-12 - 10-6M) for 30mins. The cells were stimulated with IL-1β (10ng/ml), with or 
without H2O2 (200µM), or left untreated for 4hrs. Total RNA was isolated and levels of TGF-
β1 mRNA were quantified by RT-QPCR and expressed relative to control mRNA. 
 
3.2.12 Effect of Mifepristone (RU486) on FP-suppression of oxidative stress-induced 
TGF-1 mRNA expression 
A549 cells were serum starved for 48hrs, pre-treated with Mifepristone (10-10 - 10-6M) for 
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30mins, followed by addition of FP (10-8M) for 30mins. The cells were then stimulated with 
IL-1β (10ng/ml) plus H2O2 (200µM) for 6hrs. Total RNA was isolated, and levels of TGF-β1 
mRNA were quantified by RT-QPCR. Relative expression level was normalized with 
GNB2L1 mRNA expression level as the internal control. 
 
3.2.13 Effect of IL-1 and H2O2 on IL-8/CXCL8 and GMCSF mRNA expression. 
A549 cells were serum starved for 48h before pre-treatment with FP (10-8M) for 30mins. The 
cells were then stimulated with IL-1β (10ng/ml) plus H2O2 (200µM) for 6hrs. Total RNA was 
isolated, and levels of IL-8/CXCL8 and GM-CSF mRNA were quantified by RT-QPCR with 
specific primer pairs. Relative expression levels were normalized to GNB2L1 mRNA 
expression as an internal control. 
 
 
 
3.3 RESULTS 
3.3.1 Effect of hydrogen peroxide (H2O2), IL-1ß, and fluticasone propionate (FP) on 
cell survival and cell proliferation 
H2O2 can affect cell apoptosis and death (Geiser et al., 2004; Miyoshi et al., 2006) so we 
investigated the effect of H2O2 on cell apoptosis by flow cytometry using Annexin-V and Pi-
staining. H2O2-induced cell death was only observed at the highest concentration of H2O2 
examined (2000µM) (Fig 3.1A). Both early apoptosis (PI-negative cells) and late apoptosis or 
necrosis (PI-positive cells) contributed to cell death at this concentration of H2O2. At lower 
concentrations of H2O2 no significant effect on cell death or apoptosis was seen in medium 
control, IL-1β- or FP-treated groups. 
In order to determine the effect of H2O2, IL-1β, and FP on cell proliferation, we perform 
MTT assays after 16hrs of incubation with the different treatments (Fig 3.1B). Although there 
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was a trend towards a reduction in cell proliferation with H2O2 alone this did not reach 
statistical significance and was not seen in the presence of either IL-1β or FP. 
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Figure 3.1 Effect of hydrogen peroxide (H2O2), IL-1, and fluticasone propionate 
(FP) on cell survival and cell proliferation.  (A) Effect of treatment on cell survival and 
apoptosis. A549 cells were treated with H2O2, IL-1β, and FP. Early apoptosis [annexin V 
positive, propidium iodide (PI) negative] and late apoptosis/necrosis (annexin V positive, PI 
positive) was determined after 16h by annexin V/PI staining and flow cytometry. H2O2 
increased apoptosis at the highest concentration of H2O2 investigated (2000μM). Results are 
shown as mean ± SEM. *P<0.05 compared with medium control (n=4). (B) Effect of 
treatments on cell proliferation as determined by MTT assay. A549 cells were treated with 
H2O2, IL-1β, and FP for 16hrs. Results are shown as mean ± SEM (n=3). 
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3.3.2 Effect of IL-1β and H2O2 on intracellular oxidative stress 
To examine whether H2O2 is able to induce intercellular oxidative stress in our model, A549 
cells were stimulated with IL-1β (10ng/ml), with or without H2O2 (200µM), or left untreated 
for variable times (1, 2, 4, 6 and 24hrs) (Fig 3.2). Upon stimulation with IL-1β, there was no 
difference in intracellular oxidative stress when compared to the basal fluorescence reading. 
H2O2 stimulation effectively increased intracellular oxidative status when compared to the 
basal level. In addition, IL-1β plus H2O2, in combination, further enhanced intracellular 
oxidative stress. This demonstrates that IL-1β stimulation may enhance the ability of 
exogenous H2O2 to trigger intracellular oxidative stress. The data also suggests that a 
component of the IL-1 signalling pathway is redox sensitive. 
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Figure 3.2 Effect of IL-1β and hydrogen peroxide (H2O2) on intracellular oxidative 
stress.  Cells were washed with KRH buffer and then incubated with 100 μM DCFH-DA in 
the loading medium in 5% CO2/95% air at 37°C for 30 mins. DCFH-DA was removed, and 
cells were washed and incubated with KRH buffer and finally stimulated with IL-1β, with or 
without H2O2, or left untreated for variable times (1, 2, 4, 6 and 24hrs). Results are shown as 
mean ± SEM. * p<0.05, ** p<0.01, *** p<0.005 when compared to basal status at the same 
time point. N = 3 independent experiment. 
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3.3.3 Effects of IL-1 on TGF-1 mRNA 
The effects of IL-1 on gene expression of TGF-1 were analyzed by quantitative real-
time (RT-QPCR) with TGF-1 specific primers. A549 cells were serum starved for 24hrs 
before being stimulated with various concentrations of IL-1 (0.01 - 10ng/ml) for 6hrs. The 
results demonstrated a concentration-dependent induction of TGF-1 mRNA by IL-1. 
Levels of TGF-1 mRNA increased with a maximal 1.6-fold induction (P<0.05) achieved at 
10ng/ml IL-1 (Fig. 3.3A). 
The kinetics of mRNA expression demonstrated a time-dependent induction of TGF-1 
mRNA by IL-1 (Fig. 3.3B). The level of TGF-1 in mRNA revealed a 1.5-fold increase 
(P<0.05) when compared with media control at 6hrs, and reached a maximal response at 16h 
(1.7 fold, P<0.005) which was maintained for at least 24hrs (1.5 fold, P<0.01). 
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Figure 3.3 Effect of IL-1 on TGF-1 mRNA induction. Cells were incubated with 
medium or IL-1 (0.01 - 10ng/ml) for 6hrs (A) or IL-1ß (10ng/ml) for 6, 8, 16 and 24hrs (B). 
Levels of TGF-1 mRNA were quantified by RT-QPCR and were normalized to GAPDH 
mRNA levels. #P<0.05 when compared with no treatment. *P<0.05; **P<0.01; ***P<0.005 
when compared with non-treatment (n=at least three independent experiments).
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3.3.4 Effects of H2O2 on TGF-1 message RNA expression 
H2O2 alone had a small but significant 1.3 fold induction of TGF-1 mRNA expression 
at 200M only (P<0.05) (Fig. 3.4A) but this was not concentration-dependent (Fig. 3.4A). 
This induction of TGF-1 mRNA was time-dependent (Fig. 3.4B). The level of TGF-ß1 
mRNA induced by 200M H2O2 revealed a slight increase from 6hrs, and reached a maximal 
1.6 fold (P<0.05) increase compared with media control at 16hrs. However, the induction 
ratio returned to baseline by 24hrs (Fig. 3.4B). 
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Figure 3.4 Effect of hydrogen peroxide (H2O2) on TGF-1 mRNA induction. Cells 
were incubated with medium or H2O2 (40 - 2000µM) for 6h (A) or H2O2 (200µM) alone for 
6, 8, 16 and 24hrs (B). Levels of TGF-1 mRNA were quantified by RT-QPCR and 
normalized to GAPDH mRNA levels. #P<0.05 when compared versus non-treatment. 
*P<0.05 when compared with non-treatment (n=at least three independent experiments). 
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3.3.5 Effect of IL-1 and hydrogen peroxide (H2O2) on TGF-1 release 
TGF-1 protein levels in the conditioned media of cultured A549 cells were measured 
by ELISA following IL-1 (Fig. 3.5A) or H2O2 treatment (Fig. 3.5B). Inasmuch as most cells 
secrete TGF-1 in latent form which can be activated upon extreme acidification, heat or 
protease digestion (Annes et al., 2003), total TGF-1 was determined by acidification of 
conditioned media.  
The results demonstrated a significant concentration-dependent elevation of total TGF-
1 levels in response to IL-1 (Fig 3.5A). This stimulation reached a maximal 1.7-fold 
induction (281.2±23.1 pg/ml vs 135.7±6.3 pg/ml, P<0.005) at 50ng/ml IL-1 (Fig. 3.5A), 
which is similar to the effect on TGF-1 mRNA levels (Fig. 3.3A).  
In the H2O2 alone treated group, total TGF-1 levels increased up to 1.2 fold 
(167.1±10.1 pg/ml vs 135.7±6.3 pg/ml, P<0.05) after treatment with 200µM H2O2 (Fig 3.5B). 
Interestingly, in contrast to the increases seen in TGF-1 mRNA levels, treatment with 
2000µM H2O2 produced a decrease in the levels of total TGF-1 by 1.5 fold (91.9±10.94 
pg/ml vs 135.7±6.3 pg/ml, P<0.05). 
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Figure 3.5 Effect of IL-1 (A) and hydrogen peroxide (H2O2)(B) on total TGF-1 
release. Cells were incubated with medium alone, IL-1 (0.01 - 50ng/ml) or H2O2 (40 - 
2000µM) for 8h. Supernatants were collected and assayed for TGF-1 by ELISA. *P<0.05; 
*** P<0.005 versus non-treatment. Results are expressed as means ± the SEM (n=at least 
three independent experiments.) 
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3.3.6 Hydrogen peroxide (H2O2) augments the effect of IL-1 on TGF-1 release 
The kinetics of TGF-1 mRNA expression demonstrates a time-dependent induction by 
IL-1 plus H2O2 (Fig. 3.6A). Upon IL-1 (10ng/ml) plus H2O2 (200µM) stimulation, levels 
of TGF-1 mRNA increased 1.7 fold (P<0.005) after 6h and reached a maximum 2.0 fold 
increase (p<0.005) after 8hrs when compared with media control. Although the levels of 
TGF-1 mRNA were still elevated at 16 and 24hrs there was no additional effect above that 
of IL-1 over this time (1.6 fold, P<0.05). Furthermore, the enhanced effect of IL-1 plus 
H2O2 treatment evident at 6 and 8hrs was lost by 16-24hrs. 
Upon IL-1 (10ng/ml) plus H2O2 (200µM) stimulation, measurement of TGF-1 by 
ELISA (Fig. 3.6B) demonstrated elevated levels of total TGF-1 protein when compared with 
medium alone at 8hrs (164.6±7.3 pg/ml vs 135.7±6.3 pg/ml, P<0.05) and 16hrs (316.1±11.4 
pg/ml vs 264.8±40.9 pg/ml, P<0.05). However, in contrast to the effect seen on TGF-1 
mRNA levels there was no additional effect of IL-1 plus H2O2 treatment when compared 
with IL-1ß or H2O2 induction alone at any time point examined. 
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Figure 3.6 Effect of IL-1 plus hydrogen peroxide (H2O2) on TGF-1 mRNA and 
total protein. Cells were incubated with medium alone, IL-1 (10ng/ml), H2O2 (200µM), or 
IL-1 plus H2O2 for 6, 8, 16 or 24hrs. (A) TGF-1 mRNA levels were quantified by RT-
QPCR and were normalized to GAPDH mRNA levels. (B) Supernatants were collected and 
assayed for total TGF-ß1 by ELISA. *P<0.05; **P<0.01; ***P<0.005 versus medium alone. 
Results are expressed as means ± SEM (n=at least three independent experiments). 
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3.3.7  Effect of H2O2, IL-1, and H2O2 plus IL-1 on TGF-1 production 
In an initial attempt to determine whether IL-1-induction of TGF-1 release involves de 
novo TGF-1 production rather than release from pre-formed stores, Western blot analysis of 
whole cell lysates was performed.  Using a specific TGF-1 antibody a clear immunoreactive 
band at 25kd was detected after 8h of incubation with medium alone (Fig 3.7). This was 
elevated in the presence of 10ng/ml IL-1 (1.5 fold, P<0.01) and H2O2 plus IL-1 (1.4 fold, 
P<0.05) but not by 200µM H2O2 alone (Fig 3.7B). IL-1 alone also increased intracellular 
TGF-1 at 24 hrs (1.3 fold, P<0.01)(Fig 3.7C). 
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Figure 3.7 Effect of hydrogen peroxide (H2O2), IL-1 and H2O2 plus IL-1 on TGF-
1 production. Cells were incubated with medium, H2O2 (200µM), IL-1 (10ng/ml), or 
H2O2 plus IL-1 for 8 and 24h. TGF-1 in whole cell lysates was examined by Western 
blotting (A). Bar graphs show quantitative analysis of TGF-1 expression at 8h (B) and 24h 
(C). Results are expressed as mean ± SEM of the TGF-1/-actin loading control ratio versus 
medium control at 8h and 24h. (n=3). 
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3.3.8  Determination of the signalling pathways involved in H2O2, IL-1, and H2O2 
plus IL-1 induction of TGF-1 mRNA 
To test whether NF-B, JNK or MAPK pathways are involved in the induction of TGF-1 
mRNA the selective IKK2 inhibitor AS602868 (10µM), the selective JNK inhibitor 
SP600125 (10µM) and the relatively selective inhibitor of p38α/ SB203580 (10µM) were 
added 1hr before IL-1 stimulation and incubated for a further 6hrs (Fig.3.8A). Only 
AS602868 suppressed IL-1-induced TGF-1 mRNA induced by IL-1 and by H2O2 plus IL-
1. SP600125 and SB203580 had no effect at this time point. Pretreatment with the 
transcriptional inhibitor actinomycin D (10µg/ml) prevented induction of TGF-1 mRNA by 
both IL-1 alone and by IL-1 plus H2O2 confirming a role for transcription in the increase in 
TGF-1 mRNA expression. However, actinomcyin D had no significant effect on H2O2-
induced TGF-1 mRNA expression. This suggests that other regulatory mechanisms such as 
mRNA stability must be involved in this induction of TGF-1 mRNA. We further validated 
the total TGF-β1 protein in supernatants by ELISA (Fig. 3.8B). Pretreatment with the IKK2 
inhibitor reduced both basal and stimulated levels of secreted TGF-β1 protein. These data 
emphasized the key role of the IKK2/NF-B pathway in mediating IL-1- and IL-1 plus 
H2O2-induced TGF-1 gene expression but not TGF-ß1 gene expression induced by H2O2 
alone. 
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Figure 3.8  Effect of AS602868, SP600125, SB203580 and Actinomycin D on IL-1, 
hydrogen peroxide (H2O2) and IL-1 plus H2O2 induced TGF-1 gene expression. (A) 
Cells were pretreated with AS602868 (10µM), SP600125 (10µM), SB203580 (10µM) or 
actinomyin D (10µg/ml) with or without treatment with IL-1 (10ng/ml), H2O2 (200µM), or 
IL-1 plus H2O2 for 6h. Levels of TGF-1 mRNA were quantified by RT-QPCR and 
normalized to GAPDH mRNA levels. **P<0.01 versus IL-1ß alone; #P<0.05; ##P<0.01 
versus IL-1 plus H2O2. (B) Cells were pretreated with AS602868 before stimulation with IL-
1, with or without H2O2, for 6hrs. Supernatants were collected and TGF-1 levels measured 
by ELISA. All levels are shown as an induction ratio compared to control. Results are 
expressed as mean ± SEM of fold induction versus medium control. * P<0.05 versus control; 
# P<0.05 versus IL-1 stimulation; &P<0.05 versus H2O2 stimulation; + P<0.01 versus IL-1 
plus H2O2 stimulation. 
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3.3.9  NF-B protein and activity is upregulated by IL-1β and H2O2  
To confirm whether the amount of NF-B p65 protein was increased following IL-1β 
and H2O2 stimulation, A549 cells were stimulated with IL-1β (10ng/ml), with or without 
H2O2 (200µM), for 1hr. Total cell proteins were extracted and the amount of p65 protein 
detected by Western blotting with a specific p65 antibody. The result demonstrates a small 
but significant increase in NF-B p65 protein expression following stimulation of the cells 
with IL-1β, H2O2 and IL-1β plus H2O2 although the effect of the combination treatment was 
not significantly greater than that seen with either single treatment alone (Fig 3.9A & B). 
We further checked to see whether the activation status of NF-B p65 was also 
increased by IL-1β and H2O2 by examination of p65 DNA binding using a TransAM NF-B 
p65 kit. Cells were stimulated with IL-1β (10ng/ml), with or without H2O2 (200µM), for 1hr. 
Nuclear protein was collected and activation status measured. NF-B p65 DNA binding 
activity was significantly enhanced by both IL-1 and by H2O2 albeit the effect of IL-1 was 
much greater than that of H2O2 (Fig 3.9C).  IL-1β plus H2O2 increased NF-B p65 DNA 
binding to a similar extent as seen with IL-1 alone. The data demonstrates that although 
H2O2 can enhance p65 protein to the same extent as IL-1 the functional response (DNA 
binding) to IL-1 stimulation is much greater.  This clearly demonstrates that protein levels 
per se are not the only drivers for NF-B p65 activation. 
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Figure 3.9 Effect of IL-1 and hydrogen peroxide (H2O2) on NF-B protein 
expression and DNA binding.  (A) Cells were pretreated with IL-1β, with or without H2O2, 
or left untreated for 1hr. Whole cell proteins were extracted, the amount of NF-B p65 was 
by Western blotting and compared to that of -actin as a loading control. (B) Results of 
densitometric analysis are presented graphically in (B). Results are shown as mean ± SEM. 
*p<0.05 when compared to basal status. N = three independent experiments. (C) Cells were 
pretreated with IL-1β, with or without H2O2, or left untreated for 1hr. Nuclear protein was 
extracted and activation of NF-B p65 was detected with TransAM NF-B p65 DNA binding 
kit. Results are shown as mean ± SEM. *p<0.05, **p<0.01, ***p<0.005 when compared to 
basal status. N = three independent experiments.  
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3.3.10 Binding of p65 to the TGF-1 B3 site in vitro 
An ELISA based DNA binding assay was used to investigate whether the binding of p65 
to the B3 site was DNA sequence-specific. Nuclear extracts were added to a well of a 
microtitre plate previously coated with immobilized B1, B2 or B3 oligonucleotides (Fig. 
3.10A). Protein binding to specific oligonucleotides was then detected with a p65-specific 
antibody as with a standard TransAm assay. Recruitment of p65 to the B3 oligonucleotides, 
but not to the B1, or B2 oligonucleotides, increased significantly with stimulation by IL-1β 
plus H2O2, the (Fig. 3.10B). These results indicate that p65 binding to the TGF-1 B3 site 
may be due to different intrinsic affinities of the different sites for p65.  
To determine whether p65 binding was B3 specific we then performed a competitive 
study with wild type (wB3) and mutant type B3 (mB3) oligonucleotides. The binding 
activity of p65 to the B3 oligonucleotide was decreased after addition of excess wkB3 in a 
concentration-dependent manner (Fig. 3.10C) (P<0.01 for 2M wB3) but not with the 
mutant mB3 oligonucleotide. To further confirm the specific response of IL-1β and H2O2 on 
p65 recruitment to the B3 binding site, cells were stimulated with IL-1β, with or without 
H2O2 (200M). The results demonstrates that the DNA binding activity of p65 was 
upregulated in IL-1β (P<0.01) and IL-1β plus H2O2 (P<0.01) stimulated cells (Fig. 3.10D) 
but not in cells stimulated with H2O2 alone.  
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Figure 3.10  Binding of p65 to consensus NF-B binding sites in the TGF-1 promoter 
in vitro. (A) Sequence of the DNA oligonucleotides including the B1, B2, B3 or mutated 
(m) oligonucleotides used in the NF-B promoter binding assays. Mutations from wildtype 
(w) B3 sites are underlined. (B) Cells were treated with IL-1β (10ng/ml) plus H2O2 
(200M) for 1hr. Nuclear extracts were incubated with different oligonucleotides in 96-well 
plates previously coated with B1, B2, or B3 nucleotides. Binding activities were detected 
with a specific p65 antibody. (C) Cells were incubated with wB3, or mB3 for competitor 
assays. (D) Cells were treated with IL-1β, with or without H2O2, or left untreated. Results are 
mean ± the SEM of ratio to basal levels. &&P<0.01 versus B1, B2. ##P<0.01 versus control. 
++P<0.01 versus IL-1 plus H2O2. **P<0.01 when compared with control. n = three 
independent experiments. 
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3.3.11 Selective recruitment of p65 to B response elements in the native TGF-1 
promoter 
In order to determine the role of NF-B pathways in the induction of TGF-β1 
transcriptional activation, ChIP assays with a p65 specific antibody were performed to 
measure p65 association with the native human TGF-β1 promoter. TGF-β1 promoter was 
analyzed by Alibaba (Http://www.gene-regulation.com/pub/programs/alibaba2), and the 
results showed 3 putative NF-B binding sites (B1, -2105 to -2096; B2, -2014 to -2005; 
B3, -789 to -780, from the translation start site) (Fig.3.11A). Primers pairs with QPCR 
products were designed to amplify the DNA corresponding to the putative B sites, in order 
to measure the DNA fragments immunoprecipitated by specific p65 antibody by QPCR. A set 
of primers amplifying a distal site 3' to the translation start site, 25665-25797 from the 
translation start site were used as a negative control. 
The time course of p65 ChIP analysis showed that IL-1β and IL-1β plus H2O2 
stimulation resulted in p65 recruitment to the B3 site from 60min and up to 120min 
(Fig.3.11B) but not to the B1 or B2 site (Fig.3.11C). There was no significant effect of 
H2O2 on p65 association with any of the TGF-1 promoter B sites. ChIP experiments also 
confirmed that the results were selective as none of the stimuli used at any time point 
examined had any effect on p65 association with the 3’ distal end of the TGF-1 promoter. 
These results indicate that IL-1β and IL-1β plus H2O2 induce association of p65 to the B3 
binding site but that H2O2 stimulation alone does not. 
These results further demonstrate that p65 binding to B3 sites on the TGF-1 promoter 
is sequence specific following either IL-1β or IL-1β plus H2O2 stimulation.  In addition, the 
presence of H2O2 does not enhance p65 TGF-1 promoter binding.  This cannot, therefore, 
explain the increased NF-B-dependent TGF-1 mRNA transcription that occurs with IL-
1/H2O2 stimulation. 
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Figure 3.11 Effect of IL-1 and hydrogen peroxide (H2O2) on p65 recruitment to the 
native TGF-1 promoter. (A) Schematic diagram of the TGF-1 promoter - numbers 
indicate positions in relation to the translation start site (ATG). NF-B binding sites (B1, 
B2 and B3) and a distal 3’ site are indicated. (B) Time course of p65 recruitment to the 
B3 site following stimulation with IL-1β (10ng/ml), with or without H2O2 (200M), for 0, 
30, 60 and 120mins. The p65-associated DNA was quantified by QPCR with primer pairs 
specific for the B3 site. (C) Time course of p65 recruitment to the B1 site, B2 and the 3’ 
distal sites. Associated DNA was quantified by QPCR. Values were normalized to input 
DNA. Results are mean ± the SEM of ratio to basal levels. * denotes P<0.05 versus basal 
level (same time point). n = three independent experiments.  
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3.3.12  Effect of fluticasone propionate (FP) on oxidative stress induced TGF-1 
mRNA expression in airway epithelial cells 
Glucocorticoids are used extensively for their potent anti-inflammatory effects in a 
number of chronic inflammatory lung diseases including asthma (Barnes and Adcock, 2003), 
COPD (Singh et al., 2002) and some other mild forms of interstitial lung disease (Pujols et 
al., 2004). We therefore, examined the ability of a potent synthetic glucocorticoid, fluticasone 
propionate (FP) to suppress IL-1-stimulated TGF-1 mRNA expression in the presence of 
an oxidative stress (200M H2O2). 
The effect of FP on TGF-1 gene expression was analyzed by RT-QPCR. The result 
demonstrated that FP reduced IL-1-induced TGF-β1 mRNA levels in a concentration-
dependent manner (Fig. 3.12A). The EC50 for FP inhibition of IL-1β-induced TGF-β1 was 
4.61 x 10-11M.  In contrast, the EC50 for FP inhibition of IL-1β plus H2O2-induced TGF-β1 
mRNA expression was shifted to the right 17-fold (4.61 x 10-11M versus 7.69 x 10-10M). The 
results confirmed that the potency of FP towards TGF-1 is reduced in these cells in the 
presence of H2O2. Furthermore, FP is also unable to reduce the level of IL-1/H2O2-
stimulated TGF-1 mRNA down to basal levels (Fig 3.12A). This further suggests that the 
addition of H2O2 may impair the ability of FP to suppress TGF-β1 mRNA expression. 
We then confirmed that the effect of FP on TGF-1 mRNA expression was mediated by 
GR. A549 cells were pretreated with the GR antagonist RU486 (Garside et al., 2004) (10-10 - 
10-6M) and FP (10-8M) in the presence of IL-1β (10ng/ml) plus H2O2 (200µM) for 6hrs (Fig. 
3.12B). RU486 antagonized the suppressive effects of FP on IL-1β plus H2O2 induced TGF-
β1 mRNA expression in a concentration-dependent manner with complete abrogation of FP 
effects seen with 1µM RU486. These results demonstrate that the inhibitory effects of FP on 
IL-1/H2O2-stimulated TGF-1 mRNA expression were mediated through GR.  
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Figure 3.12 Effect of hydrogen peroxide (H2O2) on fluticasone propionate (FP)-
induced suppression of TGF-1 mRNA expression. (A) Cells were pretreated with variable 
concentrations of FP (10-12 - 10-6M) for 30min before stimulation with either IL-1β (10ng/ml) 
alone or IL-1 plus H2O2 (200µM) for 6hrs. (B) Cells were pretreated with variable 
concentrations of RU486 (10-10 - 10-6M) for 30min before exposure to FP (10-8M) for 30mins 
and subsequent stimulation with IL-1β (10ng/ml) plus H2O2 (200µM) for 6h. Total RNA was 
collected, quantified by RT-QPCR with primers specific for TGF-β1 and relative expression 
levels corrected for GNB2L1 mRNA as control. Results are shown as means ± the SEM. 
#p<0.05 versus IL-1β plus H2O2. *P<0.05 versus IL-1β plus H2O2 plus FP. N = at least three 
independent experiments. 
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3.3.13 Effect of IL-1β and hydrogen peroxide (H2O2) on TGF-1 mRNA expression in 
BEAS-2B cells 
To examine whether the induction of TGF-β1 by IL-1β plus H2O2 is found in other 
airway/lung epithelial cells, BEAS-2B cells were pretreated with or without variable 
concentrations of FP (10-10 - 10-6M) for 30 mins before stimulation with IL-1β (10ng/ml), 
with or without H2O2 (200μM), for 6 hrs (Fig 3.13). The results demonstrated a small but 
significant increase in TGF-β1 mRNA expression by IL-1β (1.28±0.09 versus control: 
0.96±0.08), H2O2 (1.25 ± 0.07 versus control) and IL-1β plus H2O2 (1.40 ± 0.11 versus 
control). Unlike the effects seen in A549 cells, the increase in TGF-β1 mRNA with IL-1β 
plus H2O2 was suppressed back to basal levels by FP (10-8M and 10-6M). These results 
indicate that although IL-1β and H2O2 enhancement of TGF-β1 mRNA expression is similar 
in both cell types and the functional response to FP is distinct.  This may reflect a difference 
in anti-oxidant capacity between the two cell lines. How primary human epithelial cells 
respond is an obvious area for future research. 
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Figure 3.13 Effect of IL-1, hydrogen peroxide (H2O2) and fluticasone propionate 
(FP) on TGF-1 mRNA expression.  Cells were pretreated with FP (10-10 - 10-6) for 30mins 
followed by stimulation with IL-1β (10ng/ml), with or without H2O2 (200M), for 6h. Total 
RNA was collected and the level of TGF-β1 mRNA was quantified with specific primers and 
expression levels corrected for control GNB2L1 mRNA. Results are shown as mean ± the 
SEM. *p<0.05 when compared with control; #p<0.05 when compared with IL-1β plus H2O2 
stimulation. N = four independent experiments.  
 
3.3.14 Effect of IL-1, H2O2 and FP on GM-CSF and IL-8/CXCL8 mRNA in A549 
cells 
We further checked whether the combination of IL-1β and H2O2 also enhanced the expression 
of two NF-B associated cytokines GM-CSF and IL-8/CXCL8. Cells were pretreated with FP 
(10-8M) for 30mins before stimulation with IL-1β (10ng/ml), with or without H2O2 (200µM), 
for 6hrs. GNB2L1The results demonstrate distinct effects of IL-1/H2O2 treatment on 
GMCSF mRNA and on IL-8/CXCL8 mRNA expression. IL-1β and H2O2 stimulation induced 
a greater than additive enhancement of GMCSF mRNA expression whilst this trend was not 
seen for IL-8/CXCL8 mRNA expression. In the case of IL-8/CXCL8 mRNA, both IL-1 and 
H2O2 significantly enhanced mRNA expression but the effect of IL-1 was much greater than 
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that of H2O2. In addition, the combination of IL-1 and H2O2 did not further enhance IL-
8/CXCL8 mRNA expression. In both cases, FP effectively reduced mRNA levels but, as with 
TGF-1 mRNA, these did not return to basal levels.  A full concentration response curve was 
not performed and this may provide important additional information. 
 
 
 
 
Figure 3.14 Effect of IL-1β, hydrogen peroxide (H2O2) and fluticasone propionate 
(FP) on GMCSF and IL-8/CXCL8 mRNA expression. Cells were pretreated with FP (10-
8M) for 30mins before stimulation with IL-1β (10ng/ml) and/or H2O2 (200μM) for 6hrs. Total 
RNA was extracted and relative expression of GMCSF and IL-8/CXCL8 mRNA expression 
quantified by RT-QPCR and normalized to GNB2L1 mRNA expression. Results are shown as 
mean ± SEM. **p<0.01 compared to baseline; ##p<0.01 compared to IL-1β plus H2O2 
stimulation. N = at least three independent experiments.  
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3.4 Discussion 
 The results presented here demonstrate that IL-1β, H2O2, and IL-1β plus H2O2 can 
induce TGF-β1 mRNA expression and protein from A549 cells. H2O2 stimulation alone is not 
a strong stimulus for TGF-β1 mRNA expression but it can augment the effect of IL-1β on 
TGF-β1 mRNA expression. TGF-1 induction was mediated through the NF-B pathway. 
Global NF-B activitation was activated by both IL-1 and by H2O2 although this effect was 
gene specific as H2O2 was unable to cause recruitment of NF-B p65 to the activating B3 
promoter site in vitro or at the native TGF promoter. Further evidence for a gene-specific 
effect of H2O2 on NF-B activity and mRNA expression was provided by the differential 
induction of TGF-1, GM-CSF and CXCL8/IL-8 mRNA by the same levels of NF-B 
activation. 
We further demonstrate that the potent synthetic corticosteroid fluticasone propionate 
(FP) can downregulate the enhanced TGF-β1 mRNA expression induced by IL-1 and H2O2 
albeit with a lower efficacy and to a lesser extent than that seen with TGF-1 mRNA 
stimulated with IL-1 alone. 
It is believed that the combination of inflammation and oxidative stress may be 
important in the pathogenesis of many diseases (Koh et al., 2009; Rahman and Adcock, 2006; 
Rodriguez-Iturbe et al., 2004). We therefore exposed cells to an acute inflammatory stress 
using IL-1 to mimic the inflammatory conditions encountered in asthma and COPD and 
other airways diseases in the presence or absence of H2O2 which was used as a model of 
oxidative stress. We were unable to demonstrate a direct effect of IL-1 on intracellular 
oxidative stress but importantly the combination of IL-1 with H2O2 gave a greater 
intracellular oxidant stress than H2O2 alone. This suggests that further investigation of the 
ability of IL-1 to enhance intracellular oxidative stress should be performed using more 
sensitive assays in combination with selective inhibitors or siRNA knockdown of specific 
oxidant/anti-oxidant molecules. In disease, cells are exposed chronically to both low levels of 
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inflammation and oxidative stress and perhaps a more chronic model of these events would 
show a greater enhancement of TGF-1 responsiveness as well as effects on exaggerated cell 
apoptosis and cell death (Hildeman et al., 1999).  
TGF-β1 expression shows a concentration-dependent upregulation by IL-1 with peak 
effects at ~50µg/ml for both protein and mRNA expression. H2O2 stimulation alone enhances 
TGF-β1 mRNA and protein secretion with a maximal effect at ~200µM. Simultaneous 
treatment of A549 cells with IL-1β (10ng/ml) and H2O2 (200µM) induces a greater than 
additive increase in TGF-β1 mRNA expression but not on secreted or intracellular TGF-β1 
protein. The uncoordinated expression of TGF-β1 mRNA and protein level possibly indicates 
the post-transcriptional or post-translational regulation may affect the TGF-β1 protein 
production (Allison et al., 1998; Kim et al., 1992).  
To determine whether this effect was specific for the A549 cell line, we also checked the 
response of TGF-β1 to IL-1β plus H2O2 in BEAS-2B cells. The results demonstrated a similar 
response to IL-1β and H2O2, which possibly indicates that it is a universal finding on 
epithelial cells that TGF-β1 mRNA expression may be upregulated upon inflammation and 
oxidative stress. It is important to perform similar studies in primary human airway epithelial 
cells to confirm this. 
Using the IKK2 inhibitor, AS602868, we were able to confirm that stimulated and basal 
TGF-β1 was under the control of the NF-B pathway. Measurement of NF-B activation in 
response to IL-1β, H2O2, and IL-1β plus H2O2 demonstrated enhancement of p65 expression 
by Western blot analysis at 1h by all three treatments. Furthermore, p65 DNA binding 
showed a similar increase in DNA binding at a consensus B site and the specifc B3 TGF1 
promoter site in response to IL-1βand IL-1β plus H2O2 stimulation at 1h. The response to 
H2O2 stimulation was less pronounced as compared to the ratio difference when measured by 
Western blotting. In addition, specific recruitment of p65 to the B3 site was confirmed by 
ChIP assay which also showed that H2O2 alone or in combination with IL-1 did not affect 
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p65 TGF1 promoter binding. The reasons for the discrepancies in NF-B activity measures 
probably reflects gene specificity and the precise aspect of NF-B biology that each 
technique measures.   To study whether IL-1β and H2O2 will regulate other NF-B 
regulated cytokines, total RNA was quantified for IL-8 and GMCSF mRNA expression study. 
Upregulation of IL-8 and GMCSF mRNA were also identified. But the result showed a 
differential pattern, in which IL-1β and H2O2 stimulation induced a greater than additive 
effect on GMCSF mRNA expression, but this enhanced effect was not seen with CXCL8/IL-
8 mRNA expression. These findings support that oxidative stress, simulated by IL-1β and 
H2O2, may induce a differential response on gene expression. Further studies using a 
combination of gene arrays and/or ChIP-seq analysis may further delineate this. 
We further examined whether the synthetic corticosteroid, FP, was able to downregulate 
the expression of TGF-β1 mRNA induced by IL-1β and H2O2. FP downregulates TGF-β1 
mRNA expression at concentrations higher than 10-10M. Compared to stimulation with IL-1β 
alone, IL-1β plus H2O2 stimulation results in a relative corticosteroid insensitivity, with a 
reduced EC50 (4.61 x 10-11M versus 7.69 x 10-10M) and a reduced maximal suppression. 
The data clearly suggests that the enhanced NF-B-dependent TGF1 mRNA 
transcription rate is not due to clear changes in p65 promoter association but may reflect 
changes in transcriptional co-activator or chromatin remodeling factor recruitment perhaps as 
a consequence of H2O2-induced changes in p65 post-translational modifications (Perkins, 
2007).  The histone code hypothesis (Jenuwein & Allis Science 2001; Li, Carey & Workman 
Cell 2007) postulates that changes in histone modifications are key to transcription. Previous 
work has indicated a role for changes in histone acetylation in TGF1 mRNA induction by 
IL-1 (Lee et al., 2006) but there is no published data concerning the possible influence of 
histone methylation of TGF1 expression or whether this can affect FP modulation of TGF1 
mRNA.  
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CHAPTER FOUR 
THE ROLE OF HISTONE METHYLATION IN OXIDATIVE STRESS-
INDUCED TGF-β1 EXPRESSION 
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4.1 Rationale 
Most inflammatory genes are regulated by proinflammatory transcription factors such as 
NF-B and AP-1 (Barnes and Adcock, 1998). DNA is compacted around eight histone 
molecules (2 each of histones 2A, 2B, 3 and 4) within chromosomes and post-translational 
modification of these core histones is able to switch on or off the gene expression in a process 
known as epigenetic regulation (Adcock et al., 2006). There are at least eight known 
modifications found on histones (Kouzarides, 2007). Among them, histone acetylation and 
deacetylation are the most studied mechanism involved in regulating inflammatory lung 
diseases (Barnes et al., 2005). In bronchial biopsies from asthma patients there is a marked 
increase in HAT activity which was reversed in patients on inhaled corticosteroids (Ito et al., 
2002) whilst in COPD patients there is a marked reduction in HDAC activity which 
correlated well with disease severity (Ito et al., 2005).  
Compared with histone acetylation, the enzymes responsible for histone lysine 
methylation, lysine methyltransferases (HMTs) have enormous substrate site specificity 
compared to the non-selective HATs (Kouzarides, 2007). Methylation of different lysine 
residues on histones results in distinct functions: H3K4, H3K36 and H3K79 trimethylation is 
associated with activation of gene transcription whilst H3K9, H3K27 and H4K20 
trimethylation is associated with transcriptional repression.  
Suv39H1, a member of the suppressor of variegation 3-9 homolog family, can 
specifically trimethylate K9 on histone H3 using monomethylated H3 K9 as a substrate. 
Current research indicates that HMTs, such as Suv39H1, may team up with DNA 
methyltransferases to silence genes (Fuks, 2005). Thus, SUV39H1 may direct DNA 
methylation to pericentric heterochromatin (Lehnertz et al., 2003), and may also be 
associated with DNA methyltransferases through the adaptor protein HP1 (Fuks et al., 
2003a). In the same way that histone acetylation is reversed by HDACs the balance of histone 
methylation on specific K residues is controlled by HMTs and histone demethylases such as 
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JMJD2A, JMJD2B and JMJD3 (Shi and Whetstine, 2007). Hence, the relative activity of 
HMTs and HDMTs may be able to fine tune the methylation status of chromatin and 
subsequent gene expression profiles.  
Preliminary data from our laboratory (Kang-Yung Lee, PhD Thesis 2006) indicated that 
changes in TGF1 expression were associated with modifications in H3K9 methylation and 
that K9-specific methylases and demethylases such as LSD1 and G9a were not involved. 
Currently the effect, if any, of oxidative stress on the regulation of histone methylation is not 
clear. 
 
4.1.1 Hypothesis and aims of this Chapter 
We hypothesise that oxidative stress, in combination with IL-1β, may modify the H3K9 
methylation, and further affect the TGF-β1 production through the recruitment of H3K9 
trimethylase Suv39H1 to TGF-β1 promoter. 
The specific aims were: 
1. To determine the effect of H2O2, and in combination with IL-1β, on global H3K9 
trimethylation staus on A549 cells. 
2. To evaluate the effect of H2O2, and in combination with IL-1β on Suv39H1 
production. 
3. To examine the effect of Suv39H1 on GR function under oxidative stress. 
 
4.2 Experimental protocols 
4.2.1 Effect of oxidative stress on H3K9 trimethylation 
90% confluent A549 cells were cultured in serum-free DMEM medium supplemented with L-
glutamine for 48h before stimulation. Cells were stimulated with IL-1β (10ng/ml), with or 
without H2O2 (200µM) for 1hr. Nuclear proteins were extracted and the level of H3K9 
trimethylation was detected using a specific anti-trimethylated H3K9 antibody (Millipore). 
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4.2.2 Effect of oxidative stress on Suv39H1 mRNA expression 
A549 cells were serum-starved for 48hrs, and stimulated with IL-1β (10ng/ml), with or 
without H2O2 (200µM), or left untreated for 4hrs. At the end of stimulation, total RNA was 
isolated and Suv39H1 mRNA was determined by RT-QPCR. 
 
4.2.3 Kinetics of the Suv39H1 promoter occupancy under oxidative stress 
A549 cells were serum-starved for 48h before stimulation with IL-1β (10ng/ml), with or 
without H2O2 (200µM), or left untreated. At the end of the stimulation, proteins and DNA 
were cross-linked with 1% formaldehyde and Suv39H1-TGF-β1 promoter association was 
determined by Suv39H1 ChIP assay using a specific anti-Suv39H1 antibody (Millipore). 
Enrichment of IP DNA was quantified by RT-QPCR with primer sets amplifying NF-B 
binding sites, and a distal 3' site in the TGF-β1 gene. 
 
4.2.4 The association between Suv39H1 and GR 
A549 cells were serum-starved for 48h before stimulation with IL-1β (10ng/ml), with or 
without H2O2 (200µM), or left untreated. Whole cell proteins were extracted and were 
subsequently immunoprecipitated with an anti-GR-specific antibody (H-300, Santa Cruz 
Biotechnology). The associated Suv39H1 was determined by Western blotting with a specific 
antibody against Suv39H1. 
 
4.2.5 GR-associated histone H3K9 HMT activity 
A549 cells were stimulated with IL-1β (10ng/ml), with or without H2O2 (200µM), or left 
untreated for 2hrs in the presence or absence of FP (10-8M) pretreatment for 30mins. GR was 
immunoprecipitated from the nuclear extracts with a specific anti-GR antibody. GR-
associated H3K9 HMT activity was investigated by in vitro HMT assay with core histones as 
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the substrate, and SAM as the methyl group donor. H3K9 HMT activity was determined by 
Western blotting with a specific antibody against trimethyl H3K9. 
 
4.2.6 Effect of Suv39H1 knockdown on oxidative stress induced TGF-1 mRNA 
expression 
50% confluent A549 cells were transfected with 25nM Suv39H1 siRNA (Dharmacon, USA) 
with transfection reagent (FuGene 6, Roche) for 24hrs in DMEM medium with 10% FCS and 
L-glutamine supplementation.  The culture medium was then changed to serum-free DMEM 
for 48h. After this time A549 cells were about 85-90% confluent. These cells were pretreated 
with variable concentrations of FP (10-12 to 10-6M) 30min before stimulation with IL-1β 
(10ng/ml) in the presence or absence of H2O2 (200µM) or left untreated. At the end of 
stimulation period total RNA was isolated and TGF-β1 mRNA was determined by RT-QPCR. 
 
4.2.7 Effect of Suv39H1 overexpression on oxidative stress induced TGF-1 mRNA 
expression 
50% confluent A549 cells were transfected with 1ng Suv39H1 overexpression plasmid with 
transfection reagent (FuGene 6) for 24hrs in DMEM medium with 10% FCS, L-glutamine, 
and then the medium were changed to serum-free DMEM for starvation for 48hrs. About 85-
90% confluent A549 cells were yielded, and were stimulated with IL-1β (10ng/ml), with or 
without H2O2 (200µM), or left untreated. At the end of stimulation, total RNA was isolated 
and TGF-β1 mRNA was determined by RT-QPCR. 
 
4.2.8 Effect of Suv39H1 knockdown on oxidative stress induced GRE activation 
50% confluent A549 cells were transfected with 25nM Suv39H1 siRNA (Dharmacon) with 
Interferin (Polyplus) reagent for 24hrs in DMEM medium with 10% FCS and L-glutamine 
supplememtation.  The medium was then changed to serum-free DMEM for 48hrs. After this 
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time A549 cells were about 85-90% confluent and were stimulated with IL-1β (10ng/ml), 
with or without H2O2 (200µM), or left untreated. At the end of stimulation, nuclear proteins 
were extracted. 10ng nuclear extract was used for GRE activation study (Active motif, 
Belgium). 
 
4.2.9 NF-B p65-associated histone H3K9 HMT activity 
A549 cells were stimulated with IL-1β (10ng/ml), with or without H2O2 (200µM), or left 
untreated for 2hrs. Experiments were repeated in the presence or absence of FP (10-8M) 
pretreatment for 30mins. NF-B p65 was immunoprecipitated from the nuclear extracts with 
a specific anti-p65 antibody (Santa Cruz Biotechnolgy). NF-B p65-associated H3K9 HMT 
activity was investigated by an in vitro HMT assay with core histones as the substrate and 
SAM as the methyl group donor. H3K9 HMT activity was determined by Western blotting 
with a specific antibody against trimethyl H3K9. 
 
4.2.10 Effect of Suv39H1 knockdown on oxidative stress induced NF-B p65 activation 
50% confluent A549 cells were transfected with 25nM Suv39H1 siRNA (Dharmacon) with 
chemical transfection reagent Interferin (Polyplus) for 24h in DMEM medium with 10% FCS 
and L-glutamine supplementation.  The medium was changed to serum-free DMEM for 
48hrs. After this time A549 cells were about 85-90% confluent and were stimulated with IL-
1β (10ng/ml), with or without H2O2 (200µM), or left untreated. At the end of stimulation, 
nuclear proteins were extracted. 10ng nuclear extract was used for NF-B p65 
activation/DNA binding analysis (Active motif, Belgium). 
 
4.2.11 Effects of oxidative stress induced G9a, Suv39H2, JMJD2C, and JMJD3 mRNA 
expression 
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A549 cells were serum starved for 48hrs before stimulation with IL-1β (10ng/ml), with or 
without H2O2 (200µM), or left untreated for 6h. At the end of the stimulation, total RNA was 
isolated, and individual mRNA expression was determined by RT-QPCR with specific 
primers. The relative expression level was normalized by GNB2L1 mRNA expression.  
 
 
4.3 RESULTS 
4.3.1 IL-1 and H2O2 reduces histone 3 lysine 9 trimethylation 
In order to the effect of oxidative stress on H3K9 trimethylation, A549 cells were serum-
starved, and stimulated with IL-1β, with or without H2O2 stimulation. Nuclear proteins were 
isolated after 1hr and 16hrs and Western blot analysis performed with antibodies specific for 
H3K9 trimethylation. The global H3K9 trimethylation status was reduced by IL-1β, H2O2, 
and IL-1β plus H2O2 stimulation after 1hr (Fig. 4.1.A). Interestingly, global H3K9 
trimethylation was upregulated after 16hrs by H2O2 alone or in combination with IL-1.  In 
contrast, IL-1 alone reduced global trimethyl H3K9 (Fig. 4.1.B). These results demonstrate 
initial decreased trimethylation status after stimulation with IL-1β and H2O2 but suggest that 
there may be different regeneration or cycling mechanisms for H3K9 trimethylation at later 
time points following either IL-1β or H2O2 stimulation. 
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A. 
 
B. 
 
 
Figure 4.1 Effect of IL-1β and H2O2 stimulation on H3K9 trimethylation status. Cells 
were incubated with IL-1β (10ng/ml), with or without H2O2 (200M), or left untreated for 
1hr (A) and 16hrs (B). Nuclear extracts were obtained and H3K9 trimethylation detected by 
Western blotting. Data are examples of two independent experiments. 
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4.3.2 Oxidative stress inhibits Suv39H1 mRNA expression 
In order to determine whether the H3K9 trimethylase Suv39H1 was downregulated by 
oxidative stress, RT-QPCT quantification of Suv39H1 mRNA was performed along with 
Western blot analysis (Fig 4.2). The results demonstrate decreased expression of Suv39H1 
mRNA and protein which paralleled the reduced H3K9 trimethylation level. 
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Figure 4.2  Effect of hydrogen peroxide (H2O2), IL-1 and H2O2 plus IL-1 
stimulation on Suv39H1 protein and mRNA expression. Cells were incubated with 
medium alone or H2O2 (200µM), IL-1 (10ng/ml), and H2O2 plus IL-1 for 8h (A). (B) Level 
of TGF-1 and Suv39H1 mRNA were normalized with GAPDH mRNA levels. *P<0.05; 
**P<0.01 versus non-treatment. Results are mean ± the SEM of fold induction versus 
medium control (n=at least three independent experiments).  
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4.3.3 Suv39H1 is recruited to the TGF-β1 promoter under oxidative stress 
To examine if Suv39H1 is recruited to the TGF-β1 promoter, ChIP assays with a specific 
antibody against Suv39H1 were carried out. Cells were stimulated with IL-1β (10ng/ml), 
with or without H2O2 (200µM), or left untreated for variable time (0, 30mins, 60mins, 
120mins) (Fig 4.3).  
The results demonstrated that Suv39H1 was recruited to the TGF1 promoter B3 binding 
site following IL-1β and H2O2 stimulation for 60min and this effect was lost by 2hrs.  In 
contrast, Suv39H1 association with the control TGF1 promoter 3' distal site was unaltered 
by any stimulation.  
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Figure 4.3 Effect of IL-1β and hydrogen peroxide (H2O2) on Suv39H1 recruitment of 
to the TGF-β1 promoter. (A) Schematic of the B3 site, and DNA sequence on TGF-β1 
promoter. The number indicates nucleotide positions in relation to the translation start site. 
(B) Cells were incubated with IL-1β (10ng/ml), with or without H2O2 (200M), or left 
untreated for 0, 30, 60 or 120mins. The recruitment of Suv39H1 to the TGF-β1 promoter was 
determined by ChIP assay with specific antibodies against Suv39H1. The associated DNA 
was quantified by QPCR with primers specific for the B3 and the control 3’ distal site. 
Values are normalized by input DNA. Results are mean ± the SEM of ratio to basal levels. 
*P<0.05 versus control levels.  
A 
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4.3.4 Suv39H1 is associated with GR under IL-1 and H2O2 stimulation 
 In theory a change in H3K9 methylation status could be associated with gene repression. 
Since FP is able to suppress the upregulation of TGF-β1 under oxidative stress, we then 
tested if Suv39H1 was associated with GR under oxidative stress conditions and therby acted 
as a GR corepressor. Cells were pretreated with FP in the presence of IL-1β, with or without 
H2O2 for 2h and 4h. Whole cell extracts were immunoprecipitated with an anti-GR antibody 
and the presence of Suv39H1 detected with an anti Suv39H1 antibody. Figure 4.4.A 
demonstrates an increase in GR-associated Suv39H1 with H2O2 and IL-1β plus H2O2. The 
trend is similar at both 2h and 4h (Fig 4.4A).  
We then confirmed these results using reverse co-immunoprecipitations using an anti-
Suv39H1 antibody for immunoprecipiation and an anti-GR antibody for Western blotting. 
The results demonstrate an increased association of GR with Suv39H1 under IL-1β, and 
H2O2 stimulation, and a further increased association were seen in FP pretreatment, or FP 
pretreatment plus IL-1β+H2O2 (Fig 4.4B). These results indicate that GR is physically 
associated with Suv39H1 under oxidative stress. 
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Figure 4.4 Effect of IL-1β, hydrogen peroxide (H2O2) and fluticasone propionate 
(FP) on Suv39H1 recruitment to GR. (A) Cells were stimulated with IL-1β (10ng/ml), with 
or without H2O2 (200M), or left untreated for 2h or 4h. GR was immunoprecipitated with a 
specific antibody against GR from whole cell extracts, and the associated Suv39H1 protein 
level is detected with an antibody against Suv39H1. (B) Cells were pretreated with or without 
FP (10-8M), then stimulated with IL-1β, with or without H2O2, or left untreated for 1hr. Cells 
lysates were immunoprecipitated with antibody against Suv39H1, and the associated GR 
level was detected with antibody against GR. Data are examples from at least two 
independent experiments with similar results.  
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4.3.5 GR is associated with HMT activity 
To investigate whether GR-associated Suv39H1 has enzymic activity, we performed an in 
vitro HMT assay. Cells were pretreated with FP in the presence and absence of IL-1β and/or 
H2O2 for 2h. Nuclear extracts were immunoprecipitated with anti-GR antibody and an HMT 
reaction performed by incubating the immunoprecipitated proteins in HMT buffer with core 
histones as the substrate and SAM as the methyl donor. HMT activity, was determined by 
Western blotting with an anti-trimethyl H3K9-specific antibody. A significant increase in 
H3K9 trimethylation was detected in cells following IL-1β, H2O2, IL-1β plus H2O2, and FP 
stimulation (Fig 4.5). Together with previous co-immunoprecipitation results, it is possible 
that Suv39H1 may be responsible for this GR-associated HMT activity. 
 
 
 
 
 
Figure 4.5 GR is associated with HMT activity. (A) Cells were pretreated with or 
without fluticasone propionate (FP, 10-8M) for 30min and then stimulated with IL-1β 
(10ng/ml), with or without hydrogen peroxide (H2O2, 200M) for 1h. GR was 
immunoprecipitated from nuclear extracts with a specific antibody against GR. The in vitro 
HMT assay was performed with core histones as substrate and SAM as the methyl donor. 
H3K9 trimethylation HMT activity was determined by specific antibody against H3K9 
trimethylation. Data are examples from two independent experiments with similar results. 
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4.3.6 Knockdown effect of Suv39H1 siRNA on Suv39H1 mRNA and protein 
To test whether Suv39H1 siRNA produced an effective knockdown after transfection, 
A549 cells were pre-treated with Suv39H1 siRNA for 48hrs. Western blotting analysis of 
whole cell lysate was then performed. Using a specific Suv39H1 antibody, a band at 53kd 
was detected in the medium control group, but reduced immunoreactivity was seen in the 
Suv39H1 siRNA treated group in a concentration-dependent manner (Fig. 4.6A).  
Suv39H1 siRNA transfection also resulted in reduced Suv39H1 mRNA levels with a 
75%-80% knockdown seen after 24hrs (Fig. 4.6B).  In contrast, scrambled siRNA (10, 50, 
100nM) had no effect on Suv39H1 mRNA expression (Fig. 4.6B). 
To investigate whether the various stimuli to be used had any effect on the ability of 
Suv39H1 siRNA to knockdown Suv39H1 expression, cells were treated with FP (10-8M), 
H2O2 (200µM) and/or IL-1ß (10ng/ml) in the presence of 50nM suv39H1 siRNA.  Suv39H1 
gene expression was analyzed by quantitative RT-QPCR and the result showed a similar 
degree of knockdown (70%-80%) after Suv39H1 siRNA treatment in the absence of cell 
stimulation (Fig. 4.6C). 
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Figure 4.6  Knockdown effect of Suv39H1 siRNA on Suv39H1 mRNA and protein 
level.  
(A) Cells were incubated with medium or Suv39H1 siRNA (50, or 10nM) for 48hrs. Whole 
cell extracts were obtained and examined for Suv39H1 by Western blotting. (B) Cells (n=2) 
were incubated with medium, scrambled siRNA (100, 50, or 10nM) or Suv39H1 siRNA (100, 
50, or 10nM). Levels of Suv39H1 mRNA were quantified by RT-QPCR and were normalized 
to GNB2L1 mRNA levels. (C) Cells were pretreated with Suv39H1 siRNA (50nM) for 24hrs, 
then serum-starved for a further 24hrs before being treated with medium alone, hydrogen 
peroxide (H2O2, 200µM), IL-1 (10ng/ml) or H2O2 plus IL-1. Suv39H1 mRNA level was 
quantified with RT-QPCR and normalized with respective to GAPDH mRNA levels. Results 
are expressed as mean ± SEM of percentage versus no siRNA treated group (n=at least three 
independent experiments).  
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4.3.7 Knockdown of Suv39H1 further upregulates IL-1 and H2O2-induced TGF-1 
mRNA expression 
To investigate whether Suv39H1 is involved in regulation of TGF-β1 mRNA expression 
cells were pre-treated with Suv39H1 siRNA (Fig 4.7). Knockdown of Suv39H1 resulted in 
enhanced basal TGF1 mRNA expression and a further enhancement of TGF-ß1 mRNA 
levels were seen in the Suv39H1 siRNA treated group under stimulation with IL-1β, and IL-
1β plus H2O2 (Fig 4.7.A). The scrambled siRNA pre-treated group showed no effect on TGF-
ß1 mRNA levels when compared with the control group (Fig 4.7A).  
Previous experiments demonstrate that oxidative stress-induced upregulation of TGF-β1 
mRNA was downregulated by FP. We therefore checked whether the suppressive effect of FP 
was modified by Suv39H1 knockdown (Fig 4.7B). A549 cells were pretreated with medium 
alone, scrambled siRNA (50nM) or Suv39H1 siRNA (50nM) for 48hrs and then serum 
starved for a further 24hrs.  Cells were subsequently incubated with FP (10-8M) for 30mins, 
then stimulated with medium, H2O2 (200µM), IL-1 (10ng/ml) or H2O2 plus IL-1 for 6h 
(Fig 4.7B). The results demonstrate that in the presence of FP (10-8M), TGF-β1 mRNA 
expression was further upregulated after Suv39H1 knockdown indicating that Suv39H1 is 
somehow involved in GR regulation of TGF-β1 mRNA transcription.  
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Figure 4.7  Effect of Suv39H1 siRNA knockdown on TGF-1 message RNA. A549 
cells were incubated with medium alone, scrambled siRNA or Suv39H1 siRNA for 48hrs and 
subsequently serum starved for a further 24hrs. The cells were then incubated with FP for 
30mins followed by medium, hydrogen peroxide (H2O2, 200M), IL-1 (10ng/ml), or H2O2 
plus IL-1 for 6hrs. Levels of TGF-ß1 mRNA were quantified by RT-QPCR and were 
normalized with respective to GNB2L1 mRNA levels. Results are mean ± the SEM of fold 
induction versus medium control (n= at least 4 independent experiments). (A) # P<0.05 
versus IL-1β (pretreated with Suv39H1 scrambled siRNA); *P<0.05 versus IL-1β plus H2O2 
(pretreated with Suv39H1 scrambled siRNA). (B) *p<0.05 versus scrambled siRNA plus IL-
1β+H2O2.  
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4.3.8 Overexpression of Suv39H1 has no effect on TGF-1 mRNA expression 
In order to confirm the siRNA results we then performed an overexpression study with 
an Suv39H1 plasmid to determine whether oxidative stress-induced TGF-β1 mRNA 
expression could be downregulated by Suv39H1 overexpression.  
Two different amounts of Suv39H1 overexpression plasmid (1µg, 2µg) were tested to 
determine optimum transfection efficiency. After transfection with Suv39H1 overexpression 
plasmid, Suv39H1 protein was increased as determined by Western blotting with a specific 
Suv39H1 antibody (Fig 4.8A).  The effect on Suv39H1 mRNA upregulation was much more 
pronounced with a 10-20 thousand-fold induction when compared to the vector alone group 
(Fig 4.8B).  
To investigate whether Suv39H1 overexpression could regulate the effect of IL-1β and 
H2O2 on TGF-β1 mRNA expression, cells were pretreated with FP (10-8M) for 30mins and 
then stimulated with IL-1β (10ng/ml), with or without H2O2 (200µM), or left untreated for 
6h. TGF-β1 mRNA expression was enhanced following IL-1β+H2O2 stimulation in the vector 
alone treated cells but this did not reach statistical significance (Fig 4.8C).  Furthermore, 
there was no difference between cells treated with the Suv39H1 overexpression plasmid or 
with vector alone in the ability of FP to regulate TGF-β1 mRNA expression. 
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Figure 4.8 Effect of Suv39H1 overexpression on IL-1β, hydrogen peroxide (H2O2) 
and Fluticasone propionate (FP) induced TGF-β1 mRNA expression. Cells were 
pretreated with medium only, vector alone, or Suv39H1 overexpression plasmid (1µg, 2µg) 
for 24h. Whole cell protein extracts (A) and total RNA (B, C) were collected. Suv39H1 
protein was detected by Western blotting with a Suv39H1-specific antibody (A). Relative 
expression of TGF-β1 was quantified by RT-QPCR with primers specific for TGF-β1 (B). 
Cells were preincubated with medium alone, vector, or plasmid for 24hrs, then serum-starved 
for 24hrs. The cells were pretreated with FP for 30mins and then stimulated with IL-1β 
(10ng/ml), with or without H2O2 (200M), for 6hrs. TGF-β1 mRNA expression was 
quantified by RT-QPCR with specific primers. Results are mean ± the SEM. N= at least two 
independent experiment for (A) and (B). N=at least three independent experiments in (C).
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4.3.9  Knockdown of Suv39H1 by siRNA on IL-1 and H2O2 induced GMCSF mRNA 
expression 
IL-1β and H2O2 were shown to have a greater than additive effect on the induction of 
GMCSF mRNA in the previous experiment. We then investigate whether Suv39H1 also 
regulates GMCSF mRNA expression and its suppression by FP. 
A549 cells were pretreated with medium alone, scrambled siRNA (50nM) or Suv39H1 
siRNA (50nM) for 48hrs and then serum starved for 24hrs.  Cells were subsequently 
incubated with FP (10-8M) for 30mins, then stimulated with medium, H2O2 (200µM), IL-1 
(10ng/ml) or H2O2 plus IL-1 for 6hrs. The scrambled siRNA pre-treated group showed no 
effect on GMCSF mRNA levels when compared with the control group (Fig 4.9A). In 
contrast, increased GMCSF mRNA levels were seen in the Suv39H1 siRNA treated group 
following stimulation with IL-1β plus H2O2 when compared to scrambled siRNA treated 
group (Fig 4.9A).  
We further compared the ability of FP to downregulate GMCSF mRNA expression in 
the absence of Suv39H1 (Fig 4.9B). The ability of FP to IL-1 plus H2O2-induced GM-CSF 
mRNA expression was impaired to a small but significant extent in the Suv39H1 siRNA 
treated group when compared to the scrambled siRNA group. The results also indicate that 
Suv39H1 may involve in the FP regulation of GMCSF mRNA expression under IL-1β plus 
H2O2. A full concentration response curve should be performed to confirm this.  
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Figure 4.9  Effect of Suv39H1 knockdown by siRNA on IL-1β, hydrogen peroxide 
(H2O2) and fluticasone propionate (FP)-induced GMCSF mRNA expression.  Cells were 
incubated with Suv39H1 siRNA, scrambled siRNA, or medium alone for 48hrs. Then cells 
were pretreated with FP for 30min followed by stimulation with IL-1β (10ng/ml), with or 
without H2O2 (200M), or left untreated for 6h. Total RNA was quantified by RT-QPCR with 
primers specific for GMCSF. Relative mRNA expression was normalized by GNB2L1 
mRNA expression as an internal control. Results are shown as mean ± the SEM. (A) *p<0.05 
when compared to scrambled siRNA plus IL-1β+H2O2. (B) *p<0.05 when compared with 
scrambled siRNA plus FP+IL-1β+H2O2. N = at least three independent experiments. 
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4.3.10 Suv39H1 knockdown downregulates GR-GRE activation under oxidative stress 
To investigate whether Suv39H1 directly affects the GR-GRE activation, cells were 
preincubated with Suv39H1 siRNA, or scramble siRNA, then pretreated with FP followed by 
IL-1β, with or without H2O2, or left untreated. Nuclear protein was extracted for GR-GRE 
activation assay. GR-GRE activation was not affected by IL-1β, or H2O2. However, FP-
stimulation of GR-GRE binding was decreased after knockdown of Suv39H1 by siRNA (OD 
0.162±0.011 vs . 0.24±0.023, P<0.05)(Fig 4.10). These data suggest that Suv39H1 is actively 
involved in FP-induced GR-GRE DNA binding. 
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Figure 4.10 Suv39H1 knockdown decreases GR-GRE binding.  Cells were incubated 
with Suv39H1 siRNA, or scramble siRNA for 24hrs.  Cells were then treated with fluticasone 
propionate (FP, 10-8M) for 30mins followed by stimulation by IL-1β (10ng/ml), with or 
without H2O2 (200M), or left untreated for 1hr. Nuclear proteins were extracted for GR-
GRE activation assay. Results are mean ± the SEM. N = three independent experiments. 
*P<0.05 versus IL-1β+H2O2 plus FP with Suv39H1 siRNA knockdown. 
  
137 
 
4.3.11  Suv39H1 associates with NF-B p65 following IL-1 and H2O2 stimulation 
To study whether Suv39H1 has a direct association with NF-B p65, cells were 
pretreated with FP (10-8M) for 30mins, then stimulated with IL-1β (10ng/ml), with or without 
H2O2 (200µM) for 1hr. Whole cell proteins were collected and Suv39H1 was 
immunoprecipitated with a specific anti-Suv39H1 antibody. The associated p65 was 
determined with an anti-p65 specific antibody. A strong NF-B p65-specific band was 
detected in the Suv39H1 immunoprecipitate (Fig 4.11). The results demonstrate that the 
recruitment of p65 to Suv39H1 was increased under IL-1β, H2O2 and IL-1β plus H2O2. 
Interestingly, the association of NF-B p65 to Suv39H1 was decreased in the presence of FP 
(Fig 4.11).  
 
 
Figure 4.11 Effect of IL-1β and hydrogen peroxide (H2O2) on Suv39H1 association 
with NF-B p65. Cells were stimulated with IL-1β (10ng/ml), with or without H2O2 
(200M), for 1hr. Suv39H1 was immunoprecipitated with a specific antibody against 
Suv39H1 from whole cell extracts. In some experiments cells were pretreated with FP (10-
8M) for 30mins before stimulation with IL-1 plus H2O2. The associated p65 protein was 
detected be Western blotting with an antibody specific for NF-B p65. Data are examples 
from two independent experiments with similar results.  
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4.3.12 NF-Bp65 is associated with HMT activity 
To study whether NF-B p65 is associated with Suv39H1, a preliminary in vitro HMT 
activity assay was performed with nuclear extracts from IL-1β and H2O2 stimulated samples 
(Fig 4.12). Nuclear extracts were immunoprecipitated with an anti-p65 antibody and an HMT 
reaction performed by incubating the immunoprecipitated proteins in HMT buffer with core 
histones as substrate and SAM as the methyl donor. HMT activity was determined by 
Western blotting with an anti-trimethyl H3K9 specific antibody. Increased H3K9 
trimethylation was detected in IL-1β, H2O2, and FP pretreated cells. The sample from IL-1β 
plus H2O2 treated cells seems to be lost in this experiment and must be repeated later. This 
preliminary data suggests that NF-B p65 can associate with Suv39H1 and that Suv39H1 
may contribute, at least in part, for the NF-B p65 associated HMT activity. 
 
 
Figure 4.12 Effect of IL-1β, hydrogen peroxide (H2O2) and Fluticasone propionate 
(FP) on NF-B p65 associated histone methyltransferase (HMT) activity. Cells were 
pretreated with FP for 30mins then stimulated with IL-1β (10ng/ml), with or without H2O2 
(200M), or left untreated. Whole protein was extracted and p65 was immunoprecipitated 
with a specific anti-p65 antibody. The in vitro HMT assay was performed with core histones 
as substrate and SAM as the methyl donor. H3K9 trimethylation was determined using a 
specific antibody against trimethylated H3K9. Data is from 1 experiment.  
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4.3.13 G9a mRNA is downregulated by oxidative stress 
We also checked whether other H3K9 HMTs were affected by oxidative stress. A549 cells 
were serum-starved, then pretreated with variable concentrations of FP (10-6, 10-8, 10-10, 10-
12M) for 30min followed by stimulation with IL-1β (10ng/ml), with or without H2O2 
(200µM) for 6h. Total RNA was quantified by RT-QPCR with primers specific for TGF-β1. 
The results demonstrate that the expression of G9a mRNA is also downregulated by IL-1β 
plus H2O2 (Fig 4.13) and that FP has no effect on the repression of G9a mRNA levels (Fig 
4.13). We have also tried to detect the expression of Suv39H2 in A549 cells, but the levels 
were too low to be detected by RT-QPCR which may be due to a cell specific expression 
pattern. These results indicate that G9a and Suv39H1 have similar responses following 
exposure to oxidative stress. 
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Figure 4.13 Effect of IL-1β plus hydrogen peroxide (H2O2) on G9a mRNA expression. 
Cells were pretreated with fluticasone propionate (FP) for 30min followed by stimulation 
with IL-1β (10ng/ml) plus H2O2 (200M) or left untreated for 6h. Total RNA was quantified 
by RT-QPCR with primers specific for G9a. Results are shown as mean ± the SEM. N = 3 
independent experiments. * P<0.05 compared to medium only. 
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4.3.14 Effect of IL-1β and H2O2 on the histone demethylases JMJD2C and JMJD3 
To examine whether IL-1β and H2O2 may affect histone demethylase expression, A549 
cells were stimulated with IL-1β (10ng/ml), with or without H2O2 (200µM), or left untreated 
for 6h. Total RNA was extracted and mRNA expression for JMJD2C, a H3K9 demethylase, 
and JMJD3, a H3K27 demethylase, measured (Fig 4.14) quantified by RT-QPCR. The 
relative expression of JMJD2C and JMJD3 mRNA expression was normalized to GNB2L1 
mRNA.  
The expression of JMJD3 mRNA was increased by IL-1β and H2O2, both alone and in 
combination, and subsequently the induced JMJD3 mRNA expression was downregulated by 
FP treatment (Fig 4.15A).  Modulating the expression of Suv39H1 using Suv39H1 siRNA 
knockdown (Fig 4.15B) or Suv39H1 overexpression (Fig 4.15C) had no effect on JMJD3 
mRNA expression in response to IL-1, H2O2 or FP in comparison with scrambled siRNA. 
In contrast, the expression of JMJD2C exhibited a different response compared to 
JMJD3. JMJD2C mRNA expression was decreased by IL-1β and to a lesser extent by H2O2 
stimulation (Fig 4.15D), a similar trend to that observed for Suv39H1. 
These results demonstrate that IL-1β and H2O2 induce different profiles of histone 
demethylases. How HDM protein expression and activity is affected under these conditions 
needs examination. 
 
 
Figure 4.14 Relationship between histone methyltransferase Suv39H1 and the 
demethylases JMJD2C and JMJD3 on the N-terminal tail of histone 3.    
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Figure 4.15  Effect of IL-1β and hydrogen peroxide (H2O2) on histone demethylase 
JMJD2C and JMJD3 mRNA expression.  Cells were pretreated with or without fluticasone 
propionate (FP) for 30mins followed by stimulation with IL-1β (10ng/ml), with or without 
H2O2 (200M) for 6h. Total RNA was collected and quantified by RT-QPCR with primers 
specific for JMJD3 (A-C) or JMJD2C (D). The relative mRNA expression level was 
normalized with GNB2L1 mRNA expression. (B) Cells were incubated with Suv39H1 
overexpression plasmid or vector for 24h followed by stimulation with IL-1β and H2O2. (C) 
Cells were incubated with Suv39H1 siRNA or scrambled siRNA for 48h and then stimulated 
with IL-1β and H2O2. Results are shown as mean ± the SEM. *p<0.05, **p<0.01 when 
compared to the basal level. # p<0.05 when compared to the IL-1β plus H2O2 group. (A) and 
(D) N = at least three independent experiments. (B) and (C) N = two independent 
experiments.  
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4.4 Discussion 
 Our current results show that both IL-1β and H2O2 decrease H3K9 trimethylation status 
at 1hr.  However, differential regulation of H3K9 trimethylation is suspected as differential 
effects on H3K9 trimethyation were seen at 16hrs with IL-1 and H2O2. Suv39H1 mRNA 
expression was downregulated under IL-1β and H2O2 stimulation, which possibly accounts 
for the decreased amounts of H3K9 trimethylation. By ChIP analysis, Suv39H1 was seen to 
be recruited to the B3 binding site in the TGF-1 promoter at 1hr, and that recruitment was 
decreased after 2hrs. Knockdown of Suv39H1 expression with siRNA resulted in enhanced 
TGF-β1 mRNA expression with IL-1β plus H2O2 stimulation when compared to scramble 
siRNA. However, a 10,000-fold increase in Suv39H1 mRNA expression using an 
overexpression vector did not affect IL-1β and H2O2-induced TGF-β1 mRNA expression. It 
will be important in future to examine the effect of overexpression on HMT enzymic activity. 
As TGF-1 mRNA expression is under the control of NF-B we checked the association 
of NFB p65 with Suv39H1. Using co-immunoprecipitation, we demonstrated that NF-B 
p65 was associated with Suv39H1 under conditions of IL-1β, H2O2, and IL-1β plus H2O2 
stimulation. This association may account for the H3K9 HMT enzymic activity pulled down 
with NFB p65 in this model system.  
Interestingly, Suv39H1 siRNA also increased TGF-β1 mRNA expression following FP 
treatment which reduced TGF-1 expression to a greater extent under control conditions. 
This suggests that Suv39H1 may modulate GR function. Indeed, Suv39H1 and GR were 
shown to be part of the same complex following IL-1β and H2O2 stimulation in co-
immunoprecipitation studies. This may account for the increased GR-associated H3K9 HMT 
activity seen with IL-1β, H2O2, IL-1β plus H2O2 and FP treatment. Importantly, NF-B p65-
associated H3K9 HMT enzymic activity was reduced by the presence of FP. Furthermore, GR 
transactivation as determined by GR-GRE DNA binding assay was also attenuated in 
Suv39H1 siRNA-treated cells.  Further temporal analysis of p65, GR and Suv39H1 
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recruitment to the native TGF-1 promoter B3 site would be important to perform in future 
studies along with a comparison of GR/Suv39H1 recruitment to a native GRE using re-ChIP 
experiments. 
This effect of Suv39H1 knockdown was not restricted to TGF-1 as Suv39H1 siRNA 
was also able to upregulate GMCSF mRNA expression following IL-1β and H2O2 
stimulation. In addition, the suppressive effect of FP on GMCSF mRNA expression was also 
impaired with Suv39H1 mRNA knockdown. The combination of ChIP-seq and gene arrays 
may also give a clearer idea as to the generality of the effects described here.  Since the 
changes in H3K9 methylation shown here occur prior to changes in AcH3 And AcH4 (Lee et 
al., 2006), it would be interesting to determine whether these methylation and acetylation 
marks were linked by examining whether Suv39H1 siRNA affected changes in histone 
acetylation status.  
 We further examined whether other H3K9 methyltransferases, G9a and Suv39H2 (Rice 
et al., 2003), and their associated histone demethylases, JMJD2C and JMJD3 (Shi and 
Whetstine, 2007; Shin and Janknecht, 2007), were modulated by IL-1 and/or H2O2 in this 
model system. We were not able to detect Suv39H2 mRNA expression in A549 cells but RT-
QPCR quantification indicated that both G9a and JMJD2C show a similar downregulation of 
their respective mRNAs following treatment of cells with IL-1β and H2O2. However, in 
contrast, JMJD3 mRNA expression was upregulated in response to IL-1β and H2O2 
treatment. In addition, IL-1β and H2O2 stimulated JMJD3 mRNA expression was 
downregulated by FP. 
 Our results demonstrate the H3K9 methylation may be able to regulate specific gene 
expression in A549 cells. H3K9 trimethylation is thought to be associated with gene 
repression (Kouzarides, 2007). But under oxidative stress conditions, the level of H3K9 
trimethylation was decreased, which may account for increased gene expression. Although 
we have focussed on Suv39H1 in this thesis, G9a and Suv39H1 also showed a similar pattern 
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of downregulation in response to IL-1β and H2O2 treatment. It would be interesting to 
determine if other HMTs are also regulated in the same manner and also the mechanism for 
this apparently co-ordinated response.  Are the differences in HMT and HDM mRNA 
expression linked to changes in protein expression and, more importantly, enzymic activity? 
In addition, what is the mechanism for this action i.e. whether mRNA stability/transcription 
rate or posttranslational modifications induced by oxidative stress or inflammation alone can 
affect the expression and activity of these HMTs?  
The results also demonstrated differential regulation of H3K9 trimethylation at 16h with 
inflammatory and oxidative stress stimuli. The effect of these stimuli on the temporal 
recruitment of of HMTs to the B3 site in the native TGF-1 promoter may confirm this. The 
HMT activity assay used in this thesis is able to detect HMT activity associated with an 
immunoprecipitated protein complex. It is possible that the HMT activity may not be directly 
associated with the immunoprecipitated protein of interest but is pulled down as a passenger 
protein as part of a larger complex.  Mass spectroscopic analysis of the immunoprecipitated 
complexes in combination with HMT assays following increasing stringency of washes may 
reveal whether there is a direct protein-HMT interaction. BRET analysis may also provide 
evidence for a direct association (Pfleger and Eidne, 2006).   
It is unclear exactly how an inflammatory stimulus or an oxidative stress can target 
Suv39H1 association with p65 and/or GR. Data from our group has examined this in part for 
the recruitment of HDAC2 to p65 and GR as demonstrated that specific post-translational 
modifications were important (Ito et al., 2006b). Similar studies may reveal the same process 
occurring for Suv39H1. 
Interestingly, we also demonstrated that GR- and p65-immunopreciptated HMT-
containing complexes had a differential response to FP. NF-B p65-immunoprecipitatedHMT 
activity was downregulate with FP treatment which was not the case with GR-associated 
HMT activity. This may be a result of GR and NF-B p65 having a different affinity for 
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Suv39H1 and may also underlie the different effects on gene expression and promoter-
specific H3K9 methylation seen with various treatments. 
To our knowledge there is only one published study that has reported an effect of GR on 
H3K9 methylation (Islam and Mendelson, 2008).  Surfactant protein A (SP-A) mRNA is 
induced by IL-1 and by dibutyl cAMP and this enhanced response is completely repressed 
by dexamethasone in primary type II alveolar cells. SP-A expression in these cells is 
regulated by NF-B complexed with another transcription factor Thyroid Transcription 
Factor (TTF)-1. Using ChIP analysis the authors reported that dexamethasone increased 
H3K9 dimethylation at the TTF-1 binding element (TBE) in the SP-A promoter. This was 
associated with recruitment of heterochromatin protein 1 (HP-1).  
 The H3K27 demethylase JMJD3 mRNA showed a different response to IL-1β and H2O2 
stimulation to that seen for JMJD2C and, in addition, the increased JMJD3 mRNA expression 
can be suppressed by FP. H3K27 is another site which was thought to be related to gene 
repression (Kouzarides, 2007). Upregulation of JMJD3 can demethylate previous methylation 
marks around this site (Hong et al., 2007; Swigut and Wysocka, 2007), and further antagonize 
the effect of H3K9 methyltransferase. But this is not known whether demethylation of the 
repressive H3K27 mark is associated with gene activation (De Santa et al., 2007; Lee et al., 
2007). It will be interesting to check if JMJD3 has cross-activity with other target proteins 
which may affect gene activation/repression. The effect of IL-1 and/or H2O2 on H3K27 
methylation status at the B3 site on the native TGF-1 promoter may also be informative as 
would the recruitment of specific H3K27 HMTs. 
After transfection with Suv39H1 overexpression plasmid Suv39H1 mRNA expression 
was significantly upregulated. However, in contrast to Suv39H1 knockdown, we were unable 
to show a difference between TGF-β1 mRNA expression nor an effect on regulation of GR 
function. This may simply reflect the non-linear relationship between mRNA and protein 
expression we saw for Suv39H1 expression (Fig 4.8A and B) or a non-significant effect on 
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enzymic activity (not measured) or H3K9 methylation status (not measured). Alternatively, it 
is possible that the natural level of Suv39H1 expression produces the maximal effect on TGF-
1 mRNA expression and GR function possible in these cells and Suv39H1 overexpression 
may not, therefore, be able to modulate these effects. 
There is evidence in the literature that changes in histone methylation and the 
recruitment of HMTs are linked to changes in DNA methylation (Fuks et al., 2003a; Lehnertz 
et al., 2003). We, therefore, examined whether IL-1 and/or H2O2 could modulate DNA 
methylation status.  
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CHAPTER FIVE 
THE EFFECT OF OXIDATIVE STRESS ON DNA METHYLATION AND 
UPREGULATION OF TGF-β1 mRNA EXPRESSION 
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5.1 Rationale 
DNA methylation is one of the important covalent modifications involved in epigenetic 
regulation of gene repression (Fuks, 2005). DNA methylation occurs at the carbon-5 position 
of cytosine (mC5) and is catalysed by the DNA methyltransferases DNMT1, DNMT3a and 
DNMT3b using the methyl donor S-adenosyl-L-methionine (Yen et al., 1992). Approximately 
50% of protein coding genes have GC-rich areas of DNA in their promoters (CpG islands) 
consisting of regions of >500 base pairs with a GC content greater than 55% and methylation 
of these islands usually silences gene expression. In cancer, aberrant CpG island methylation 
in tumour suppressor gene is associated with cancer progression (McCabe et al., 2009).  More 
recently, it has become evident that DNA methylation can occur outside of promoter CpG 
sites at sites known as DNA shores (Irizarry et al., 2009).   
DNA methylation was for many years considered a static or invariant mark that could 
not be removed (Gehring et al., 2009; Ramchandani et al., 1999).  However, a recent study 
described cyclical methylation of the ps2 and ER promoters (Kangaspeska et al., 2008). 
These data indicates that the CpG island methylation may be not be permanently fixed and 
that DNA methylation and demethylation is a dynamic process that potentially regulated by 
specific enzymes. The search for specific enzymes that regulate demethylation of DNA is 
ongoing (Gehring et al., 2009).  Active DNA demethylation underlies key facets of 
reproduction in flowering plants and mammals and serves a general genome housekeeping 
function in plants. A family of 5-methylcytosine DNA glycosylases catalyzes plant 
demethylation via DNA base-excision-repair process. However, mammals lack counterparts 
to the plant demethylases. Recent results have suggested that DNA repair is also a plausible 
mechanism for global DNA demethylation in mammals (Gehring et al., 2009). Alternative 
methods of causing active DNA demethylation have also been proposed utilising active 
transcriptional processes and histone acetylation (D'Alessio et al., 2007) and the methyl-CpG 
binding domain protein MBD3 (Brown et al., 2008).  
149 
 
Histone methylation is thought to be related to DNA methylation, and a reinforcing 
cycle was described to aid in gene repression (Fuks, 2005).  It is unclear whether histone 
methylation provides a mark to enable the recruitment of a DNA methyltransferase or 
whether DNA methylation provides a scaffold for HMT recruitment (Fuks et al., 2003b; 
Kouzarides, 2002).  The precise order of events may be both gene- and context-specific (Bird, 
2002; Fischle, 2008) 
It has been reported that DNA methylation was affected by oxidative stress mainly 
though the actions of lipid secondary metabolic products.  This results in the formation of an 
impaired DNMT1 binding site (Turk et al., 1995), or through the impaired function of MBP 
(Valinluck et al., 2004).  
Among the various DNA methyltransferase, we focus on the DNMT1, the maintenance 
DNA methyltransferase, since it is important in re-establishing DNA methylation after the 
methylation mark in one of the parent strand of DNA. Additionally, DNMT1 is directly 
associated with Suv39H1 (Fuks et al., 2003a).  Thus, the DNA methyltranferase, DNMT1, 
might be a good candidate to study the effect of oxidative stress on DNA methylation. 
 
5.1.1 Hypothesis and aims of this Chapter 
We hypothesise that oxidative stress, in combination with IL-1β, may change the 
methylation status of CpG island on the TGF-β1 promoter. 
The specific aims were: 
1. To determine the effect of H2O2, and in combination with IL-1β, on CpG island 
methylation on A549 cells. 
2. To evaluate the effect of H2O2, and in combination with IL-1β, on DNMT1 
production, and the recruitment of DNMT1 to the NF-κB binding site on TGF-β1 
promoter. 
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3. To examine the effect of H2O2 alone, and in combination of IL-1β on CpG island 
methylation on TGF-β1 promoter by Bisulphite sequence 
 
 
5.2 Experiment Protocols 
5.2.1 Effect of 5-aza on oxidative stress induced TGF1 mRNA expression 
90% confluent A549 cells were cultured in serum-free DMEM medium supplemented with L-
glutamine for 48hrs before stimulation. Cells were pretreated with the DNA methylation 
inhibitor 5-Aza (1ng/ul) for 30 mins before stimulation before stimulation with IL-1β 
(10ng/ml), with or without H2O2 (200µM) or left untreated for 4h. RNA was isolated, and 
levels of TGF-β1 mRNA were quantified by RT-QPCR. 
 
5.2.2 Bisulphite sequencing 
90% confluent A549 cells were cultured in serum-free DMEM medium supplemented with L-
glutamine for 48hrs before stimulation. Cells were then stimulated with IL-1β (10ng/ml), 
with or without H2O2 (200µM), or left untreated for variable times (0, 1hr). Cells were 
collected, and DNA was extracted according to protocol described in Chapter 2. 500ng 
genomic DNA was obtained and taken forward for bisulphite treatment. The bisulphite-
treated DNA was sent for sequencing. 
 
5.2.3 Effect of oxidative stress on DNMT1 mRNA expression  
Cells were incubated with medium or IL-1β (10ng/ml), with or without H2O2 (200µM), for 
6hrs. RNA was isolated and levels of DNMT1 mRNA were quantified by RT-QPCR. 
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5.2.4 Effect of oxidative stress on DNTM1 protein expression 
Cells were incubated with medium alone or IL-1β (10ng/ml), with or without H2O2 (200µM), 
for 1hr. Protein extracts were obtained and examined for DNMT1 by Western blotting. 
 
5.2.5 The association between DNMT1, Suv39H1 and NF-B p65 
Cells were incubated with medium alone or IL-1β (10ng/ml), with or without H2O2 (200µM), 
for 1hr. Cell lysates were immunoprecipitated by a specific antibody against DNMT1. The 
associated Suv39H1 and NF-B p65 were determined by Western blotting using specific 
antibodies. 
 
5.2.6 Enrichment of mC5 at the NF-B binding site on TGF-1 promoter 
Cells were incubated with medium alone or IL-1β (10ng/ml), with or without H2O2 (200µM), 
for variable times (1 and 2hrs). DNA was extracted and incubated with 1µg antibody specific 
for 5mC antibody (Calbiochem, UK) overnight. The immunoprecipitated DNA was purified 
with proteinase K, and phenol/chloroform/alcohol method. The enrichment of 5mC at the 
NF-B binding site was quantified by comparing amplified DNA by RT-QPCR with primers 
specific for B3 binding site. 
 
5.2.7 Effect of IL-1β and H2O2 on TGF-1 promoter occupancy by DNMT1 
A549 cells were serum-starved for 48hrs before incubating with medium alone or IL-1β 
(10ng/ml), with or without H2O2 (200µM), for variable times (0, 30 mins and 1hr). At the end 
of stimulation, proteins and DNA were cross-linked with 1% formaldehyde and DNMT1-
TGF-β1 promoter association was determined by DNMT1 ChIP assay with specific antibody 
against DNMT1 (H300, Santa Cruz Biotechnology). Enrichment of IP DNA was quantified 
by RT-QPCR with primer sets amplifying the B3 site. 
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5.2.8 Effect of FP on IL-1 and H2O2 induced DNMT1 gene expression 
90% confluent A549 cells were cultured in serum-free DMEM medium supplemented with L-
glutamine for 48hrs before stimulation. Cells were then pretreated with FP (10-8M) for 
30mins before being stimulated with IL-1β (10ng/ml), with or without H2O2 (200 M), or left 
untreated for 6hrs. At the end of stimulation, total RNA was isolated and DNMT1 mRNA was 
determined by RT-QPCR. The relative expression level of DNMT1 mRNA was normalized 
with GNB2L1 mRNA as an internal control. 
 
 
 
 
5.3 Results 
5.3.1 5-aza upregulates the expression of TGF-1 mRNA 
To investigate whether DNA methylation affects the regulation of TGF-β1 mRNA, cells were 
preincubated with the DNA methylation inhibitor, 5-aza (10µM), 30min before stimulation 
with IL-1β (10ng/ml), with or without H2O2 (200µM), or left untreated for 6h. Upon 5-Aza 
pretreatment, TGF-β1 mRNA expression was further upregulated when stimulated with IL-1β 
alone (P<0.05, 1.35 ± 0.05 versus 1.70 ± 0.08), H2O2 alone (P<0.05, 1.15 ± 0.06 versus 1.45 
± 0.08) and or IL-1β plus H2O2 (P<0.05, 1.52 ± 0.08 versus 1.94 ± 0.12)(Fig 5.1). The result 
demonstrates that DNA methylation involved in regulation of TGF-β1 mRNA expression. 
These cells were not proliferating and so intercalation of 5-Aza into de novo DNA does not 
account for the effects observed. 
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Figure 5.1 Effect of 5-aza-cytidine (5-Aza) on IL-1β plus hydrogen peroxide (H2O2)-
induced TGF-β1 mRNA expression. Cells were pretreated with 5-Aza (10M) for 30mins, 
followed by stimulation with IL-1β (10ng/ml), with or without H2O2 (200M), or left 
untreated. TGF-β1 mRNA expression was quantified by RT-QPCR with primers specific for 
TGF-β1, and compared with GNB2L1 mRNA as internal control. Results are shown as mean 
± the SEM. N equal to three independent experiments. &p<0.5 when compared to basal level; 
*p<0.5 when compared to IL-1β; $p<0.5 when compared with H2O2; #p<0.5 when compared 
to IL-1β plus H2O2.
154 
 
5.3.2 IL-1 and H2O2 induced differential changes of mC5 at the B3 binding site and 
the ATG start site of the TGF-1 promoter 
To determine the effect of IL-1β and H2O2 on the methylation status of the TGF-1 
promoter CpG island, we have sequence two areas of the TGF-β1 promoter site, one includes 
the B3 binding site, which represents a high density CpG island area; and the other includes 
ATG starting site, which represents a low CpG island density area (Fig 5.2A). Unfortunately, 
due to technical difficulties we were not able to sequence the region which includes the B3 
binding site due to the very high C to T changes seen after bisulphite treatment (Fig 5.2B).  
Interestingly, we were able to demonstrate that there are variable methylation changes 
occurring around the ATG starting site area. There were significant rapid (60 mins) T to C 
changes after both IL-1β and H2O2 stimulation, when compared to medium alone (Fig 5.2C) 
demonstrating that there is a rapid methylation of residues occurring at this site.  
Interestingly, in the case of IL-1, there was a reversal of this methylation process by 2hrs 
indicating that an active demethylation event was also occurring at this site (Fig 5.2C).  
Further investigation of this effect with IL-1 and with H2O2 is required as is the possible 
effect of FP. 
We have repeated this experiment but again were unable to obtain sequencing data at the 
B3 site possibly suggesting interference from variable methylation status of the CpG islands 
on TGF-β promoter after acute stimulation with IL-1β or H2O2.  This indicates that there are 
possibly two or more different amplified DNA sequences present. We are currently in 
discussion with the Sequence provider, Cogenics, with the aim of obtaining a better 
signal/noise ratio for this sequence. 
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Figure 5.2 Effect of IL-1β and hydrogen peroxide (H2O2) on mC5 at the TGF-β1 
promoter. (A) Schematic diagram of DNA sequence for B3 site and ATG site. Numbers 
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represent distance for ATG translation start site. Focused area for sequencing was underlined. 
Cells were stimulated with IL-β (10ng/ml), H2O2 (200M), or left untreated for 1hr or 2hrs. 
DNA was collected, and treated with Bisulphite for transformation of non-methylated C to T 
bases. DNA was sequenced with specific primers for areas near the B3 binding site, which 
represents a high density CpG island area (B), and for a region near the ATG translation start 
site (C). On the sequence graph, green colour represents A base, red colour represent T base, 
blue colour represents C base; while black colour represent G base. Different height of the 
graph means density by sequence for individual base. N = 1 in this study. 
 
 
 
5.3.3 IL-1 and H2O2 downregulate the production of DNMT1 
To investigate whether oxidative stress and inflammation have effects on the DNMT1 
mRNA expression, A549 cells were pretreated with IL-1β with or without H2O2. The RT-
QPCR results demonstrate that the expression of DNMT1 mRNA was downregulated by IL-
1β, with or without H2O2 stimulation, after 4hrs (Fig 5.3A).  
To confirm that DNMT1 protein production was also decreased, Western blot analysis of 
whole cell lysates was performed. Using a specific anti-DNMT1 antibody, a trend to a 
decrease in DNMT1 expression (band at 105kDa) was seen after 1 and 4hrs of incubation 
(Fig 5.3B). The loss in DNMT1 protein expression was prevented by the presence of the 
proteasomal inhibitor MG-132 (Fig 5.3C). 
FP had no apparent effect on IL-1 + H2O2-repressed DNMT1 mRNA expression (Fig 
5.3A) although some attenuation in the loss was seen for DNMT1 protein expression (Fig 
5.3B). However, further experiments are required to confirm this result. 
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Figure 5.3  Effect of IL-1β and hydrogen peroxide (H2O2) on DNMT1 mRNA and 
protein expression. (A) Cells were pretreated with fluticasone propionate (FP, 10-8M) for 
30mins, then stimulated with IL-1β (10ng/ml), with or without H2O2 (200M), or left 
untreated for 4hrs. Total RNA was collected and DNMT1 mRNA expression was quantified 
by RT-QPCR with primers specific for DNMT1 and normalized to GNB2L1 mRNA. Results 
are shown as mean ± SEM. N = 3 independent experiments. * p<0.05, ** P<0.01 as 
compared to basal level. (B) Cells were pretreated FP (10-8M) for 30mins, then stimulated 
with IL-1β, with or without H2O2, or left untreated for 1hr. Whole cell protein was extracted. 
The amount of DNMT1 protein was detected by Western blotting with DNMT1 antibody. (C) 
Cells were pretreated with variable concentration of MG-132 (1, 10μM) for 1hr, then 
stimulated with IL-1β plus H2O2 or left untreated for 1hr. Whole cell protein was extracted, 
and amount of DNMT1 protein was detected by DNMT1 antibody. N = 1 experiment. 
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5.3.4 Exaggerated methylation of CpG islands on B3 binding site in the TGF-1 
promoter area  
We further performed a Methylation dependent immunoprecipitation assay (MeDIP 
assay), using an anti-mC5 antibody to pull down the methylated Cytosine residue. QPCR 
experiments with primers specific for the B3 binding site on TGF-β1 promoter area 
indicated that both H2O2 and IL-1β induced an increase in C5 methylation at the B3 binding 
site at 1h when compared to control alone (Fig 5.4A).  This increase reached significance at 
4hrs (Fig 5.4A). 
We also examined the effect of the DNA methyltransferase inhibitor 5-Aza on DNA 
methylation status at the B3 and ATG start sites in the presence of IL-1 plus H2O2 (Fig 
5.3B).  There was a rapid (30mins) decrease in DNA methylation at the ATG start site in 
response to 5-Aza in the presence and absence of IL-1 + H2O2 (Fig 5.4B). This effect was 
reduced over time and no clear effect was seen at 4hrs. In contrast, there was no clear effect 
pattern of methylation changes seen at the B3 site in response to 5-Aza. Further 
experimentation are needed to confirm these results. 
The apparent discrepancy between the data sets for the B3 site in the experiments 
shown in Fig 5.4A and B (the ratio between 5-Aza and control sample is lower in B than in 
A) may be due to the solvent used for 5-Aza. DMSO has been reported to upregulate CpG 
island methylation (Iwatani et al., 2006). Further experimentations will be required to resolve 
this. 
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Figure 5.4 IL-1β and hydrogen peroxide (H2O2) upregulate DNA methylation at the 
TGF-β1 promoter. (A) Cells were stimulated with IL-1β (10ng/ml), with or without H2O2 
(200M), for 1 and 4hrs. Genomic DNA was extracted and sonicated to <2000bp.  
Methylated C5 residues were immunoprecipitated with a specific anti-mC5 antibody overnight 
and the immunoprecipitated DNA purified. DNA enrichment was quantified by QPCR with 
primers specific for the B3 site and normalized by input DNA. Results are shown as mean ± 
SEM. N = three independent experiment. *p<0.05, **p< 0.01 compared to unstimulated cells. 
(B) Cells were pretreated with 5-aza-cytidine (5-Aza, 10M) for 1hr and then stimulated with 
IL-1β plus H2O2 for variable time (30mins, 1hr, 2hrs, 4hrs). Genomic DNA was collected and 
sonciated, then immunoprecipitated with antibody specific for mC5. The immunoprecipitated 
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DNA was purified, and quantified by QPCR with primers specific for the B3 and ATG sites. 
Enriched DNA was normalized to input DNA. Results are shown as mean ± SEM. N = two 
independent experiments. 
 
5.3.5 Suv39H1 is associated with DNMT1 
To study whether Suv39H1 has increased recruitment to DNMT1 under oxidative stress, cells 
were pretreated with FP (10-8M), then stimulated with IL-1β, with or without H2O2, or left 
untreated for 1hr. Whole cell proteins were extracted and immunoprecipitated with a specific 
anti-DNMT1 antibody before detection of Suv39H1 by Western blot analysis. The results 
demonstrate that Suv39H1 was recruited to DNMT1 (Fig 5.5), but that this association was 
independent of cell stimulation. The reverse co-IP was also performed. The results also 
indicated that the association of both proteins occurred independent from cell stimulation –
compare Ab control control lanes with basal non-stimulated cells in Fig 5A and 5B.  
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Figure 5.5 Suv39H1 is associated with DNMT1.  Cells were pretreated with or without 
fluticasone propionate (FP, 10-8M) for 30mins and then stimulated with IL-1β (10ng/ml) 
and/or hydrogen peroxide (H2O2, 200M) for 1hr. Total protein was extracted, and the 
associated protein was checked with antibody specific for interested protein. Blots are 
representative of N = 2 independent experiments. 
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5.3.6 NF-B p65 is associated with DNMT1 
To study whether NF-B p65 was recruited to DNMT1 under IL-1β and H2O2 
stimulation a co-immunoprecipitation experiment using whole cell extracts was used and 
demonstrated an increased association of p65 with DNMT1 in H2O2 and IL-1β plus H2O2 
stimulated cells at 60 mins (Fig 5.6, lanes 4 and 5).  The control experiment using 
immunoprecipitation with pre-immune serum showed no association between p65 and 
DNMT1 (Fig 5.6 last lane). These results indicate that DNMT1 is actively associated with 
NF-Bp65 under IL-1β and H2O2 stimulation. 
Pre-treatment of cells with FP (10-8M, 30 mins) attenuated complex formation between 
p65 and DNMT1 induced by combined H2O2 and IL-1 (Fig 5.6, lane 7).  In contrast, FP 
alone had no effect on basal complex association. Further experiments are required to 
confirm these data with different DNMT1 antibody. 
 
Figure 5.6 NF-B p65 is complexed with DNMT1. Cells were pretreated with 
fluticasone propionate (FP, 10-8M) for 30min and then stimulated with IL-1β (10ng/ml), with 
or without H2O2 (200M), or left untreated for 1h. DNMT1 protein was immunoprecipitated 
with a specific anti-DNMT1 antibody and the associated NF-B p65 detected by Western 
blotting. Results are representative of N = 2 independent experiments showing a similar 
trend.  
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5.3.7 DNMT1 is recruited to the TGF-1 promoter under oxidative stress conditions 
Analysis of the TGF-β1 promoter had previously revealed consensus NF-B binding sites of 
which B3 was associated with p65 DNA binding to the native promoter (Fig 5.7A). We 
therefore examined whether DNMT1 is recruited to NF-B binding sites in the TGF-β1 
promoter area using ChIP assays. DNMT1 was recruited to B3 site in a time-dependent 
manner with a significant effect seen at 30mins with IL-1 only (Fig 5.7B). Association of 
DNMT1 with the B3 site was not affected by H2O2 or IL-1 + H2O2 at any time point 
studied (Fig 5.7B).  These results demonstrate that DNMT1 is recruited to the TGF-β1 
promoter possibly by tethering to NF-B.  Further experiments looking at recruitment to the 
ATG start site may reveal distinct patterns. 
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Figure 5.7 Effect of IL-1β and hydrogen peroxide (H2O2) on DNMT1 recruitment to 
TGF-β1 promoter. (A) Schematic diagram of the TGF-β1 promoter. The numbers indicate 
positions in relation to the translation start site (ATG). Consensus NF-B binding sites 
including the B3 site are indicated. (B) Cells were pretreated with IL-1β (10ng/ml), with or 
without H2O2 (200M), for various times (0, 30mins, 1hr & 2hrs). DNMT1 recruitment was 
determined by ChIP assay and the associated DNA quantified by quantitative RT-QPCR with 
primer pairs specific for the putative B3 site. The values were normalized to input DNA. 
Results are mean ± the SEM of ratio to basal levels. * denotes P<0.05 versus basal level 
(same time point). n = three independent experiments. 
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5.4 Discussion 
The present study examined the effect of oxidative stress and IL-1 on the methylation 
status at a CpG island and at the ATG start site in the native TGF-β1 promoter.  The DNMT 
inhibitor 5-Aza further enhanced IL-1β and H2O2 upregulation of TGF-β1 mRNA which 
suggests that DNA methylation plays a role in the regulation of TGF-β1 mRNA expression. 
5-Aza is classically thought to act in a delayed manner by intercalating into newly 
synthesisied DNA (Christman, 2002; Palii et al., 2008) but this is unlikely to be the case in 
these experiments as the cells are not proliferating and the time-course of the effect is too 
rapid. It is possible that 5-Aza blocks the actions of DNMTs by sitting in the active site of the 
enzyme. 
Direct sequencing of genomic DNA after bisulphite treatment enabled us to examine 
DNA methylation at the ATG transcriptional start site but not at the CpG Island associated 
with the B3 site.  The later was due to technical reasons due to the very high methylation 
status around the B3 binding site and a subsequent failure to obtain primers that could 
produce an effective sequence read.  Direct sequencing in future may provide a better way of 
analysing this region of the TGF-1 promoter. We observed a rapid (60 mins) induction of C5 
methylation at the ATG start site with both IL-1 and H2O2 and a restoration of the basal 
demethylated status at 120 mins with IL-1. 
We also performed MeDIP analysis to confirm the DNA sequencing data. The results 
demonstrated that CpG island methylation at the B3 site was enhanced at 4h, but not at 1h, 
after stimulation with IL-1β and H2O2. We have also tried to use 5-Aza to inhibit DNMT 
function, but the ratio between 5-Aza and control sample was lower than with our previous 
results. The solvent, DMSO, which was used to dissolve 5-Aza has been reported to increase 
CpG island methylation (Iwatani et al., 2006). This may explain the disparity between the 
results as a trend for upregulated CpG island methylation was seen in our initial experiment. 
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It will be important to measure the effects of 5-Aza on the mC5 status throughout the TGF-1 
promoter. 
This data raises several issues relating to the site of cytosine methylation and the rapid 
demethylation of the ATG start site that occurs between 0 and 60 mins.  DNA methylation is 
considered a stable epigenetic mark that is heritable but there is now clear evidence that DNA 
methylation marks can be removed although this process is not well understood (Gehring et 
al., 2009). Methylation can be lost passively through a failure to maintain methylation status 
following DNA replication or via a more active process whereby mC5 is enzymatically 
removed (Gehring et al., 2009). This process is clearly occurring in the context of our 
experiments looking at the TGF-1 promoter. In plants, this process is driven by DNA 
glycosylases which are normally associated with DNA repair but there are no mammalian 
homologues for these enzymes (Gehring et al., 2009).  Alternative methods of causing active 
DNA demethylation have also been proposed utilising active transcriptional processes and 
histone acetylation (D'Alessio et al., 2007) and the methyl-CpG binding domain protein 
MBD3 (Brown et al., 2008).  However, it is becoming evident that active DNA demethylation 
in vertebrates can be mediated through other DNA excision repair enzymatic machineries that 
promote coupling of deamination, base and nucleotide-excision repair in the process of DNA 
demethylation (Ma et al., 2009). What the mechanism is for targeting the rapid DNA 
demethylation seen at the ATG but not the B3 site would be interesting to investigate 
further. Whether these changes occur at other gene start sites or elsewhere in the genome and 
if the acute response is altered with chronic exposure to ROS is also important to investigate. 
    Analysis of 8-OH-dG presence in the TGF-1 promoter may reveal a potential mechanism 
that could affect DNMT1 DNA binding and subsequent recruitment of MeCP2 (Turk et al., 
1995; Valinluck et al., 2004).  These are both valid areas of future research particularly as 8-
OH-dG provides a link to DNA excision repair processes (Jackson and Bartek, 2009) that 
have been implicated in DNA demthylation events (Gehring et al., 2009) and see below). 
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    For many years it has been assumed that changes in DNA methylation occur in CpG 
islands but this concept has recently been challenged, at least in cancer.  Recent evidence 
from Fienberg and colleagues (Irizarry et al., 2009) has reported that most methylation 
changes in colon cancer do not occur at CpG Islands, or even in promoters, but can occur in 
sequences up to 2 kb distant from CpG Islands at regions termed 'CpG island shores'. This 
group strongly correlated CpG island shore methylation with gene expression.  Subsequently, 
several other studies have also reported that non-CpG DNA methylation is associated with 
changes in gene expression and cell function.  Dlx5 is an important transcription factor that 
regulates runx2 whose expression is a hallmark of osteogenesis. 5-Azacytidine enhanced dlx5 
expression in mesenchymal stem cells and this was associated with reduced hypermethylation 
in the dlx5 promoter "CpG island shore".  In contrast, the dlx5 promoter CpG Island 
remained in a hypomethylated state (Zhou et al., 2009).  In addition, the oestrogen receptor 
(ER)-associated CpG shore ESR1 promoter C, rather than the CpG islands, showed a greater 
variability in methylation status in breast cancer cells and an inverse associations with ER 
and progesterone receptor expression (Gaudet et al., 2009). 
    It will be interesting to perform an extended and more complete time course to examine 
DNA methylation and demethylation at the B3 and ATG sites in response to IL-1, H2O2 
and FP.  Furthermore, when the biochemistry of DNA demethylation is better understood we 
will be better able to investigate this process in relation to the model system used here or 
ideally in primary human airway epithelial cells. 
As a first step to understanding the DNA methylation occurring at the TGF-1 promoter 
we examined whether NF-B p65 was able to recruit DNMT1 to the TGF1 promoter by 
ChIP assay.  Initial experiments indicated that NF-B p65 was able to associate with DNMT1 
and that this complex formation was increased in the presence of oxidative stress. We then 
demonstrated that DNMT1 was recruited to the B3 binding site at 30min and that this 
recruitment was decreased with time. These findings suggest that other DNMTs may also be 
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important in inducing the longer lasting methylation seen with the MeDIP assay. Recruitment 
of other DNMTs to the TGF-1 promoter by NF-B along with a functional analysis of the 
enzymic activity of p65-associated DNMTs under IL-1β and H2O2 stimulation should be 
undertaken.  Intermediate time points between those already studied should also be 
performed. 
Analysis of enzymic activities are particularly important as we were able to demonstrate 
that IL-1β and H2O2 stimulation down-regulated the expression of DNMT1 protein and 
mRNA.  The loss of protein expression was prevented by the proteosome inhibitor MG-132 
implicating a possible role for the various ubiquitin-associated pathways to regulate DNMT1 
expression.  Further investigation of the pathways important in DNMT1 degradation and the 
involvement of other possible post translational modifications of DNMT1 induced by IL-1 
and/or H2O2 may also provide fruitful areas of research. 
We showed that Suv39H1 was associated with DNMT1 and NF-B p65 in unstimulated 
cells by co-immunoprecipitation experiments. However, there were no differences in the 
relative protein amounts following cell stimulation. This surprising result may possibly relate 
to the antibody used to immunoprecipitate the protein i.e. it was not possible to 
immmunoprecipitate one of the proteins as a binding epitope was blocked by the other 
antibody. The other possibility remains that, the amount of DNMT1 protein was 
downregulated by oxidative stress, thus it is not possible to show the difference between 
various stimulations.  It is also possible that an MBP such as MeCP2 could act as an 
intermediate protein.  Determination of a full time-course for these experiments and a 
measure of enzymic activity may resolve these later issues.  The use of tagged proteins and 
subsequent co-immunopreciptation or BRET experiments may also prove informative.  As 
with all these studies translation of these effects into primary cells will ultimately determine 
whether the results reported here may have any clinical relevance. 
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CHAPTER 6 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
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TGF-β1 is a pleotropic cytokine that regulates physiological processes including cell 
proliferation, differentiation, apoptosis, early embryonic development, and extracellular 
matrix process (Gawaziuk et al., 2007; Li et al., 2006b; ten Dijke and Arthur, 2007). It is 
actively involved in pathological changes in airway disease, like COPD (de Boer et al., 
1998), asthma (Redington et al., 1997a) and interstitial lung disease (Khalil et al., 1996). 
Systemic oxidative stress is enhanced in asthma, smoker and COPD patients (Rahman et al., 
1996). H2O2, among one of the key mediator of oxidative stress, is also involved in COPD 
patients (Dekhuijzen et al., 1996) and is associated with asthma severity (HORVATH et al., 
1998). However, there are few studies examining the transcriptional regulation of TGF-β1 
under conditions of oxidative stress. Here, we would like to summarize our novel findings 
concerning the roles of the transcription factor NF-B; histone H3K9 methyltransferase, 
Suv39H1; and DNA methylation over a CpG island and at the ATG start site in the TGF-β1 
promoter on upregulation of TGF-β1 under oxidative stress.  
 
IL-1β and IL-1β plus H2O2 induce TGF-β1 mRNA and protein expression 
Our current findings demonstrate that IL-1β and H2O2, which represent a model of 
inflammation and oxidative stress leading to exaggerated intracellular oxidative stress, can 
upregulate the expression of TGF-β1 mRNA expression, secreted TGF-β1 and intracellular 
TGF-β1 levels in A549 cells. H2O2 alone has minimal effects on the expression of TGF-β1, 
but in combination with IL-1β stimulation, it acts in an additive manner to induce TGF-β1 
mRNA expression. From our results, there was no additive effect on TGF-β1 protein 
production in supernatants by ELISA or of intercellular protein by Western blot.  This may be 
due to the limitation of the need for supernatant acidification in order to measure total TGF-
β1 or as a result of post-translational modification of TGF-β1 under oxidative stress. Similar 
effects on TGF-β1 under IL-1β- and IL-1β plus H2O2-stimulation can also be demonstrated 
on BEAS-2B cells which indicates that this upregulation could be a universal phenomenon.  
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This upregulation of TGF-1 gene expression by IL-1β and H2O2 stimulation could also be 
seen with GMCSF and IL-8 mRNA expression. However, the response to the combination of 
IL-1β and H2O2 is different. A greater than additive effect of the combination of IL-1β plus 
H2O2 can only be identified on GMCSF mRNA expression but not on IL-8 mRNA 
expression. This needs to be confirmed in primary cells. 
 
The involvement of NF-B in TGF-β1 production under IL-1β and IL-1β plus H2O2 
stimulation 
Using the IKK2 inhibitor AS602868 we demonstrated that the upregulation of TGF-β1 
by IL-1β or IL-1β plus H2O2 is predominantly NF-B-dependent.  In contrast, there was a 
much smaller effect seen on TGF-1 by both the JNK inhibitor (SB600125) and the P38 
inhibitor (SB203580). However, induction of TGF-β1 mRNA by H2O2 is not fully inhibited 
by the IKK2 inhibitor indicating that other pathways are likely to be important.  Using 
Western blot analysis we were able to show that NF-B p65 production was also enhanced 
under IL-1β, H2O2 or IL-1β plus H2O2 exposure. 
Using ChIP analysis, we clearly demonstrated that NF-B p65 was recruited to the B3 
site in the TGF-1 promoter upon stimulation with IL-1β and H2O2 and this was associated 
with the enhanced TGF-β1 mRNA expression. There are three possible NF-B binding sites 
on TGF-β1 promoter but only the proximal one, the B3 site, which is 867 bp away from the 
translation start site, is a target for NF-B binding to the native promoter. This was 
demonstrated by both ChIP and in vitro binding assays.  The reason for the selective 
recruitment to the B3 site is currently unclear but may involve sequence-specific changes in 
DNA binding site:NF-B p50 affinity.  Although also seen with in vitro assays where no 
histones are involved there may also be an important role for localised chromatin structure in 
the native promoter. 
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The histone methyltransferase, Suv39H1, involved in GR effect on suppression TGF-β 1 
induced by IL-1β, or IL-1β plus H2O2 
 Our study indicates that the upregulation of TGF-β1 under IL-1β, or IL-1β plus H2O2, 
can be suppressed by FP in a concentration-dependent manner. The effect of oxidative stress 
on enhanced TGF-β1 production induces a rightward shift in the dexamethasone IC50 which 
indicates a relatively steroid resistant model. Current concepts relating to the induction of 
relative dexamethasone resistance under oxidative stress conditions suggest that oxidative 
stress may affect various aspects of the GR activation pathway including nuclear 
translocation (Adcock et al., 2005; Xu and Chu, 2008), altered cross-talk with pathways 
linked to proinflammatory cytokines and intracellular signalling (Adcock et al., 2005) and/or 
reduction in GR-corepressor proteins such as HDAC2 (Ito et al., 2005; Ito et al., 2001). 
In this thesis we were able to demonstrate that GR has an associated HMT activity and 
that this activity can be induced by IL-1β or IL-1β plus H2O2.  In particular, we demonstrated 
that GR is associated with the H3K9 methyltransferase, Suv39H1.  Knockdown of Suv39H1 
expression using siRNA results in the upregulation of TGF-β1 mRNA expression following 
IL-1β and H2O2 stimulation and a reduction in the ability of FP to suppress TGF-β1 mRNA 
expression.  In addition, Suv39H1 knockdown significantly downregulates GR-GRE DNA 
binding, a measure of GR transactivation, following IL-1β and IL-1β plus H2O2 stimulation.  
These findings support the concept that Suv39H1 may act as a corepressor on GR function. 
We also examined the effect of overexpressing Suv39H1 using an overexpression 
plasmid.  Although we induced a significant upregulation of Suv39H1 mRNA and protein 
following transfection of the Suv39H1 overexpression plasmid there were no effects on GR 
associated suppression of TGF-β1 function. This failure to confirm the knockdown data may 
be due to a number of reasons including overwhelming basal histone methylation as a 
consequence of cell activation or an insufficient induction of Suv39H1 expression and 
importantly activity. 
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Fig 6.1 Possible model for H3K9 methyltransferase, Suv39H1 on TGF-β1 gene 
regulation.  Inside the nucleus, Suv39H1 may directly associate with NF-B p65 and after 
stimulation of cells with IL-1β or IL-1β plus H2O2 Suv39H1 is recruited to the B3 site (2) 
and thereby change the local H3K9 trimethylation status.  Dexamethasone stimulation results 
in binding to, and activation of, cytoplasmic glucocorticoid receptors (GRs) in the cytoplasm 
which then translocate into the nucleus.  Within the nucleus Suv39H1 may directly associate 
with GR (3), form part of a complex with GR and NF-B or associates with GR at a GRE (1) 
to inhibit GR-=mediated transactivation. 
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The H3K9 histone methyltransferase G9a, Suv39H2, and the H3K9 demethylase JMJD2C, 
and H3K27 demethylase under IL-1β, and IL-1β plus H2O2 stimulation 
Competition between methyltransferases and demethylases acting at the same histone 
residue may control gene regulation (Kouzarides, 2007; Shi and Whetstine, 2007) . We have 
also examined the expression of two other H3K9 histone methyltransferases, G9a and 
Suv39H2. Suv39H2 is undetected in our cell model, and G9a shows a similar response as 
Suv39H1 being downregulated upon stimulation with IL-1β and H2O2.  
The expression of the H3K9 demethylases JMJD2A and JMJD2C mRNA were also 
checked, and the results demonstrated decreased mRNA expression under IL-1β and IL-1β 
plus H2O2 stimulation. Surprisingly, the H3K27 histone demethylase, JMJD3, exhibits a 
distinct response to IL-1β and H2O2. JMJD3 is reported to be bind to Polycomb group (PcG) 
proteins, and regulates H3K27me3 levels and transcriptional activity (De Santa et al., 2007). 
It can be upregulated by LPS and TNF-α through the effect of NF-B (De Santa et al., 2007). 
Our study demonstrated that upregulation of JMJD3 mRNA expression was seen after IL-1β 
and H2O2 stimulation and that JMJD3 mRNA expression can be downregulate by FP 
treatment.  Since H3K27 trimethylation is also associated with gene repression (Hong et al., 
2007), it is possible that the upregulation of JMJD3 by IL-1β and H2O2 may elicit an H3K27 
response which favours gene expression. The suppressive effect of FP on JMJD3 mRNA 
expression raises the possibility that it may be also play a role in FP gene repressive actions. 
 
CpG island methylation on TGF-β1 promoter induced by IL-1β and H2O2 associates with 
TGF-β1 mRNA expression 
CpG island methylation in promoter area of normal cells is associated with X-
chromosome inactivation (Hansen et al., 1996), control of imprinted genes (Paulsen and 
Ferguson-Smith, 2001) or cell-specific gene expression (Esteller, 2007). Methylation can be 
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lost through the enzymatic removal of mC5 or a failure to maintain methylation status 
following DNA replication (Gehring et al., 2009). 
To investigate CpG island methylation changes at the TGF-β1 promoter, we initially 
performed bisulphite sequencing.  Unfortunately, we are not able to direct sequence the B3 
site directly due to the high CpG percentage around that area and we were notable to design 
specific primer pairs to span that area. Using an alternative method to analysise C5 
methylation, the MeDIP assay, and demonstrated that the mC5 levels increased at the B3 
under with IL-1β, H2O2, and IL-1β plus H2O2 exposure and reached a peak at 4h. Our results 
also demonstrate that DNMT1 directly associates with NF-B, but failed to show a difference 
under different stimulatory conditions. This may be due to problems with the antibody pairs 
used in the experiments and when other antibodies become commercially available these will 
be tested in the model system. The effect on DNMT1 activity associated with p65 under 
various stimulations should also be investigated as it ispossible that although p65:DNMT1 
association doesn’t change there may be a change in enzymic activity associated with the 
complex following ROS stress. Overall, we postulate that DNA methyltransferases are 
potentially involved in methylation at the B3-associated CpG island in the TGF-1 
promoter, that these events can be upregulated under oxidative stress and that this results in 
the modulation of gene expression.   
The rapid changes in DNA demethylation are interesting. Our preliminary results 
demonstrated that IL-1β and H2O2 stimulation can induce rapid induction of methylation 
change around ATG translation start site area around 1h and that the demethylated state was 
restored back to normal after 2h. This data suggests that there possibly is a short-term site 
specific demethylation event occurring at the TGF-1 start site between 60 and 120 minutes 
post IL-1 stimulation. It will be important to investigate whether this has any functional 
effect on TGF-1 expression and whether the changes are more permanent under chronic 
ROS stimulation.   
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Epidemiological studies have indicated that exposure to traffic pollution or cigarette 
smoke can have a marked effect on the profile of promoter methylation with specific gene 
hypermethylation e.g. tumour suppressors and global hypomethylation ((Baccarelli et al., 
2009; Breton et al., 2009)).  Experiments to examine the effect of cigarette smoke or diesel 
particles/PM10s on the rapid changes seen here may indicate a mechanism underlying the 
epidemiological data. 
 
Interplay between histone methylation and DNA methylation on TGF-β1 promoter 
Since histone methyltransferase Suv39H1 (Fuks et al., 2003a) or G9a (Estève et al., 
2006) also directs associates with DNA methyltransferase, it would be interesting to see if 
histone modifications may act alone or in combinations with DNA methylation to initiate or 
gene transcription. 
Using co-immunoprecipitations, we are able to demonstrate that DNMT1 is associated 
with Suv39H1 but we unable to show differential recruitment with the various stimulations.  
This may reflect the problems with the antibody pairs as discussed previously. In ChIP 
experiments, DNMT1 was recruited to the B3 site by IL-1β after 30min. We were not able 
to show differences, however, with H2O2, or IL-1β plus H2O2 stimulation.  Further 
experiments with different antibody pairs may resolve whether this is a result of a decrease in 
total DNMT1 protein as we demonstrated with H2O2 or if there was a change in recruited 
DNMT1 activity associated with Suv39H1.    
 Our results show that both IL-1β and H2O2 decreased H3K9 trimethylation at 1h and 
that this is linked temporally to the changes in DNA methylation that we have also seen.  
Further analysis of the time-courses of these events may provide a better indication as to the 
linkage between the two events at the TGF-1 promoter.  By ChIP analysis, Suv39H1 was 
seen to be recruited to the B3 binding site in the TGF-1 promoter at 1h presumably whilst 
complexed with NF-B. Knockdown of Suv39H1 expression with siRNA resulted in 
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enhanced TGF-β1 mRNA expression and reduced FP responsiveness. A similar effect was 
seen with GM-CSF and ideally a combination of ChIP-seq and gene arrays may also give a 
clearer idea as to the generality of the effects described here under Suv39H1 control.  Indeed, 
Suv39H1 and GR were shown to be part of the same complex which also modulated GR-
GRE DNA binding.  Further temporal analysis of p65, GR and Suv39H1 recruitment to the 
native TGF-1 promoter B3 site would be important to perform in future studies along with 
a comparison of GR/Suv39H1 recruitment to a native GRE using re-ChIP experiments. 
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Future directions 
Currently, due to time limitations, there are some experiments which have been 
performed only once or twice or require further optimisation. It will be important to increase 
the n number of certain experiments to validate the initial results and enable valid statistical 
analysis. 
Throughout the whole study our model has focussed on an alveolar type II cell line - 
A549 cells. The finding of upregulation of TGF-β1 upon stimulation with IL-1β and H2O2 
was also shown in another epithelial cell line, BEAS-2B cells, which may suggest that this 
regulation is a universal phenomenon in epithelial cells. But ideally these findings need to be 
repeated in primary cells and in cells from patients with disease e.g. severe asthma or COPD. 
Analysis of differences in H3K9 methylation status and the expression of HMT e.g. Suv39H1 
and HDMs such as JMJD2 in primary cells frompatients with asthma, particularly severe 
asthma, or COPD should be investigated. 
Furthermore, we would examine in greater biochemical detail the links between histone 
and DNA methylation and how this is modulated by oxidative stress. A more stringent 
analysis of DNA methylation across the TGF-1 promoter over time along with 
determination of the mechanism of active DNA demethylation would greatly enhance this 
area. An extensive Western blot-co-immunoprecipitation or LC-MS/MS analysis of protein-
protein interactions linked to analysis of enzyme activity could also be undertaken to examine 
the time-course of complex formation.  In order to determine whether the various changes in 
DNA methylation, histone methylation and/or acetylation are co-ordinated, knockdown of 
DNMT1 for example may be examined for its ability to affect the ability of IL-1 and/or 
H2O2 to modulate histone methylation and acetylation.  Similar experiments could be 
conducted in the presence of FP to examine whether there is an essential early ‘hit’ for GR 
function. Additionally, the balance between HMTs and HDMs can also be studied to 
understand its role under oxidative stress (Shi, 2007). 
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In addition to histone modifications, ATP requiring histone remodelling complex 
members such as Brg-1 (Bilodeau et al., 2006) could be assessed as potential targets for GR 
function in these cells. Furthermore, we can also use Luciferase reporter assays to study GR 
function. Our results also indicate that the H3K27 demethylase, JMJD3, is possibly involved 
in IL-1β- and H2O2-induced inflammation. JMJD3 may also be involved in GR actions in 
suppressing inflammation. Further investigation to study the role of JMJD3 with ChIP for 
study for timely recruitment to NF-B binding site, and its association with GR, would be 
interesting to delineate the function of this demethylase. 
Our results also demonstrate that, GR, Suv39H1, and NF-B are recruited to B3 site at 
similar time point (1hr). Co-immunoprecipitation can show the spatial protein-protein 
relationship under stimulation, but it is not able to show the functional importance regarding 
the recruitment to binding site on promoter area. It will be better to do sequential ChIP study, 
to check the co-occupancy of transcriptional factor binding site, which can elicit the 
upregulation or downregulation of specified gene response. 
We have demonstrated that DNMT1 is actively recruited to the B3 site by ChIP 
analysis. Recently, other related DNA methytransferase, such as DNMT3b, and methyl-group 
binding proteins (MBD), in addition to DNMT1, also involved hormone-induced 
transcriptional derepression (Kim et al., 2009). It would be interesting to study broadly these 
other DNA methyltransferases under IL-1β, and IL-1β plus H2O2 stimulation. 
We had problems with the specificity and selectively of some of the antibodies used. 
This lack of useful commercial tools has restricted much of the work in the epigenetics field 
although the production of selective high affinity antibodies produced by phage display by 
the Structural Genomics Consortia (SGC) based in Oxford, Toronto and Stockholm may 
resolve this problem.  Until these tools become available in an open-access manner, 
alternative approaches to study protein-protein interactions are needed.  We can design 
overexpression plasmids with different tags for proteins of interest in order to show protein-
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protein interactions either by immunoprecipitation or by BRET analysis. In addition, deletion 
mutants may reveal interaction sites in vitro between the various proteins of interest.  
Alternatively, protein-protein interactions between NF-B p65 and DNMTs and HMTs may 
be investigated using LC-MS/MS analysis. 
It will also be important to determine the effect of oxidative stress on DNA and histone 
methylation status in a more global manner.  Linking global analysis of DNA methylation and 
H3K9 methylation status as measured by ChIP-seq with transcriptomic and/or proteomic 
arrays will allow a better picture of the potential functional consequences of oxidative stress 
on inflammatory gene expression and the possible involvement of methylation changes. 
Since the changes in H3K9 methylation shown here occur prior to changes in AcH3 And 
AcH4 (Lee et al., 2006), it would be interesting to determine whether these methylation and 
acetylation marks were linked by examining whether Suv39H1 siRNA affected changes in 
histone acetylation status. In addition, it is unclear exactly how an inflammatory stimulus or 
an oxidative stress can target Suv39H1 association with p65 and/or GR. Data from our group 
has examined this in part for the recruitment of HDAC2 to p65 and GR as demonstrated that 
specific post-translational modifications were important (Ito et al., 2006b). Similar studies 
may reveal the same process occurring for Suv39H1. 
 
Possible therapeutic opportunities for novel drugs that alter histone or DNA 
modifications 
Current evidence supports that changes in histone methylation, through the recruitment 
of methyl-binding proteins and adaptor proteins, are linked to the changes in DNA 
methylation (Fuks, 2005). These epigenetic changes help to keep genes in a repressed status. 
Recent advances have connected DNA methylation to chromatin-remodelling enzymes, and 
understanding this link will be central to the design of new therapeutic drugs.  
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A growing number of human diseases have been found to be associated with aberrant 
DNA methylation, and histone modifications. For example, evidence supports that mutation 
in methyl-CpG binding protein 2 (MeCP2) have been linked to the human mental retardation 
disorder Rett syndrome (Fan and Hutnick, 2005), and various changes in DNA methylation 
are associated with human neurodevelopmental syndromes and development (Okano et al., 
1999; Robertson, 2005; Robertson and Wolffe, 2000). These links between disease and 
epigenetics changes confirm the changes are epigenetics through drug modification possible 
have its role in diease treatment. 
To study the possible therapeutic opportunities for the development of novel drugs, we 
may need to use the in vitro model cell line system first to test the optimal dosing, and 
interval of treatment to obtain the desired result of the novel drugs. For example, if the novel 
drugs exhibit the effects on the DNA CpG island methylation, we may focus on interested 
promoter area which are disease relevant and do methylation specific PCR after Bisulfite 
treatment, or methylation dependent immunoprecipitation assay using antibodies which are 
5MeC or MeCP2 specific to study the methylation changes after the specific drug. A global 
study of methylation changes can also be performed after immunoprecipitation of the DNA 
first with 5MeC antibody or MeCP2 antiobody followed by DNA microarrays to analyze the 
protomoter area of interested genes. If the drug has its effect on histone methylation, we may 
test the effect of global histone methylation changes with western blot study, or further using 
Chromatin immunoprecipitation study to confirm the specific changes on promoter area. 
 After the in vitro results are available, it will be interesting to test the effect of the novel 
drugs with the in vivo model. Using the in vivo model, we may further test the effect of the 
novel drugs on epigenetic changes wheter based on DNA CpG island methylation or histone 
methylation changes depends on its presumed effects. First, we may investigate effects of the 
drugs on bone marrow cells, or peripheral blood monocytes with the aforementioned methods 
to detect the changes on histone methylation or DNA methylation, and further effects or gene 
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activation/inactivation using different dosing and timing of treatment. Furthermore, we may 
use other drugs which are already proved to have different effect on the epigenetic gene 
silencing, and possibly to have the synchorized effect with the novel drug, to investigate 
whether this combination is able to reverse or enhance the gene activation or inactivation 
status. We may go further to check the effects of the novel drugs based on the established 
disease model on animals. For example, we may use the ovalbumin-induced airway 
hyperresponsiveness model to check if these novel drugs have effects on the progression of 
asthma change. 
 Recently, the combined DNA methyltransferase and histone deacetylase inhibition has 
been shown to have the clinical response in the myeloid neoplasms (Gore et al., 2006). Huang 
et al. also described the novel oligoamine analogues which inhibits LSD1 could induce 
reexpansion of epigenetically scilenced genes (Huang et al., 2009). These firm evidences 
suggest that, drugs which modulate the epigenetics changes may possibly play a role in 
controlling disease progression. Aggressively investigation of the drugs with the well 
established models will offer the opportunity to find the novel drugs which possess the effects 
on epigenetic modification for therapeutic purpose.  
 
STATEMENT OF ORIGINALITY 
I confirm that these experiments and experimental protocols were designed and carried out by 
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